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Adenotonsillectomy	  is	  currently	  indicated	  as	  a	  treatment	  for	  sleep-­‐related	  breathing	  
disorders	  in	  children	  because	  removal	  of	  the	  tonsils	  opens	  up	  the	  airway	  and	  lowers	  airway	  
resistance	  to	  breathing.	  Overnight	  pulse	  oximetry	  and	  polysomnography	  are	  two	  common	  
investigations	  used	  to	  diagnose	  sleep-­‐related	  breathing	  disorders,	  but	  these	  are	  overnight	  
and	  time-­‐consuming	  procedures.	  This	  thesis	  proposes	  that	  a	  simple	  non-­‐invasive	  
measurement	  of	  peak	  inspiratory	  flow	  rates	  may	  help	  in	  decision-­‐making	  towards	  patient	  
selection	  for	  surgical	  treatment	  of	  sleep-­‐related	  breathing	  disorders.	  Since	  the	  upper	  airway	  
cause	  of	  any	  sleep-­‐related	  breathing	  disorder	  is	  believed	  to	  be	  obstruction	  of	  oral	  and	  nasal	  
airways	  due	  to	  enlarged	  tonsils	  or	  adenoids,	  it	  seems	  reasonable	  that	  patient	  selection	  for	  
surgery	  could	  be	  better	  managed	  by	  simple	  measurements	  of	  the	  severity	  of	  airway	  
obstruction	  rather	  than	  the	  consequences	  of	  this	  obstruction	  as	  determined	  by	  overnight	  
studies	  
	  
This	  thesis	  investigates	  the	  severity	  of	  upper	  airway	  obstruction	  in	  patients	  undergoing	  
tonsillectomy	  +/-­‐	  adenoidectomy	  by	  measuring	  peak	  nasal	  and	  oral	  inspiratory	  airflow	  (PNIF,	  
POIF).	  The	  study	  was	  conducted	  in	  two	  phases:	  	  the	  first	  phase	  on	  the	  day	  of	  surgery	  and	  the	  
second	  phase	  approximately	  one	  month	  after	  surgery.	  Fifty	  subjects	  were	  recruited	  for	  the	  
first	  phase	  of	  the	  study	  from	  a	  cohort	  of	  patients	  on	  the	  waiting	  list	  for	  tonsillectomy	  with	  or	  
without	  	  adenoidectomy	  at	  University	  Hospital	  Wales.	  Twenty-­‐five	  of	  these	  subjects	  were	  
followed	  up	  in	  the	  second	  phase	  of	  the	  study	  at	  the	  Common	  Cold	  Centre.	  All	  the	  subjects	  





This	  study	  demonstrated	  that	  a	  simple	  non-­‐invasive	  inspiratory	  flow	  meter	  could	  be	  used	  to	  
measure	  both	  POIF	  and	  PNIF.	  Postoperative	  POIF	  and	  PNIF	  had	  increased	  compared	  to	  the	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  1.1	  Epidemiology	  of	  Sleep-­‐Related	  Breathing	  Disorders	  (SRBD)	  
	  
The	  change	  in	  trends	  for	  the	  indication	  of	  adenotonsillectomy	  from	  infections	  to	  obstructive	  
symptoms	  suggests	  that	  the	  prevalence	  of	  sleep-­‐related	  breathing	  disorders	  (SRBD)	  is	  either	  
increasing	  or	  being	  more	  frequently	  diagnosed.	  A	  review	  of	  the	  literature	  gives	  an	  estimated	  
prevalence	  rate	  of	  SRBD	  between	  0.7	  %	  and	  13%	  (Bixler	  et	  al.,	  2009).	  The	  prevalence	  of	  
SRBD	  varies	  widely	  depending	  on	  the	  demographics	  of	  the	  population	  studied,	  definitions	  of	  
the	  disorder	  and	  the	  method	  of	  diagnosis.	  A	  review	  of	  the	  literature	  revealed	  a	  multitude	  of	  
diagnostic	  methods	  used	  to	  diagnose	  SRBD,	  from	  clinical	  suspicion	  and	  questionnaires	  to	  
pulse	  oximetry	  and	  the	  standard	  Polysomnography.	  As	  SRBD	  is	  a	  continuum	  from	  simple	  
snoring	  to	  upper	  airway	  resistance	  syndrome	  (UARS)	  to	  full	  blown	  obstructive	  sleep	  apnoea	  
syndrome,	  this	  prevalence	  is	  for	  the	  whole	  spectrum	  of	  SRBD	  rather	  than	  an	  individual	  
component.	  
	  
A	  cross-­‐sectional	  study	  of	  346	  patients	  aged	  between	  two	  and	  six	  years	  attending	  a	  well	  
baby	  clinic	  in	  Brooklyn,	  using	  the	  Paediatric	  Sleep	  Questionnaire	  (PSQ),	  reported	  a	  
prevalence	  of	  snoring	  of	  13.9%	  and	  SRDB	  of	  9.4%	  (Goldstein	  et	  al.,	  2005).	  The	  prevalence	  of	  
snoring	  for	  black	  children	  was	  2.5	  as	  great	  as	  that	  for	  white	  children,	  and	  for	  Hispanic	  
children	  it	  was	  2.3	  as	  great	  as	  that	  for	  white	  children	  (p	  =	  0.031).	  This	  study	  suggests	  that	  
prevalence	  of	  SRBD	  is	  multifactorial	  and	  it	  is	  more	  common	  in	  black	  and	  Hispanic	  races	  than	  
in	  Caucasians.	  Kohler	  et	  al.	  have	  reviewed	  27studies,	  examining	  a	  total	  of	  5588	  children	  
(1615	  obese).	  On	  examining	  these	  studies,	  around	  half	  report	  a	  significant	  relationship	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between	  obesity	  and	  SRDB	  (Kohler	  et	  al.,	  2008).	  	  
	  
The	  prevalence	  of	  SRBD	  was	  assessed	  by	  Bixler	  and	  colleagues	  via	  a	  random	  sample	  survey	  
of	  elementary	  school	  pupils	  (Bixler	  et	  al.,	  2009).	  This	  study	  was	  conducted	  in	  two	  phases:	  
the	  first	  phase	  (N=5740)	  included	  a	  sleep-­‐related	  brief	  questionnaire	  and	  the	  second	  phase	  
was	  on	  randomly	  selected	  children	  (N=700)	  who	  underwent	  overnight	  polysomnography.	  
This	  study	  concluded	  that	  the	  prevalence	  of	  Apnoea	  Hypopnea	  index	  (AHI)	  ≥	  5	  was	  1.2%	  in	  a	  
representative	  sample	  of	  elementary	  school	  children.	  Risk	  factors	  for	  SRDB	  included	  waist	  
circumference,	  nasal	  abnormalities	  (e.g.,	  chronic	  sinusitis/rhinitis)	  and	  ethnic	  minority.	  The	  
authors	  also	  concluded	  that	  a	  strong	  linear	  relationship	  exists	  between	  waist	  circumference	  
and	  BMI	  across	  all	  degrees	  of	  severity	  of	  SRDB	  and	  metabolic	  factors	  may	  be	  among	  the	  
most	  important	  risk	  factors	  for	  SRDB	  in	  children.	  
	  
Goodwin	  et	  al.	  (2010)	  assessed	  the	  incidence	  and	  remission	  of	  SRBD	  in	  children	  aged	  6	  to	  17.	  
This	  cross-­‐sectional	  study	  involved	  screening	  7055	  children	  with	  sleep-­‐related	  
questionnaires,	  of	  whom	  319	  children	  completed	  two	  home	  polysomnograms	  
approximately	  five	  years	  apart.	  Body	  mass	  index	  percentiles	  were	  also	  calculated	  with	  
childhood	  growth	  charts	  from	  the	  Centers	  for	  Disease	  Control	  and	  Prevention,	  adjusted	  for	  
sex	  and	  age.	  The	  mean	  age	  at	  assessment	  was	  8.5	  years	  at	  baseline	  and	  13.7	  years	  at	  follow-­‐
up,	  respectively.	  Incident	  SRDB	  was	  more	  common	  in	  boys	  (odds	  ratio	  [OR]	  =	  3.93,	  P	  =	  .008).	  
Children	  with	  prevalent	  SRDB	  were	  more	  likely	  to	  be	  boys	  (OR	  =	  2.48,	  P	  =	  .006)	  and	  had	  a	  
greater	  increase	  in	  body	  mass	  index	  percentile	  change	  (OR	  1.01,	  P	  =	  .034).	  Children	  with	  
prevalent	  SRDB	  also	  had	  3.41	  greater	  odds	  for	  development	  of	  obesity	  from	  baseline	  to	  
follow-­‐up.	  This	  study	  concluded	  that	  adolescent	  boys	  are	  more	  likely	  to	  have	  persistent	  and	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incident	  SRDB	  than	  girls.	  Children	  with	  prevalent	  SRDB	  are	  more	  likely	  to	  develop	  obesity.	  
	  
Hultcrantz	  et	  al.	  (1995)	  assessed	  the	  incidence	  of	  SRBD	  in	  a	  cohort	  of	  five	  hundred	  four-­‐year-­‐
old	  children	  having	  their	  annual	  health	  check	  in	  Sweden.	  Parents	  were	  asked	  to	  fill	  in	  a	  
questionnaire	  detailing	  their	  child's	  snoring,	  sleep	  apnoea,	  sucking	  habits	  and	  infections.	  
Children	  with	  a	  history	  of	  snoring	  were	  further	  evaluated	  by	  sleep	  study,	  lateral	  
cephalogram	  and	  dental	  casts.	  This	  study	  suggested	  that	  6.2%	  snore	  every	  night	  by	  age	  four	  
and	  another	  18%	  when	  infected.	  Tonsillar	  infection	  is	  three	  times	  more	  common	  in	  the	  
snorers	  and	  twice	  as	  many	  of	  their	  parents	  have	  undergone	  adenoidectomy	  ±	  tonsillectomy.	  
The	  dental	  casts	  show	  a	  significant	  difference	  in	  width	  of	  the	  maxilla	  and	  length	  of	  the	  
mandible.	  
	  
Anuntasree	  et	  al.	  (2001)	  studied	  the	  prevalence	  of	  habitual	  snoring	  and	  its	  associations	  with	  
tonsillar	  size,	  allergic	  rhinitis,	  obesity	  and	  parental	  smoking,	  as	  well	  as	  the	  prevalence	  of	  
obstructive	  sleep	  apnoea	  (OSAS),	  in	  a	  sample	  of	  1008	  children	  aged	  six	  to	  thirteen	  years	  
from	  seven	  randomly	  selected	  schools	  in	  Southern	  Thailand.	  8.5%	  of	  the	  children	  were	  
habitual	  snorers	  and	  the	  prevalence	  was	  same	  in	  boys	  and	  girls.	  Significant	  and	  independent	  
association	  was	  present	  between	  snoring	  and	  allergic	  rhinitis,	  with	  an	  odds	  ratio	  of	  5.27.	  The	  
odds	  ratio	  was	  significantly	  increased	  to	  2.65,	  5.72	  and	  11.06	  in	  children	  with	  tonsillar	  size	  of	  
2+,	  3+,	  and	  4+,	  respectively.	  This	  study	  concluded	  that	  the	  prevalence	  of	  OSAS	  among	  Thai	  
schoolchildren	  was	  7/1008	  (0.69%).	  An	  association	  of	  snoring	  with	  tonsillar	  size	  and	  allergic	  
rhinitis	  was	  demonstrated.	  
	  
Brunetti	  et	  al.	  (2010)	  assessed	  the	  prevalence	  of	  sleep-­‐related	  breathing	  disturbances	  in	  a	  
14 
 
large	  cohort	  of	  school-­‐aged	  and	  preschool-­‐aged	  children	  in	  Southern	  Italy.	  This	  study	  was	  
conducted	  in	  two	  phases:	  the	  first	  phase	  was	  a	  screening	  phase,	  which	  aimed	  to	  identify	  
symptomatic	  children	  from	  a	  cohort	  of	  1207	  via	  a	  self-­‐administered	  questionnaire,	  and	  the	  
second	  was	  an	  instrumental	  phase	  for	  the	  definition	  of	  sleep	  related	  breathing	  disorders.	  In	  
total,	  1207	  children	  were	  screened	  via	  a	  self-­‐administered	  questionnaire	  and	  were	  classified	  
into	  three	  groups	  based	  on	  their	  answers	  as	  non-­‐snorers,	  occasional	  snorers	  or	  habitual	  
snorers.	  All	  habitual	  snoring	  children	  underwent	  a	  polysomnographic	  home	  evaluation,	  and	  
those	  with	  an	  oxygen	  desaturation	  index>	  2	  were	  considered	  for	  nocturnal	  polygraphic	  
monitoring	  (NPM).	  Children	  with	  an	  apnoea/hypopnoea	  index	  >	  3	  received	  a	  diagnosis	  of	  
obstructive	  sleep	  apnoea	  syndrome	  (OSAS).	  This	  study	  demonstrated	  that	  the	  prevalence	  of	  
snoring	  in	  this	  cohort	  was	  4.9%	  and	  OSAS	  was	  1.8%.	  
	  
Gislason	  and	  Benediktsdottir	  (1995)	  conducted	  a	  cross-­‐sectional	  epidemiologic	  study	  on	  555	  
children	  aged	  between	  six	  months	  and	  six	  years	  in	  a	  small	  town	  in	  Iceland.	  This	  study	  was	  
conducted	  in	  two	  stages:	  first	  by	  questionnaires	  and	  second	  by	  overnight	  investigation	  of	  
children	  symptomatic	  of	  sleep	  apnoea	  syndrome.	  Snoring	  was	  reported	  as	  occurring	  ‘often’	  
or	  ‘very	  often’	  among	  fourteen	  children	  (3.2%)	  and	  ‘occasionally’	  in	  seventy-­‐three	  (16.7%).	  
Apnoeic	  episodes	  were	  observed	  in	  seven	  children	  (1.6%).	  Kaditis	  and	  colleagues	  (2004)	  
studied	  the	  prevalence	  and	  clinical	  factors	  associated	  with	  sleep-­‐disordered	  breathing	  in	  
3680	  children	  and	  adolescents	  attending	  schools	  in	  central	  Greece,	  who	  were	  surveyed	  
using	  questionnaires	  distributed	  to	  parents.	  They	  found	  a	  similar	  prevalence	  of	  habitual	  
snoring	  (present	  every	  night)	  among	  three	  different	  age	  groups	  (5.3%,	  4%,	  and	  3.8%	  in	  1–6,	  
7–12,	  and	  13–18	  year-­‐old	  subjects).	  Seventy	  randomly	  selected	  subjects	  among	  307	  snorers	  
without	  adenoidectomy	  and/or	  tonsillectomy	  underwent	  polysomnography.	  The	  estimated	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frequency	  of	  obstructive	  sleep	  apnoea-­‐hypopnoea	  among	  children	  without	  adenoidectomy	  
and/or	  tonsillectomy	  was	  4.3%.	  Factors	  associated	  with	  snoring	  were:	  male	  gender	  (odds	  
ratio	  1.5	  [	  1.2–1.9]);	  chronic	  rhinitis	  (2.1	  [1.6–2.7]);	  snoring	  in	  father	  (1.5	  [1.2–1.9]),	  mother	  
(1.5	  [1.1–2.0]),	  or	  siblings	  (1.7	  [1.2–2.4]);	  adenoidectomy	  in	  mother	  (1.5	  [1.0–2.2]);	  and	  
passive	  smoking	  (1.4	  [1.1–1.8].	  	  
	  
From	  this	  review	  of	  the	  literature,	  it	  is	  clearly	  evident	  that	  the	  prevalence	  of	  SRBD	  is	  
multifactorial.	  The	  prevalence	  is	  more	  common	  in	  boys	  and	  has	  a	  strong	  predilection	  in	  the	  
Black	  and	  Hispanic	  race	  compared	  to	  Caucasians.	  High	  BMI	  has	  a	  linear	  relation	  with	  the	  
severity	  of	  SRBD;	  similarly,	  the	  width	  of	  the	  maxilla	  and	  the	  length	  of	  the	  mandible	  also	  
determine	  the	  severity	  of	  SRBD.	  The	  size	  of	  the	  tonsil	  may	  be	  the	  single	  strongest	  predicting	  
factor	  to	  determine	  the	  severity	  of	  SRBD.	  There	  is	  a	  strong	  association	  between	  SRBD	  and	  
chronic	  rhinitis,	  family	  history	  of	  snoring	  and	  exposure	  to	  cigarette	  smoke.	  Table	  1	  
summarises	  the	  prevalence	  of	  SRBD	  from	  the	  literature.	  
	  
	  





















































































































































































































































































































































































































































































































































































1.2.	  Aetiology	  and	  pathogenesis	  
Before	  discussing	  in	  detail	  the	  aetiology	  and	  pathogenesis	  of	  SRBD,	  it	  would	  be	  prudent	  to	  
understand	  the	  sleep	  mechanism,	  as	  the	  entity	  SRBD	  involves	  breathing	  disorder	  occurring	  
during	  sleep.	  	  
	  
1.2.1	  Sleep	  Physiology	  
According	  to	  the	  Macmillan	  Dictionary	  for	  Students,	  sleep	  is	  defined	  as	  a	  naturally	  recurring	  
state	  characterized	  by	  reduced	  or	  absent	  consciousness,	  relatively	  suspended	  sensory	  
activity	  and	  inactivity	  of	  nearly	  all	  voluntary	  muscles.	  In	  mammals	  and	  birds,	  sleep	  is	  divided	  
into	  two	  broad	  types:	  rapid	  eye	  movement	  (REM)	  and	  non-­‐rapid	  eye	  movement	  (NREM).	  A	  
newborn	  infant	  spends	  about	  sixteen	  to	  eighteen	  hours	  asleep	  in	  a	  day,	  60%	  of	  which	  is	  
REM.	  This	  decreases	  to	  twelve	  to	  fifteen	  hours	  at	  one	  year	  and	  they	  spend	  about	  30%	  of	  
total	  sleep	  time	  in	  the	  REM	  stage.	  The	  function	  of	  the	  different	  stages	  of	  sleep	  is	  unclear,	  
but	  REM	  sleep	  (the	  predominant	  state	  during	  foetal	  and	  early	  post-­‐natal	  life)	  may	  be	  a	  basic	  
activation	  programme	  for	  the	  central	  nervous	  system	  that	  increases	  the	  functional	  
competence	  of	  neurons,	  circuits	  and	  complex	  patterns	  (Royal	  College	  of	  Paediatrics	  and	  
Child	  Health	  Guidelines.	  2009).	  The	  duration	  of	  the	  REM/NREM	  cycles	  also	  changes	  during	  
sleep	  from	  around	  fifty	  minutes	  in	  early	  infancy	  to	  sixty	  minutes	  at	  six	  months	  and	  to	  the	  
adult	  period	  of	  ninety	  minutes	  during	  late	  childhood	  to	  early	  adolescence	  (Azaz	  et	  al.,	  1992).	  
	  
The	  NREM	  stage	  of	  sleep	  is	  further	  divided	  into	  four	  stages.	  Stage	  1	  is	  the	  lightest	  stage,	  and	  
is	  rather	  a	  transitional	  stage	  where	  one	  drifts	  off	  and	  usually	  last	  for	  five	  to	  ten	  minutes,	  just	  
enough	  to	  allow	  the	  body	  to	  slow	  down	  and	  muscles	  to	  relax.	  Stage	  2	  is	  still	  considered	  a	  
light	  stage,	  where	  the	  brain	  activity	  slows	  down,	  the	  heart	  rate	  and	  breathing	  are	  regular	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and	  eye	  movement	  decreases	  significantly.	  Stage	  3	  is	  a	  stage	  of	  deep	  sleep:	  the	  brain	  
activity	  further	  slows	  down	  in	  this	  stage,	  breathing	  slows	  and	  muscle	  relaxes.	  Children	  
sometimes	  wet	  the	  bed	  during	  this	  stage	  of	  sleep.	  Stage	  4	  is	  the	  deepest	  stage	  of	  sleep	  and	  
is	  characterized	  by	  very	  slow	  brain	  waves.	  	  
	  
The	  REM	  stage	  is	  characterized	  by	  rapid	  eye	  movements	  even	  though	  the	  eyes	  are	  closed,	  
and	  breathing	  is	  rapid,	  irregular	  and	  shallow.	  The	  heart	  rate	  and	  blood	  pressure	  increase.	  
Arm	  and	  leg	  muscles	  experience	  a	  type	  of	  paralysis	  that	  keeps	  people	  from	  acting	  out	  their	  
dreams.	  	  
	  
Obstructive	  sleep	  apnoea	  has	  been	  recognized	  to	  be	  more	  severe	  in	  the	  REM	  stage	  of	  sleep	  
than	  in	  the	  NREM	  stage	  because	  of	  differences	  in	  ventilation	  patterns	  during	  the	  REM	  stage.	  
During	  NREM	  sleep,	  breathing	  is	  regular,	  but	  the	  tidal	  volume	  and	  respiratory	  rate	  are	  
decreased.	  This	  results	  in	  a	  decrease	  in	  minute	  ventilation	  and	  a	  decrease	  in	  the	  functional	  
residual	  capacity.	  However,	  during	  REM	  sleep,	  apart	  from	  breathing	  being	  erratic,	  with	  
variable	  respiratory	  rate	  and	  tidal	  volume,	  the	  tone	  of	  pharyngeal	  dilators	  will	  be	  greatly	  
reduced	  to	  account	  for	  symptoms	  of	  OSA.	  
	  
 1.2.2	  Definition	  of	  SRBD 
Sleep	  related	  breathing	  disorder	  (SRBD)	  This	  term	  is	  used	  to	  describe	  a	  spectrum	  of	  
respiratory	  disturbances	  that	  occur	  during	  sleep.	  The	  International	  Classification	  of	  Sleep	  
Disorder	  (ICSD)	  is	  a	  primary	  diagnostic,	  epidemiological	  and	  coding	  resource	  for	  clinicians	  
and	  researchers	  in	  the	  field	  of	  sleep	  and	  sleep	  medicine	  in	  its	  2nd	  edition.	  ICSD-­‐2	  has	  defined	  
two	  major	  categories	  of	  SBD:	  Central	  Sleep	  Apnoea	  Syndrome	  (CSAS)	  and	  Obstructive	  Sleep	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Apnoea	  Syndrome	  (OSAS)	  (Thorphy	  et	  al.,	  2005).	  The	  fundamental	  difference	  between	  these	  
two	  categories	  is	  the	  central	  respiratory	  (ventilator)	  drive.	  In	  CSAS,	  there	  is	  no	  central	  
respiratory	  drive,	  but	  in	  OSAS	  there	  is	  central	  respiratory	  drive,	  but	  the	  chest	  wall	  does	  not	  
ventilate	  due	  to	  upper	  airway	  obstruction,	  causing	  symptoms	  of	  sleep	  apnoea.	  
	  
Obstructive	  sleep	  apnoea	  syndrome	  is	  often	  considered	  as	  a	  continuum	  from	  primary	  
snoring	  to	  upper	  airway	  resistance	  syndrome	  (UARS)	  to	  full-­‐blown	  Obstructive	  Sleep	  Apnoea	  
Syndrome	  (OSAS).	  	  
	  
Snoring-­‐	  Snoring	  is	  noisy	  breathing	  caused	  by	  turbulent	  airflow	  through	  the	  upper	  airway	  
without	  the	  sequel	  of	  obstructive	  apnoea,	  frequent	  arousals	  from	  sleep	  or	  disordered	  gas	  
exchange	  (Marcus	  et	  al.,	  2002).	  
	  
Upper	  airway	  resistance	  syndrome	  (UARS)-­‐	  UARS	  was	  first	  described	  in	  1992	  and	  is	  defined	  
as	  the	  combination	  of	  a	  clinical	  complaint	  of	  excessive	  daytime	  sleepiness	  with	  
documentation	  of	  flow	  limitation	  and	  demonstration	  of	  increased	  respiratory	  efforts	  with	  
arousal	  just	  following	  peak	  negative	  oesophageal	  pressure	  during	  inspiration	  (Guilleminault,	  
1993).	  One	  of	  the	  characteristic	  features	  of	  UARS,	  different	  from	  snoring,	  is	  that	  there	  is	  
negative	  intrathoracic	  pressure	  as	  measured	  by	  oesophageal	  manometry.	  
	  
Obstructive	  sleep	  apnoea	  syndrome-­‐	  Obstructive	  sleep	  apnoea	  is	  defined	  as	  a	  disorder	  of	  
breathing	  during	  sleep	  that	  is	  characterised	  by	  prolonged	  partial	  upper	  airway	  obstruction	  
and/or	  intermittent	  complete	  obstruction	  that	  adversely	  affects	  ventilation	  during	  sleep	  and	  




Apnoea-­‐	  Obstructive	  apnoea	  is	  the	  absence	  of	  oronasal	  airflow	  in	  the	  presence	  of	  continued	  
respiratory	  effort.	  The	  significance	  of	  apnoea	  duration	  depends	  on	  background	  respiratory	  
frequency	  (ranging	  from	  sixty	  beats	  per	  minute	  in	  a	  premature	  infant	  to	  a	  rate	  of	  twelve	  
beats	  per	  minute	  in	  adolescents),	  hence	  a	  duration	  of	  two	  respiratory	  cycle	  times	  is	  a	  useful	  
measure,	  which	  corrects	  for	  this	  (Carroll	  et	  al.,	  1995).	  The	  number	  of	  such	  apnoeic	  episodes	  
per	  hour	  is	  termed	  the	  Apnoea	  Index.	  
	  
Hypopnoea-­‐	  is	  defined	  as	  reduction	  (either	  qualitative	  or	  quantitative)	  in	  airflow	  over	  two	  or	  
more	  respiratory	  cycles,	  accompanied	  by	  a	  3%	  or	  4%	  fall	  in	  oxygen	  saturation	  and/or	  
terminated	  by	  an	  arousal	  (Halbower	  et	  al.,	  2007).	  The	  number	  of	  such	  hypopnoeic	  episodes	  
per	  hour	  is	  termed	  the	  Hypopnea	  Index.	  
	  
Arousal	  Index-­‐	  is	  a	  measure	  of	  sleep	  fragmentation	  and	  is	  defined	  as	  the	  number	  of	  arousal	  
events	  occurring	  during	  sleep.	  Respiratory	  effort	  related	  arousals	  (RERAs)	  are	  specific	  to	  
SRBD.	  
	  
Apnoea	  Hypopnea	  Index	  (AHI)	  /	  Respiratory	  Disturbance	  Index	  (RDI)-­‐The	  total	  number	  of	  
apnoea/hypopnea	  divided	  by	  hours	  of	  sleep	  is	  termed	  as	  AHI	  or	  RDI.	  	  
	  
1.2.3	  Aetiology	  of	  SRBD	  
The	  causes	  of	  SRBD	  are	  multifactorial.	  As	  described	  by	  Marcus	  (2000),	  a	  combination	  of	  
upper	  airway	  narrowing	  due	  to	  anatomical	  factors,	  abnormal	  upper	  airway	  tone	  and	  other	  
factors	  such	  as	  genetic	  factors	  contribute	  to	  the	  spectrum	  of	  SRBD.	  However,	  the	  severity	  of	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the	  spectrum	  of	  SRBD	  varies	  among	  individuals.	  
	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
Figure	  1:	  Adapted	  from	  Carroll	  and	  Loughlin	  (1995)	  Childhood	  OSAS	  results	  from	  a	  
combination	  of	  upper	  airway	  (UA)	  narrowing,	  abnormal	  upper	  airway	  neuromotor	  tone	  and	  
other,	  poorly	  understood	  factors.	  (ATH-­‐	  Adenotonsillar	  Hypertrophy,	  UA-­‐	  Upper	  airway)	  
	  
Upper	  Airway	  Obstruction-­‐	  
Upper	  airway	  obstruction	  could	  be	  due	  to	  obstruction	  to	  the	  airway	  from	  the	  nose	  to	  the	  
epiglottis,	  as	  described	  below.	  
 
Nose	   Deviated	  nasal	  septum	  (Lavie	  et	  al.,	  1982)	  
Hypertrophied	  inferior	  turbinates	  
Masses-­‐benign/malignant	  
Mucosal	  disease-­‐	  Allergic	  rhinitis	  (Brouillette	  	  
et	  al.,	  2001)	  	  
Nares	  (Kramer	  et	  al.,	  2004)	  	  
Nasophaynx	   Adenoid	  hypertrophy	  (Brooks	  et	  al.,	  1998)	  
Chonal	  Atresia	  






Systemic	  iIlness	   Cerebral	  palsy	  (Kotagal	  et	  al.,	  1994;	  Magardino	  et	  
al.,	  1999)	  
Myotonic	  dystrophies	  (Suresh	  et	  al.,	  2005)	  
Obesity	  (Verhulst	  et	  al.,	  2008;	  Stepanski	  et	  al.,	  
1999;	  Rosen	  et	  al.,	  1999;	  Carroll	  et	  al.,	  1995)	  
Sickle	  cell	  disease	  (Samuels	  et	  al.,	  2007)	  
Mucopolysaccharidoses	  (Mogayzel	  et	  al.,	  1998)	  
Achondroplasia	  (Mogayzel	  et	  al.,	  1998)	  
Craniofacial	  Syndromes	   Downs	  syndrome	  (Shott	  et	  al.,	  2006;	  Marcus	  et	  al.,	  
1991)	  
Pierre	  Robin	  syndrome	  (Buchenau	  et	  al.,	  2007)	  
Crouzon	  	  syndrome	  (Gonsalez	  et	  al.,	  1998)	  
Aperts	  syndrome	  (Gonsalez	  et	  al.,	  1998)	  
Treacher	  Collins	  syndrome	  (Johnston	  et	  al.,	  1981)	  
	  
Other	   Genetic,	  	  
Familial	  predisposition	  
	  
Table	  2:	  Etiological	  factors	  causing	  upper	  airway	  obstruction	  
	  
Role	  of	  nasal	  pathology	  in	  SRBD	  
Historically,	  even	  in	  the	  Hippocratic	  era,	  it	  was	  thought	  that	  the	  nose	  played	  a	  role	  in	  
snoring	  and	  caused	  restless	  sleep.	  The	  nasal	  airway	  is	  the	  preferred	  route	  of	  respiration	  
during	  both	  wakeful	  and	  sleep	  states	  and	  the	  nose	  is	  the	  first	  port	  of	  air	  entry:	  thus,	  the	  
nose	  and	  various	  nasal	  pathologies	  can	  have	  a	  significant	  impact	  on	  collapsibility	  of	  different	  
segments	  of	  the	  pharyngeal	  lumen	  (Olsen,	  1991).	  Nasal	  congestion	  is	  one	  of	  the	  most	  
important	  predisposing	  factors	  for	  OSAS	  (Papsidero,	  1993).	  Nasal	  congestion	  can	  be	  due	  to	  
structural	  abnormality	  in	  the	  nose,	  such	  as	  a	  deviated	  nasal	  septum,	  or	  mucosal	  disease	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such	  as	  allergic	  rhinitis	  or	  NARES	  (non-­‐allergic	  rhinitis	  with	  eosinophillic	  syndrome).	  	  Lavie	  et	  
al.	  (1982)	  reported	  that	  twelve	  of	  the	  fourteen	  patients	  with	  excessive	  sleepiness	  and	  
chronic	  fatigue	  who	  underwent	  septal	  corrective	  surgery	  had	  subjective	  improvement	  in	  the	  
level	  of	  diurnal	  alertness	  and	  quality	  of	  nocturnal	  sleep.	  
	  	  
	  Kramer	  et	  al.	  (2004)	  conducted	  a	  study	  on	  twenty-­‐six	  patients	  presenting	  with	  symptoms	  of	  
sleep	  apnoea	  .	  Ten	  of	  these	  patients	  also	  had	  symptoms	  of	  nasal	  obstruction	  and	  rhinorrhea	  
and	  were	  diagnosed	  as	  having	  NARES.	  These	  ten	  NARES	  patients	  were	  compared	  with	  
sixteen	  age-­‐	  and	  BMI-­‐matched	  individuals	  without	  any	  nasal	  inflammation.	  All	  the	  patients	  
underwent	  overnight	  polysomnography	  and	  the	  investigators	  concluded	  that	  NARES	  
patients	  had	  statistically	  significant	  (p<.	  01)	  impaired	  polysomnographic	  parameters	  
compared	  with	  patients	  without	  any	  nasal	  inflammation.	  
	  
Brouillette	  et	  al.	  (2001)	  conducted	  a	  randomised,	  triple-­‐blinded,	  placebo	  controlled,	  parallel-­‐
group	  trial	  of	  nasal	  fluticasone	  propionate	  versus	  placebo	  in	  twenty-­‐five	  children	  aged	  one	  
to	  ten	  years	  with	  obstructive	  sleep	  apnoea	  proven	  on	  polysomnography	  and	  found	  that	  the	  
mixed/obstructive	  apnoea/hypopnea	  index	  decreased	  in	  twelve	  of	  thirteen	  subjects	  treated	  
with	  fluticasone	  versus	  six	  of	  twelve	  treated	  with	  placebo.	  They	  concluded	  that	  nasal	  
fluticasone	  decreased	  the	  frequency	  of	  mixed	  and	  obstructive	  apnoeas	  and	  hypopnoeas,	  
suggesting	  that	  topical	  corticosteroids	  may	  be	  helpful	  in	  ameliorating	  paediatric	  obstructive	  
sleep	  apnoea.	  
	  
From	  the	  above	  studies,	  it	  is	  evident	  that	  nasal	  pathology	  is	  an	  important	  factor	  in	  the	  
aetiology	  of	  SRDB,	  and	  thorough	  nasal	  examination	  is	  a	  critical	  step	  in	  evaluating	  a	  patient	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with	  SRBD.	  Simple	  measures	  like	  avoidance	  of	  allergens,	  treating	  patients	  with	  steroid	  nasal	  
spray	  in	  allergic	  rhinitis	  or	  NARES	  syndrome	  and	  correction	  of	  any	  anatomical	  structural	  
abnormality	  in	  the	  nose	  may	  relieve	  symptoms	  of	  SRBD.	  
	  
Role	  of	  adenoid	  and	  tonsillar	  hypertrophy	  in	  SRBD	  
The	  anatomical	  location	  of	  the	  adenoid	  in	  the	  nasopharyngeal	  isthmus	  and	  palatine	  tonsil	  in	  
the	  oropharyngeal	  isthmus	  plays	  an	  important	  role	  in	  the	  processing	  of	  inhaled	  and	  ingested	  
antigens	  and	  immunity.	  Adenotonsillar	  hypertrophy	  is	  an	  undisputed	  major	  contributor	  to	  
the	  development	  of	  SRBD.	  Anatomical	  impingement	  of	  the	  upper	  airway	  by	  enlarged	  upper	  
airway	  lymphoid	  tissues	  will	  increase	  the	  pharyngeal	  resistance,	  and	  may	  ultimately	  result	  in	  
episodic	  airway	  narrowing	  and	  collapse	  that	  characterize	  OSAS	  (Marcus,	  2000;	  Marcus	  et	  al.,	  
1994)	  .The	  prevalence	  of	  OSAS	  in	  children	  peaks	  at	  three	  to	  seven	  years	  of	  age	  parallel	  to	  
the	  age	  of	  adenotonsillar	  enlargement.	  Not	  all	  children	  with	  adenotonsillar	  hypertrophy	  
suffer	  from	  OSAS.	  Nevertheless,	  despite	  contribution	  from	  other	  factors	  like	  neuromuscular	  
tone	  and	  genetic	  factors,	  the	  severity	  of	  OSAS	  has	  been	  associated,	  at	  least	  in	  part,	  with	  
tonsillar	  and	  adenoidal	  size	  (Brooks	  et	  al.,	  1998).	  
	  
In	  sedated	  young	  children	  (4.8	  ±	  2.1	  yr;	  range,	  1.9–9.3	  yr),	  there	  was	  a	  positive	  linear	  
correlation	  between	  the	  tonsil	  and	  adenoid	  volume	  and	  the	  AHI	  ,	  but	  there	  was	  no	  such	  
correlation	  with	  airway	  volume	  (Arens	  et	  al.,	  2001).	  In	  unsedated,	  older	  children	  (9.5	  ±	  1.2	  
yr;	  range,	  7–12	  yr),	  the	  tonsil	  cross-­‐sectional	  area	  (CSA),	  soft	  palate	  CSA,	  oropharyngeal	  
volume	  and	  ratio	  of	  the	  retropalatal	  airway	  to	  soft	  palate	  CSA	  were	  strongly	  correlated	  
(tonsils	  and	  palate)	  or	  inversely	  correlated	  (ratio	  of	  retropalatal	  airway	  to	  soft	  palate)	  with	  
the	  obstructive	  AHI	  (Fregosi	  et	  al.,	  2003).	  A	  correlation	  with	  apnoea	  severity	  was	  observed	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with	  the	  younger	  children’s	  combined	  adenotonsillar	  volume	  (Arens	  et	  al.,	  2001),	  but	  not	  
with	  the	  older	  children’s	  combined	  adenotonsillar	  CSA	  (Fregosi	  et	  al.,	  2003).	  
	  
Yagi	  et	  al.	  (2009)	  assessed	  the	  morphological	  features	  in	  141	  patients	  diagnosed	  with	  OSAS,	  
and	  found	  that	  the	  body	  mass	  index,	  narrowness	  of	  the	  fauces,	  neck	  circumference	  and	  
tonsil	  size	  showed	  significant	  correlations	  with	  the	  apnoea-­‐hypopnoea	  index.	  Brodsky	  et	  al.	  
(1989)	  evaluated	  sixty	  children	  aged	  between	  three	  and	  eleven	  intraoperatively	  to	  
determine	  variations	  in	  nasopharyngeal	  and	  orpharyngeal	  dimensions	  due	  to	  adenotonsillar	  
hypertrophy	  in	  OSAS.	  A	  significantly	  larger	  oropharyngeal	  diameter	  was	  found	  in	  children	  
with	  small	  non-­‐obstructing	  tonsils	  (p	  <	  0.01).	  Children	  with	  large	  non-­‐obstructing	  tonsils	  had	  
a	  similar	  oropharyngeal	  diameter	  to	  those	  with	  large	  obstructing	  tonsils.	  However,	  tonsil	  
volume,	  not	  weight,	  was	  increased	  in	  the	  children	  with	  large	  obstructing	  tonsils	  as	  
compared	  to	  those	  with	  large	  non-­‐obstructing	  tonsils	  and	  small	  non-­‐obstructing	  tonsils	  (p	  <	  
0.04).	  A	  shorter	  soft	  palate	  was	  associated	  with	  larger	  obstructing	  tonsils	  (p	  <	  0.004).	  The	  
length	  of	  the	  hard	  palate	  was	  similar	  in	  all	  patients;	  however,	  a	  trend	  towards	  a	  higher	  
arched	  palate	  was	  seen	  in	  patients	  with	  larger,	  obstructing	  tonsils.	  The	  distance	  from	  soft	  
palate	  to	  posterior	  pharyngeal	  wall	  was	  greater	  in	  obstructed	  patients	  with	  adenotonsillar	  
hypertrophy	  (p	  <	  0.003).	  In	  patients	  requiring	  adenoidectomy,	  the	  nasopharyngeal	  volume	  
prior	  to	  adenoidectomy	  was	  significantly	  smaller	  in	  patients	  with	  obstructive	  symptoms	  (p	  <	  
0.001).	  Post-­‐adenoidectomy,	  no	  significant	  difference	  was	  found	  in	  the	  nasopharynx	  volume	  
amongst	  all	  subjects.	  These	  data	  indicate	  that	  subtle	  differences	  in	  oropharyngeal	  
dimensions	  exist,	  which,	  along	  with	  increased	  lymphoid	  tissue	  volume,	  lead	  to	  the	  




Greenfeld	  et	  al.	  (2003)	  conducted	  a	  study	  on	  twenty-­‐nine	  children	  aged	  less	  than	  eighteen	  
months,	  who	  were	  diagnosed	  with	  OSAS	  by	  polysomnography,	  and	  compared	  their	  pre-­‐	  and	  
post-­‐adenotonsillectomy	  body	  weight	  and	  developmental	  assessment	  by	  parents.	  The	  
authors	  concluded	  that	  there	  was	  significant	  weight	  gain,	  and	  improvement	  in	  clinical	  
symptoms.	  Bhattacharjee	  et	  al.	  (2010)	  assessed	  the	  nocturnal	  polysomnograms	  of	  578	  
children	  undergoing	  adenotonsillectomy	  for	  the	  diagnosis	  of	  OSAS	  at	  six	  paediatric	  sleep	  
centres	  and	  found	  that	  adenotonsillectomy	  resulted	  in	  a	  significant	  AHI	  reduction	  from	  18.6	  
to	  4.1	  /hour	  total	  sleep	  time.	  
	  
From	  the	  above	  studies,	  it	  is	  clear	  that	  adenotonsillar	  hypertrophy,	  along	  with	  subtle	  
changes	  in	  the	  pharyngeal	  dimensions,	  does	  play	  a	  important	  role	  in	  the	  aetiology	  of	  SRBD,	  
and	  hence	  the	  practice	  guidelines	  established	  by	  the	  American	  Academy	  of	  Paediatricians	  
recommends	  adenotonsillectomy	  	  as	  the	  first	  line	  of	  treatment	  for	  childhood	  OSAS	  (Marcus	  
et	  al.,	  2002)	  .	  
	  
Role	  of	  Systemic	  Illness	  in	  SRBD	  
A	  review	  of	  the	  literature	  suggests	  that	  systemic	  illness,	  as	  mentioned	  in	  Table	  2,	  does	  have	  
a	  role	  in	  the	  aetiology	  and	  pathogenesis	  of	  SRBD.	  There	  appears	  to	  be	  a	  clear	  link	  between	  
obesity	  and	  SRBD	  in	  adults,	  but	  the	  association	  between	  body	  mass	  and	  SRDB	  severity	  
amongst	  children	  is	  not	  straightforward.	  
	  
Obesity	  is	  the	  presence	  of	  excess	  fat	  or	  adipose	  tissue.	  The	  International	  Obesity	  Task	  Force	  
has	  defined	  cut-­‐off	  points	  for	  overweight	  and	  obesity	  based	  on	  body	  mass	  index	  (BMI:	  the	  
ratio	  of	  weight	  in	  kg	  to	  the	  square	  of	  height	  in	  m),	  corrected	  for	  age	  and	  gender	  (Bellizzi	  et	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al.,	  1999),	  and	  recommended	  that	  paediatric	  growth	  charts	  be	  readily	  available.	  Amongst	  
children,	  a	  BMI	  between	  the	  85th	  and	  95th	  percentile	  for	  age	  is	  considered	  overweight	  and	  
a	  BMI	  at	  or	  above	  the	  95th	  percentile	  is	  considered	  obese	  (McLennan,	  2004).	  	  
	  
Obesity	  may	  influence	  SRBD	  predominantly	  via	  mass	  exerted	  on	  upper	  airway	  structures	  
and/or	  by	  the	  influences	  of	  excess	  adipose	  tissue	  on	  neuromotor	  physiology.	  Rosen	  et	  al.	  
(1999)	  retrospectively	  evaluated	  the	  PSG	  data	  from	  326	  children	  who	  had	  been	  referred	  for	  
evaluation	  of	  snoring	  and	  difficulty	  breathing	  during	  the	  night.	  Based	  on	  a	  BMI	  greater	  than	  
the	  95th	  percentile	  for	  age,	  or	  an	  ideal	  body	  weight	  greater	  than	  120%	  of	  ideal	  body	  weight	  
for	  height,	  28%	  of	  the	  study	  population	  were	  obese.	  However,	  obesity	  did	  not	  increase	  the	  
likelihood	  for	  OSAS	  diagnosis.	  The	  authors	  explain	  these	  results	  in	  terms	  of	  a	  referral	  bias	  
based	  on	  the	  adult	  experience	  but	  acknowledge	  that	  the	  role	  of	  obesity	  in	  childhood	  SDB	  
remains	  to	  be	  determined.	  Similarly,	  Carroll	  et	  al.	  (1995),	  in	  an	  evaluation	  of	  symptoms	  
amongst	  eighty-­‐three	  children	  referred	  for	  clinical	  evaluation	  of	  snoring	  and	  SDB,	  found	  that	  
26%	  of	  the	  total	  group	  were	  defined	  as	  obese	  (weight	  greater	  than	  the	  95th	  percentile	  for	  
age).	  However,	  there	  was	  no	  difference	  in	  the	  proportion	  of	  obese	  children	  when	  comparing	  
those	  diagnosed	  with	  OSAS	  to	  those	  who	  demonstrated	  primary	  snoring	  only.	  Finally,	  
Stepanski	  et	  al.	  (1999)	  found	  that	  28%	  of	  198	  consecutive	  patients	  referred	  for	  overnight	  
PSG	  (97%	  were	  specifically	  to	  rule	  out	  SRDB)	  were	  obese;	  however,	  the	  incidence	  of	  OSAS	  
did	  not	  vary	  according	  to	  weight	  across	  the	  total	  group.	  A	  study	  reporting	  on	  liver	  function	  
in	  518	  habitually	  snoring	  children	  showed	  that	  while	  27%	  of	  patients	  were	  obese,	  and	  that	  
severity	  of	  SRDB	  was	  greater	  amongst	  obese	  children,	  BMI	  z-­‐scores	  were	  not	  different	  when	  
comparing	  children	  later	  diagnosed	  with	  OSAS	  and	  those	  without	  OSAS	  (Kheirandish	  Gozal	  
et	  al.,	  2008).	  Clearly	  therefore,	  the	  association	  between	  body	  mass	  and	  SRDB	  severity	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amongst	  children	  is	  not	  straightforward,	  and	  other	  factors	  may	  influence	  the	  association. 	  
 
Verhulst	  et	  al.	  (2008)	  reviewed	  some	  of	  the	  evidence	  for	  obesity	  being	  a	  significant	  risk	  
factor	  for	  SRDB	  amongst	  children.	  In	  addition,	  they	  explored	  adenotonsillar	  hypertrophy	  as	  
a	  modulator	  of	  this	  association	  and	  effectiveness	  of	  adenotonsillectomy	  in	  treating	  SRDB	  
amongst	  obese	  children.	  Their	  conclusions	  are	  justified	  based	  on	  the	  evidence	  presented,	  
which,	  to	  summarize,	  suggests	  that	  childhood	  obesity	  is	  linked	  with	  an	  increased	  prevalence	  
of	  SRDB,	  and	  is	  often	  mediated	  by	  enlarged	  adenoids	  and/or	  tonsils.	  As	  such,	  
adenotonsillectomy	  has	  been	  shown	  to	  be	  an	  effective	  primary	  treatment	  in	  the	  majority	  of	  
cases.	  Kohler	  et	  al.	  (2008)	  performed	  a	  critical	  review	  to	  see	  whether	  there	  is	  a	  clear	  link	  
between	  overweight/obesity	  and	  SRBD	  in	  children	  and	  suggested	  that	  a	  greater	  proportion	  
of	  studies	  amongst	  older	  children	  demonstrate	  a	  significant	  association	  between	  obesity	  
and	  SRDB	  severity	  compared	  to	  those	  amongst	  younger	  children.	  Developmental	  changes	  to	  
neuromuscular	  control,	  body	  fat	  distribution	  and/or	  cephalometric	  changes	  may	  underlie	  
this	  observation.	  They	  also	  found	  that	  significant	  associations	  between	  obesity	  and	  SRDB	  
severity	  appear	  to	  be	  more	  prevalent	  amongst	  children	  of	  certain	  ethnicities,	  such	  as	  Africa	  
American	  and	  possibly	  Asian.	  Irrespective	  of	  these	  potential	  moderators,	  adenotonsillar	  
hypertrophy	  appears	  to	  be	  a	  critical	  consideration	  when	  considering	  SRDB	  and	  treatment	  
efficacy	  amongst	  obese	  children	  compared	  to	  normal	  weight	  children.	  	  
	  
Children	  with	  Sickle	  Cell	  disease	  (SCD)	  experience	  hypoxemia	  during	  wakefulness	  and	  sleep,	  
and	  thus,	  low	  baseline	  values	  on	  oximetry	  or	  abnormal	  desaturation	  during	  sleep	  are	  not	  
unexpected.	  In	  a	  prospective	  randomized	  study	  involving	  SCD	  patients	  (most	  of	  whom	  were	  
referred	  for	  suspected	  SRBD),	  Samuels	  et	  al.	  (1992)	  reported	  that	  eighteen	  of	  fifty-­‐three	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subjects	  (36%)	  had	  OSAS;	  16%	  had	  episodic	  hypoxemia	  (SaO2	  ≤	  80%)	  and/or	  baseline	  SaO2	  <	  
95.8%.	  After	  adenotonsillectomy,	  PSG	  was	  performed	  on	  fifteen	  of	  the	  eighteen	  patients	  
with	  OSAS.	  All	  subjects	  demonstrated	  improvement	  in	  symptoms	  and	  a	  reduction	  or	  
abolition	  of	  episodic	  hypoxemia.	  	  
	  
Children	  with	  Cerebral	  Palsy	  (CP)	  are	  at	  high	  risk	  for	  developing	  OSA	  (Kotagal	  et	  al.,	  1994).	  
The	  medulla	  oblongata	  is	  responsible	  for	  control	  of	  respiration	  and	  is	  also	  believed	  to	  
coordinate	  contractions	  of	  the	  diaphragm	  and	  upper	  airway	  musculature	  to	  maintain	  a	  
patent	  airway	  during	  inspiration.	  Asynchronous	  medullary	  neural	  output	  has	  been	  recorded	  
in	  children	  with	  CP.	  This	  dysfunctional	  neuromuscular	  control	  is	  thought	  to	  contribute	  to	  the	  
collapse	  of	  oropharyngeal	  tissues	  into	  the	  upper	  airway	  via	  the	  negative	  pressure	  generated	  
by	  an	  inspiratory	  effort.	  Decreased	  tone	  of	  the	  pharyngeal	  musculature	  during	  sleep	  further	  
contributes	  to	  this	  potential	  for	  upper	  airway	  collapse.	  Children	  with	  CP	  and	  spastic	  
quadriplegia	  are	  unable	  to	  effectively	  move	  their	  body	  during	  sleep.	  Therefore	  they	  are	  less	  
able	  to	  compensate	  for	  upper	  airway	  obstruction	  with	  repositioning	  than	  normal	  children	  
(Kotagal	  et	  al.,	  1994).	  Increased	  oropharyngeal	  secretions,	  increased	  gastrooesophageal	  
reflux	  and	  seizure	  disorders,	  all	  of	  which	  commonly	  affect	  children	  with	  CP,	  have	  all	  been	  
shown	  to	  contribute	  to	  the	  development	  of	  OSA. Magardino	  et	  al.	  (1999)	  retrospectively	  
reviewed	  twenty-­‐seven	  children	  with	  cerebral	  palsy	  who	  underwent	  surgical	  treatment	  for	  
obstructive	  sleep	  apnoea	  and	  recommended	  that	  tonsillectomy	  or	  adenoidectomy,	  or	  both,	  
is	  indicated	  for	  initial	  surgical	  management	  of	  OSA	  in	  CP	  children	  if	  there	  is	  evidence	  of	  
tonsillar	  and/or	  adenoidal	  hyperplasia.	  Post-­‐operatively,	  these	  patients	  should	  be	  closely	  
monitored	  in	  an	  ICU	  for	  upper	  airway	  obstruction.	  Aggressive	  medical	  management	  of	  
gastro-­‐oesophageal	  reflux	  and	  seizure	  disorders	  is	  essential	  to	  successful	  treatment	  of	  OSA.	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With	  this	  medical	  and	  surgical	  approach,	  they	  found	  that	  84%	  of	  their	  CP	  children	  with	  OSA	  
avoided	  tracheotomy.	  
	  
Many	  neuromuscular	  dystrophies	  are	  associated	  with	  SRBD,	  and	  respiratory	  abnormalities	  
occur	  due	  to	  a	  variety	  of	  underlying	  factors,	  including	  primary	  weakness	  of	  the	  diaphragm	  
and	  other	  muscles	  of	  respiration,	  bulbar	  weakness,	  restrictive	  lung	  disease,	  impaired	  central	  
respiratory	  control,	  recurrent	  infection,	  impaired	  cough,	  malnutrition,	  and	  obesity	  (Gozal,	  
2000).	  	  Suresh	  et	  al.	  (2005)	  reported	  a	  bi-­‐modal	  presentation	  of	  SRBD,	  with	  OSAS	  in	  the	  first	  
decade	  of	  life,	  followed	  by	  sleep	  related	  hypoventilation	  in	  the	  second.	  Ten	  (31%)	  of	  thirty-­‐
two	  Duchenne	  Muscular	  Dystrophy	  patients	  referred	  for	  suspected	  SRBD	  had	  OSAS	  on	  
overnight	  PSG	  (median	  age	  eight	  years,	  mean	  AHI	  12,	  median	  nadir	  SpO2	  87%).	  Fifteen	  
(47%)	  were	  normal	  (median	  age	  ten	  years,	  median	  nadir	  SpO2	  94%),	  and	  eleven	  (32%)	  had	  
sleep	  related	  hypoventilation	  (median	  age	  thirteen	  years,	  mean	  AHI	  13,	  median	  nadir	  SpO2	  
90%).	  Children	  or	  adolescents	  with	  mucopolysaccharidoses	  (MPS)	  are	  at	  risk	  for	  OSAS.	  
Santamaria	  et	  al.	  (2007)	  compared	  overnight	  PSG,	  nasal	  endoscopy	  and	  upper	  airway	  CT	  
scans	  in	  five	  children	  (median	  age	  6.9	  years)	  to	  six	  adults	  (median	  age	  twenty-­‐five)	  with	  
various	  types	  of	  MPS.	  They	  found	  OSAS	  (mean	  AI	  10.4	  and	  AHI	  14.7)	  in	  all	  five	  children	  with	  
MPS,	  but	  in	  only	  one	  adult	  (mean	  AI	  2.3	  and	  AHI	  7.4).	  Nasal	  endoscopy	  demonstrated	  
adenoidal	  hypertrophy	  in	  all	  subjects.	  Mogayzel	  et	  al.	  (1998)	  studied	  the	  prevalence	  of	  SRBD	  
in	  eighty-­‐eight	  children	  with	  achondroplasia,	  and	  found	  that	  48%	  showed	  respiratory	  PSG	  
abnormalities,	  including	  hypoxemia.	  
	  
	  
Role	  of	  Craniofacial	  Syndromes	  in	  SRBD	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The	  role	  of	  craniofacial	  anatomy	  cannot	  be	  ignored	  in	  the	  aetiology	  of	  upper	  airway	  
obstruction	  leading	  to	  SRBD.	  The	  patency	  of	  the	  airway	  depends	  on	  the	  bony	  framework	  
and	  the	  soft	  tissue,	  and	  any	  abnormality	  of	  the	  bony	  framework	  in	  the	  presence	  or	  absence	  
of	  soft	  tissue	  abnormality	  will	  have	  an	  impact	  on	  breathing	  by	  reducing	  the	  patency	  of	  the	  
airway.	  A	  review	  of	  the	  literature	  suggests	  an	  increased	  incidence	  of	  SRBD	  in	  syndromes	  
with	  abnormal	  craniofacial	  anatomy.	  
	  
Down’s	  Syndrome	  children	  are	  at	  significant	  risk	  for	  SRBD	  due	  to	  craniofacial	  anomalies	  such	  
as	  midfacial	  hypoplasia	  and	  glossoptosis,	  as	  well	  as	  hypotonia,	  increased	  secretions,	  tracheal	  
anomalies,	  obesity,	  and	  hypothyroidism.	  Marcus	  et	  al.	  (1991)	  reported	  that	  all	  of	  their	  
overnight	  polysomnographic	  studies,	  performed	  in	  sixteen	  patients	  with	  Down’s	  syndrome,	  
were	  abnormal	  for	  the	  presence	  of	  OSAS	  in	  63%,	  hypoventilation	  in	  81%	  and	  oxygen	  
desaturation	  in	  56%.	  Shott	  et	  al.	  (2006)	  prospectively	  studied	  the	  incidence	  of	  OSAS	  in	  sixty-­‐
five	  children	  aged	  between	  two	  and	  four	  years	  with	  Down’s	  syndrome	  using	  PSG,	  and	  also	  
assessed	  the	  parents’	  ability	  to	  predict	  sleep	  abnormalities	  in	  this	  group	  of	  patients.	  The	  
PSGs	  revealed	  that	  57%	  of	  the	  children	  had	  abnormal	  results	  and	  evidence	  of	  obstructive	  
sleep	  apnoea	  syndrome.	  Overall,	  69%	  of	  parents	  reported	  no	  sleep	  problems	  in	  their	  
children,	  but	  in	  this	  group,	  54%	  of	  PSGs	  had	  abnormal	  results.	  The	  study	  concluded	  that	  
because	  of	  the	  high	  incidence	  of	  obstructive	  sleep	  apnoea	  syndrome	  in	  young	  children	  with	  
Down’s	  syndrome,	  and	  the	  poor	  correlation	  between	  parental	  impressions	  of	  sleep	  
problems	  and	  PSG	  results,	  baseline	  PSG	  is	  recommended	  in	  all	  children	  with	  Down’s	  
syndrome	  at	  age	  three	  to	  four	  years.	  This	  recommendation	  is	  in	  keeping	  with	  the	  guidelines	  
of	  the	  Working	  Party	  on	  Sleep	  Physiology	  and	  Respiratory	  Control	  Disorders	  in	  Childhood,	  
which	  recommends	  that	  Down’s	  syndrome	  children	  with	  abnormal	  screening	  for	  SRBD	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should	  have	  PSG,	  and	  if	  significant	  SRBD	  with	  hypoxia	  is	  noted,	  then	  appropriate	  treatment	  
should	  be	  offered.	  
	  
Children	  with	  Pierre	  Robin	  syndrome	  (PRS)	  and	  Treacher	  Collin	  syndrome	  usually	  have	  poorly	  
formed	  jaws	  and	  tongues	  that	  fall	  back	  into	  the	  throat.	  These	  two	  features	  will	  cause	  upper	  
airway	  obstruction	  and	  lead	  to	  SRBD	  (Johnston	  et	  al.,	  1981).	  Buchenau	  et	  al.	  (2007)	  
performed	  cardiorespiratory	  studies	  in	  infants	  with	  Pierre	  Robin	  syndrome.	  The	  primary	  aim	  
of	  this	  study	  was	  to	  evaluate	  the	  use	  of	  an	  intra-­‐oral	  appliance,	  and	  thus	  only	  infants	  with	  an	  
AHI	  ≥	  3	  were	  included.	  However,	  the	  authors	  found	  that	  sixteen	  of	  twenty-­‐one	  (76%)	  infants	  
met	  this	  criterion.	  Data	  presented	  on	  eleven	  subjects	  who	  participated	  in	  the	  trial	  showed	  a	  
mean	  AHI	  of	  13.8,	  suggesting	  that	  infants	  with	  Pierre	  Robin	  sequence	  have	  mild-­‐to-­‐
moderate	  OSAS.	  
	  
Other	  craniofacial	  dysostosis	  syndromes,	  such	  as	  Crouzon’s	  and	  Apert’s	  syndrome,	  are	  
associated	  with	  high	  risk	  of	  SRBD	  (Gonsalez	  et	  al.,	  1998).	  The	  Working	  Party	  on	  Sleep	  
Physiology	  and	  Respiratory	  Control	  Disorders	  in	  Childhood	  recommends	  that	  all	  children	  
with	  syndromes	  involving	  mid	  facial	  hypoplasia	  or	  micrognathia	  should	  be	  evaluated	  for	  
SRBD	  with	  a	  minimum	  assessment	  of	  oximetry,	  preferably	  with	  a	  measure	  of	  CO2.	  This	  
should	  be	  performed	  urgently	  if	  they	  have	  any	  clinical	  signs	  of	  airway	  obstruction	  and	  within	  
the	  first	  four	  weeks	  of	  life	  in	  any	  event.	  Clinicians	  should	  be	  aware	  that	  infants	  with	  Pierre	  
Robin	  syndrome	  may	  have	  worsening	  airway	  obstruction	  between	  four	  and	  eight	  weeks	  and	  
ascertain	  whether	  symptoms	  worsen	  at	  this	  age.	  If	  so,	  repeat	  assessment	  should	  be	  carried	  
out.	  Reassessment	  for	  SRBD	  in	  children	  with	  syndromes	  involving	  midfacial	  hypoplasia	  or	  
micrognathia	  should	  occur	  at	  three-­‐	  to	  six-­‐monthly	  intervals	  in	  the	  first	  year	  of	  life,	  and	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subsequently	  should	  be	  dictated	  by	  clinical	  symptoms	  and	  signs.	  
	  
The	  role	  of	  genetics	  or	  familial	  predisposition	  in	  SRBD	  
Sleep-­‐related	  breathing	  disorders	  are	  common	  in	  some	  races,	  including	  Africo-­‐	  Americans	  
and	  Hispanics,	  when	  compared	  to	  Caucasians.	  This	  could	  be	  because	  of	  associated	  factors	  
like	  obesity,	  socioeconomic	  status	  or	  craniofacial	  abnormality.	  However,	  there	  is	  a	  
possibility	  of	  familial	  predisposition,	  which	  could	  perhaps	  increase	  the	  risk	  of	  SRBD	  in	  some	  
groups	  of	  children.	  
	  
Descriptive	  reports	  of	  families	  with	  multiple	  affected	  members	  (Strohl	  et	  al.,	  1978)	  show	  
that	  there	  could	  be	  a	  potential	  role	  of	  inheritance	  apart	  from	  familial	  influence.	  Another	  
study	  (Gislason	  et	  al.,	  2002)	  calculated	  the	  estimated	  risk	  ratios	  for	  relatives	  of	  patients	  with	  
OSA	  and	  found	  that	  they	  were	  increased.	  The	  risk	  ratio	  for	  first-­‐degree	  relatives	  was	  2.0	  for	  
parents	  and	  1.9	  for	  siblings.	  For	  second-­‐degree	  relatives	  (half-­‐siblings,	  uncles/	  aunts,	  
grandparents)	  the	  estimated	  risk	  ratios	  were	  1.9,	  1.3	  and	  1.3,	  respectively,	  with	  the	  first	  two	  
being	  significant.	  The	  estimated	  risk	  ratio	  for	  cousins	  was	  1.3,	  which	  was	  also	  statistically	  
significant.	  From	  these	  studies,	  it	  is	  clear	  that	  familial	  predisposition	  does	  have	  a	  role	  to	  play	  
in	  the	  aetiology	  of	  SRBD,	  but	  the	  exact	  gene	  responsible	  is	  still	  not	  clear.	  More	  research	  on	  





Abnormal	  upper	  airway	  tone	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From	  the	  above	  discussion,	  it	  is	  clear	  that	  anatomical	  narrowing	  of	  the	  upper	  airway	  plays	  a	  
role	  in	  the	  aetiology	  of	  SRBD.	  The	  collapse	  of	  the	  pharynx,	  either	  partial	  or	  complete,	  during	  
OSA	  is	  not	  entirely	  due	  to	  anatomical	  narrowing	  of	  the	  upper	  airway,	  as	  OSA	  is	  not	  seen	  in	  
every	  child	  with	  upper	  airway	  narrowing,	  and	  also	  most	  children	  with	  OSA	  can	  breathe	  
normally	  and	  do	  not	  desaturate	  during	  the	  wakeful	  state.	  This	  could	  be	  due	  to	  activity	  of	  
upper	  airway	  dilator	  muscles,	  which	  keep	  the	  airway	  patent	  during	  the	  wakeful	  state.	  There	  
appear	  to	  be	  high	  levels	  of	  upper	  airway	  dilator	  muscle	  activity	  present	  during	  wakefulness	  
in	  OSA	  patients	  (Mezzanotte	  et	  al.,	  1992),	  thereby	  compensating	  for	  the	  deficient	  anatomy.	  
At	  sleep	  onset,	  upper	  airway	  dilator	  muscle	  activity	  is	  reduced	  in	  both	  OSA	  patients	  and	  
controls	  (Fogel	  et	  al.,	  2005)	  and	  this	  likely	  contributes	  to	  airway	  collapse	  in	  patients	  with	  
OSA	  and	  the	  increase	  in	  airway	  resistance	  observed	  in	  healthy	  individuals	  (Trinder,	  et	  al.,	  
1994).	  One	  can	  conclude	  from	  the	  above	  that	  there	  appears	  to	  be	  an	  inverse	  relation	  




The	  upper	  airway,	  extending	  from	  the	  nasal	  chonae	  to	  the	  level	  of	  the	  epiglottis,	  lacks	  rigid	  
bony	  support	  and	  hence	  is	  a	  collapsible	  segment.	  It	  serves	  many	  functions,	  including	  
swallowing,	  speaking	  and	  breathing.	  During	  the	  inspiratory	  phase	  of	  breathing,	  negative	  
pressure	  is	  generated	  in	  the	  upper	  airway,	  due	  to	  activation	  of	  the	  diaphragm	  and	  
intercostal	  muscles.	  Under	  normal	  circumstances,	  this	  negative	  pressure	  is	  compensated	  by	  
the	  activity	  of	  pharyngeal	  dilator	  muscles,	  preventing	  this	  segment	  from	  collapsing	  
(Remmers	  et	  al.,	  1978).	  Narrowing	  of	  the	  upper	  airway	  due	  to	  anatomical	  obstruction,	  as	  
discussed	  in	  the	  section	  on	  aetiology,	  will	  increase	  the	  upper	  airway	  resistance.	  To	  maintain	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adequate	  airflow	  through	  a	  narrow	  lumen,	  the	  patient	  must	  increase	  respiratory	  effort.	  
Because	  of	  the	  Bernoulli	  effect,	  there	  will	  be	  further	  increase	  in	  intraluminal	  negative	  
pressure,	  forcing	  the	  compliant	  upper	  airway	  to	  collapse	  and	  leading	  to	  the	  cessation	  of	  
airflow.	  
	  
As	  in	  adults	  (Smith	  et	  al.,	  1998),	  the	  upper	  airway	  in	  children	  has	  been	  shown	  to	  behave	  in	  
accordance	  with	  the	  Starling	  resistor	  model,	  when	  a	  collapsible	  pharyngeal	  segment	  is	  
situated	  between	  two	  non-­‐collapsible	  segments	  with	  fixed	  diameters,	  resistance	  and	  
pressures	  (nasal	  and	  tracheal),	  as	  described	  in	  Figure	  2:	  	  	  
	  
Figure	  2:	  Adapted	  from	  Marcus	  et	  al.	  (1994)	  The	  Starling	  resistor	  model	  of	  the	  upper	  airway.	  
The	  airway	  is	  represented	  by	  a	  tube	  with	  a	  collapsible	  segment	  (pharynx)	  between	  two	  rigid	  
segments	  with	  fixed	  diameters,	  resistances	  and	  pressures	  (nasal	  and	  tracheal	  segments).	  The	  
airway	  collapses	  when	  the	  pressure	  surrounding	  the	  airway	  becomes	  greater	  than	  the	  
pressure	  within	  the	  airway.	  
	  
In	  this	  model	  of	  the	  upper	  airway,	  inflow	  pressure	  at	  the	  airway	  opening	  (the	  nares)	  is	  
atmospheric	  and	  downstream	  pressure	  is	  equal	  to	  tracheal	  pressure	  (diaphragm).	  Collapse	  
would	  occur	  when	  the	  pressure	  surrounding	  the	  collapsible	  segment	  of	  the	  upper	  airway	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(critical	  pressure	  or	  Pcrit)	  becomes	  greater	  than	  the	  pressure	  within	  the	  collapsible	  segment	  
of	  the	  airway.	  Pcrit	  reflects	  upper	  airway	  neuromuscular	  control	  as	  well	  as	  anatomical	  
factors,	  as	  discussed	  in	  Table	  1.	  
	  
Marcus	  et	  al.	  (1994)	  determined	  the	  Pcrit	  in	  OSA	  children	  by	  correlating	  the	  maximal	  
inspiratory	  airflow	  with	  the	  level	  of	  positive	  or	  negative	  nasal	  pressure	  applied	  via	  a	  nasal	  
mask.	  They	  found	  that	  the	  maximal	  inspiratory	  airflow	  varied	  in	  proportion	  to	  upstream	  
(nasal)	  rather	  than	  downstream	  (tracheal)	  pressure	  changes.	  Pcrit	  was	  1	  +/-­‐	  3	  cmH2O	  in	  
OSAS	  compared	  with	  -­‐20	  +/-­‐	  9	  cmH2O	  in	  primary	  snorers	  (P<	  0.002).	  Three	  of	  these	  OSAS	  
patients	  were	  further	  re-­‐evaluated	  after	  tonsillectomy	  and	  adenoidectomy	  and	  Pcrit	  was	  
found	  to	  have	  declined	  to	  -­‐7.2	  +/-­‐4.0	  cmH2O.	  Children	  with	  OSA	  have	  a	  higher	  Pcrit	  than	  do	  
the	  control	  subjects	  (Marcus	  et	  al.,	  2005)	  and	  children	  with	  habitual	  snoring	  (Marcus	  et	  al.,	  
2005).	  However,	  the	  Pcrit	  in	  patients	  with	  OSA	  after	  adenotonsillectomy	  did	  not	  decrease	  to	  
the	  level	  in	  control	  subjects	  (Marcus,	  CL	  et	  al.1994)	  or	  even	  primary	  snorers	  (Marcus	  et	  al.,	  
2005),	  suggesting	  that	  subtle	  abnormalities	  of	  anatomy	  or	  neuromuscular	  control	  remain	  
after	  treatment.	  
	  
Gozal	  et	  al.	  (2004)	  measured	  the	  upper	  airway	  collapsibility	  (UAC)	  using	  acoustic	  
pharyngometry	  before	  and	  after	  application	  of	  topical	  1%	  cetacaine	  spray. The	  UAC	  was	  
examined	  in	  twenty-­‐seven	  control	  children	  and	  twenty-­‐seven	  children	  with	  known	  SDB.	  The	  
groups	  were	  matched	  for	  age,	  sex	  and	  ethnicity.	  Mean	  cross-­‐sectional	  area	  (CSA)	  was	  1.88	  
+/-­‐	  0.27	  cm2	  in	  control	  children	  and	  1.67	  +/-­‐	  0.28	  cm2	  in	  patients	  with	  SRDB	  (p	  <	  0.01).	  
Similarly,	  the	  minimal	  CSA	  was	  1.03	  +/-­‐0.17	  cm2	  in	  control	  children	  and	  0.95	  +/-­‐	  0.18	  cm2	  in	  
patients	  with	  SRDB,	  respectively,	  (p	  <	  0.04).	  Mean	  UAC	  in	  control	  children	  was	  -­‐5.3	  +/-­‐1.9%	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compared	  with	  -­‐40.7	  +/-­‐	  1.6%	  in	  SDB	  (p	  <0.0001).	  This	  study	  shows	  that	  the	  upper	  airway	  is	  
smaller,	  and	  UAC	  is	  markedly	  and	  significantly	  greater,	  in	  children	  with	  SDB.	  
	  
From	  both	  the	  above	  studies,	  it	  is	  clear	  that	  there	  is	  greater	  upper	  airway	  resistance	  in	  OSA	  
patients	  than	  in	  the	  normal	  population,	  and	  that	  the	  upper	  airway	  is	  smaller	  and	  more	  
collapsible	  than	  normal.	  Despite	  these	  changes,	  the	  upper	  airway	  muscles	  that	  are	  
phasically	  activated	  during	  inspiration	  increase	  both	  the	  luminal	  size	  and	  the	  stiffness	  of	  the	  
airway.	  It	  is	  only	  during	  the	  rapid	  eye	  movement	  stage	  of	  sleep	  that	  phasic	  muscle	  activity	  of	  
the	  oropharyngeal	  dilator	  muscles	  may	  be	  significantly	  depressed.	  Diaphragmatic	  activation	  
continues	  to	  generate	  negative	  oropharyngeal	  pressures,	  but	  the	  tone	  of	  the	  upper	  airway	  
tissues	  is	  reduced,	  leading	  to	  increased	  upper	  airway	  resistance	  and	  partial	  or	  complete	  
airway	  obstruction	  during	  inspiration.	  Anatomical	  obstruction	  and	  decreased	  muscle	  tone	  
causes	  cessation	  of	  airflow,	  which	  leads	  to	  physiologic	  changes	  including	  acidosis,	  
hypercapnia	  and	  hypoxemia.	  Once	  sufficient	  changes	  in	  the	  partial	  pressure	  of	  oxygen	  (PO2),	  
the	  partial	  pressure	  of	  carbon	  dioxide	  (PCO2)	  and	  pH	  occur,	  central	  and	  peripheral	  
chemoreceptors	  and	  baroreceptors	  are	  stimulated	  to	  cause	  arousal	  and	  awakening	  from	  
sleep,	  which	  may	  occur	  many	  times	  in	  a	  night.	  Therefore,	  the	  quality	  of	  sleep,	  both	  
physiologic	  and	  psychological	  restful	  sleep,	  is	  markedly	  disturbed,	  which	  may	  lead	  to	  
behavioural	  changes	  such	  as	  hypersomnolence,	  hyperactivity	  and	  learning	  difficulties	  
(Bradley	  et	  al.,	  1985).	  
	  
Pharyngeal	  dilator	  muscles,	  including	  the	  genioglossus,	  hyoglossus	  and	  styloglossus,	  help	  in	  
maintaining	  the	  patency	  of	  the	  upper	  airway	  lumen,	  but	  genioglossus	  muscle	  function	  has	  
been	  studied	  extensively	  and	  measured	  by	  Elecromyography	  (EMG	  gg).	  The	  main	  function	  of	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genioglossus	  is	  forward	  and	  outward	  movement	  of	  the	  tongue,	  thereby	  increasing	  the	  
orophayrngeal	  dimension.	  Both	  tonic	  and	  phasic	  inspiratory	  activity	  of	  genioglossal	  activity	  
have	  been	  noted	  in	  children	  (Kartz	  et	  al.,	  2003).	  When	  children	  are	  in	  a	  wakeful	  state,	  the	  
EMGgg	  is	  greater	  in	  the	  OSA	  group	  than	  in	  the	  control	  group	  (Kartz	  et	  al.,	  2003).	  This	  could	  
be	  due	  to	  an	  increase	  in	  upper	  airway	  resistance,	  in	  turn	  increasing	  the	  negative	  airway	  
pressure,	  which	  would	  activate	  the	  reflex	  mechanoreceptors.	  Application	  of	  topical	  
anaesthesia	  acts	  on	  these	  mechanoreceptors	  and	  decreases	  airway	  size	  in	  patients	  with	  OSA	  
(Gozal	  et	  al.,	  2004).	  
	  
With	  the	  onset	  of	  sleep,	  the	  EMGgg	  decreases	  in	  both	  normal	  and	  OSA	  patients	  (Kartz	  et	  al.,	  
2003).	  This	  suggests	  that	  the	  central	  respiratory	  drive	  and/or	  neuromuscular	  compensatory	  
mechanisms	  are	  diminished	  during	  the	  transition	  to	  sleep.	  The	  reduction	  in	  muscular	  activity	  






































Figure	  3	  The	  sequence	  of	  events	  in	  an	  OSA	  patient.	  Upper	  airway	  narrowing	  will	  increase	  the	  
negative	  luminal	  pressure,	  which	  will	  activate	  the	  mucosal	  mechanoreceptors	  to	  increase	  the	  
function	  of	  the	  upper	  airway	  dilators	  to	  maintain	  the	  upper	  airway	  patency.	  However,	  sleep	  




In	  normal	  children,	  EMGgg	  remains	  below	  the	  wakeful	  baseline	  during	  stable	  Stage	  2	  and	  
Stage	  4	  sleep,	  suggesting	  that	  additional	  neuromuscular	  activity	  is	  not	  necessary	  with	  a	  
Upper	  airway	  narrowing	  
Negative	  intraluminal	  pressure	  
Mucosal	  mechanoreceptors	  
Activation	  of	  Pharyngeal	  dilators	  
Increases	  the	  upper	  airway	  patency	  
Sleep	  
	  	  	  	  	  	  Inactivated	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mechanically	  stable	  airway	  (Katz	  et	  al.,	  2004).	  However,	  most	  children	  with	  severe	  OSA	  have	  
a	  rebound	  increase	  in	  EMGgg	  activity	  during	  Stage	  2	  sleep,	  consistent	  with	  a	  reflex	  driven	  by	  
mechano-­‐	  and/or	  chemoreceptors	  (Katz	  et	  al.,	  2004).	  There	  is	  a	  significant	  correlation	  
between	  OSA	  severity	  (i.e.	  AHI)	  and	  EMGgg	  activity	  in	  all	  sleep	  stages.	  Finally,	  applying	  
continuous	  positive	  airway	  pressure	  to	  patients	  with	  OSA	  during	  sleep	  results	  in	  a	  reduction	  
in	  the	  EMGgg	  coincident	  with	  reductions	  in	  respiratory	  effort	  and	  PCO2	  (Katz	  et	  al.,	  2004).	  
	  
As	  a	  consequence	  of	  the	  collapse	  of	  this	  upper	  airway,	  minute	  ventilation	  decreases,	  and	  to	  
maintain	  adequate	  ventilation	  there	  is	  a	  compensatory	  increase	  in	  respiratory	  effort.	  In	  the	  
initial	  stage	  of	  sleep,	  this	  can	  be	  compensated	  by	  the	  stimulation	  of	  mucosal	  
mechanoreceptors	  causing	  an	  increase	  in	  upper	  airway	  patency,	  thus	  increasing	  the	  minute	  
ventilation,	  and	  OSA	  patients	  can	  escape	  episodes	  of	  hypopnoea	  or	  apnoea.	  During	  the	  REM	  
stage	  of	  sleep,	  in	  the	  absence	  of	  the	  activity	  of	  mucosal	  mechanoreceptors,	  this	  protective	  
mechanism	  to	  maintain	  the	  patency	  of	  the	  upper	  airway	  is	  lost	  and	  minute	  ventilation	  
decreases	  and	  induces	  a	  compensatory	  increase	  in	  the	  respiratory	  rate:	  this	  results	  in	  
physiological	  responses	  like	  hypercapnia	  and	  hypoxemia.	  Once	  sufficient	  changes	  in	  partial	  
pressure	  of	  oxygen	  (PO2),	  partial	  pressure	  of	  carbon	  dioxide	  (PCO2)	  and	  pH	  occur,	  central	  
and	  peripheral	  chemoreceptors	  and	  baroreceptors	  are	  stimulated	  to	  cause	  arousal	  and	  
awakening	  from	  sleep.	  
	  
Arousal	  from	  sleep	  immediately	  opens	  the	  airway	  and	  normalizes	  gas	  exchange	  
abnormalities. The	  principal	  stimulus	  for	  arousal	  appears	  to	  be	  respiratory	  effort	  and	  
hypercapnia,	  whereas	  hypoxemia	  is	  a	  poor	  arousing	  stimulus.	  Increased	  respiratory	  effort	  
alone	  may	  induce	  subtle	  frequency	  changes	  in	  the	  surface	  EEG	  (Lopes	  et	  al.,	  2006).	  Arousal	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from	  sleep	  increases	  the	  gain	  of	  central	  chemoreceptors	  and	  augments	  neuromuscular	  
activation	  of	  the	  upper	  airway,	  thereby	  decreasing	  airway	  resistance.	  But	  frequent	  arousal	  
results	  in	  fragmentation	  of	  the	  sleep	  cycle	  and	  disturbed	  sleep.	  
	  
To	  summarise,	  apart	  from	  anatomical	  narrowing,	  neuromuscular	  tone	  plays	  a	  important	  role	  
in	  the	  pathogenesis	  of	  OSA.	  To	  overcome	  resistance	  in	  the	  upper	  airway,	  mucosal	  
mechanoreceptors	  are	  stimulated	  during	  the	  wakeful	  state	  and	  in	  non-­‐REM	  stages;	  
however,	  this	  protective	  mechanism	  is	  not	  fully	  functional	  during	  the	  REM	  stage,	  resulting	  in	  
obstructive	  events.	  	  
	  
1.3	  Signs	  and	  Symptoms	  of	  SRBD	  in	  Children	  
A	  thorough	  history	  of	  symptoms	  is	  the	  key	  to	  diagnosing	  SRBD	  in	  children.	  It	  is	  not	  physically	  
possible	  to	  subject	  every	  suspected	  SRBD	  child	  to	  overnight	  objective	  investigation	  and	  most	  
clinicians	  rely	  on	  history	  from	  parents	  before	  deciding	  on	  treatment	  options.	  Children	  will	  
not	  be	  aware	  of	  symptoms,	  as	  these	  obstructive	  events	  occur	  during	  sleep	  and	  parents	  in	  
the	  developed	  countries	  do	  not	  share	  the	  same	  bedroom	  with	  their	  children	  and	  hence	  may	  
not	  give	  a	  detailed	  sequence	  of	  obstructive	  events.	  Often	  these	  children	  manifest	  with	  
different	  signs	  and	  symptoms,	  corresponding	  to	  their	  developmental	  stage,	  underling	  
aetiology	  and	  severity.	  The	  three	  most	  predictive	  symptoms	  are	  loud	  snoring,	  difficulty	  
breathing	  during	  sleep	  and	  sleep-­‐related	  pauses	  in	  breathing	  witnessed	  by	  the	  parents	  
(Brouillette	  et	  al.,	  1984).	  Brouillette	  et	  al.	  (1984)	  assessed	  the	  frequency	  of	  signs	  and	  
symptoms	  using	  a	  postal	  survey	  with	  a	  standard	  questionnaire	  to	  parents	  of	  twenty-­‐three	  
children	  who	  were	  diagnosed	  with	  OSA	  and	  forty-­‐three	  age-­‐	  and	  sex-­‐matched	  controls,	  as	  
detailed	  in	  the	  table	  below.	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Signs	  and	  symptoms	   Frequency	  OSAS	  
Patients	  (%)	  
Frequency	  in	  	  
Controls	  (%)	  
Difficulty	  breathing	  while	  asleep	   96	   2	  
Snoring	   96	   9	  
Stops	  breathing	  during	  sleep	   78	   5	  
Restless	  sleep	   78	   23	  
Chronic	  rhinorrhea	   61	   11	  
Mouth	  breathes	  when	  awake	   87	   18	  
Frequent	  upper	  respiratory	  infections	   83	   28	  
Frequent	  vomiting/	  nausea	   30	   2	  
Difficulty	  swallowing	   26	   2	  
Sweating	  when	  asleep	   50	   16	  
Hearing	  problems	   13	   0	  
Excessive	  daytime	  somnolence	   33	   9	  
Poor	  appetite	   30	   9	  
Recurrent	  middle	  ear	  disease	   43	   17	  
Pathological	  shyness	  	  
Social	  withdrawal	  
22	   5	  
	  
Table	  3:	  Adapted	  from	  Brouillette	  et	  al.’s	  (1984)	  study	  on	  the	  frequency	  of	  signs	  and	  
symptoms	  in	  OSAS	  patients	  compared	  with	  controls.	  
	  
From	  the	  above	  study,	  it	  is	  clear	  that	  difficulty	  breathing	  while	  asleep,	  snoring,	  restless	  sleep	  
and	  stopping	  breathing	  during	  sleep	  dominate	  the	  nocturnal	  symptoms	  in	  OSAS	  patients.	  As	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an	  effect	  of	  sleep	  fragmentation	  and	  sleep	  disturbance,	  children	  with	  SRBD	  will	  also	  







Loud	  habitual	  snoring	  





Abnormal	  sleeping	  position	  
Enuresis	  







Difficulty	  in	  waking	  up	  
Mood	  changes	  
Poor	  attention	  span/academic	  problems	  
Increased	  nap/daytime	  sleepiness	  
Chronic	  nasal	  congestion/rhinorrhea	  
Frequent	  upper	  respiratory	  tract	  infections	  
Difficulty	  in	  swallowing/poor	  appetite	  
Hearing	  problems	  
	  
Table	  4:	  Adapted	  from	  Au	  et	  al.	  (2009)	  Symptoms	  of	  childhood	  obstructive	  sleep	  apnoea.	  
	  
Almost	  all	  children	  with	  OSAS	  snore	  and	  have	  increased	  effort	  while	  breathing	  (Brouillette	  et	  
al.,	  1984;	  Carroll	  et	  al.,	  1995).	  Parents	  often	  complain	  of	  difficulty	  breathing	  when	  asleep,	  




Nocturnal	  enuresis	  was	  reported	  in	  8-­‐47%	  of	  children	  with	  OSAS	  (Hoban	  et	  al.,	  2009).	  
Weider	  et	  al.	  (1991)	  reported	  a	  77%	  reduction	  in	  the	  number	  of	  enuretic	  nights	  each	  week	  
five	  months	  after	  adenotonsillectomy	  for	  OSA.	  Basha	  et	  al.	  (2005)	  described	  61%	  resolution	  
and	  23%	  decrease	  in	  enuresis	  events	  following	  adenotonsillectomy	  in	  children	  with	  OSA.	  
Normally	  spontaneous	  resolution	  of	  nocturnal	  enuresis	  occurs	  at	  a	  relatively	  regular	  and	  
steady	  state	  throughout	  middle	  childhood,	  as	  the	  underlying	  cause	  is	  thought	  to	  be	  delayed	  
maturation	  of	  the	  bladder	  mechanism,	  or	  of	  portions	  of	  central	  nervous	  system.	  	  The	  
proposed	  mechanism	  for	  enuresis	  in	  children	  with	  OSA	  is	  secondary	  to	  increased	  negative	  
intrathoracic	  pressure	  as	  a	  result	  of	  increased	  inspiratory	  effort	  during	  sleep.	  The	  continual	  
swing	  in	  intrathoracic	  pressure	  causes	  cardiac	  distention,	  which	  can	  lead	  to	  the	  release	  of	  
atrial	  natriuretic	  peptide,	  triggering	  enuresis.	  There	  is	  a	  positive	  correlation	  between	  plasma	  
ANP	  levels	  and	  the	  degree	  of	  change	  in	  intra-­‐thoracic	  pressure	  (Krieger	  et	  al.,	  1991;	  Gozal	  et	  
al.,	  2001).	  Therefore,	  it	  can	  be	  assumed	  that	  by	  treating	  OSAS,	  there	  might	  eventually	  be	  a	  
reduced	  atrial	  volume,	  which	  could	  reduce	  secretion	  of	  ANP,	  which	  in	  turn	  could	  decrease	  
nocturnal	  urinary	  output.	  
	  
Daytime	  symptoms	  like	  mouth	  breathing,	  morning	  headache,	  difficulty	  in	  waking	  up	  and	  
increased	  naptime	  are	  common	  in	  children	  with	  SRBD.	  Excessive	  daytime	  sleepiness	  (EDS)	  is	  
one	  of	  the	  most	  common	  findings	  in	  adult	  OSA	  patients.	  But	  studies	  have	  shown	  that	  EDS	  is	  
not	  a	  major	  feature	  in	  children	  with	  OSA	  as	  assessed	  by	  parental	  questionnaire	  (Carroll	  et	  
al.,	  1995),	  and	  objective	  tools	  like	  the	  multiple	  sleep	  latency	  test	  (Gozal	  et	  al.,	  2001).	  This	  
does	  not	  mean	  that	  OSA	  children	  will	  have	  undisturbed	  sleep,	  but	  they	  will	  have	  fewer	  
arousals,	  as	  demonstrated	  by	  fewer	  EEG	  arousals,	  compared	  to	  the	  adults,	  hence	  




As	  a	  sequel	  to	  increased	  intra-­‐thoracic	  pressure	  and	  disturbed	  sleep,	  children	  with	  OSA	  will	  
develop	  reversible	  cardiopulmonary	  and	  neurocognitive	  behaviour	  changes.	  Severe	  
untreated	  OSAS	  can	  lead	  to	  pulmonary	  hypertension	  and	  corpulmonale	  (Brouillette	  et	  al.,	  
1982;	  Guilleminault	  et	  al.,	  1981).	  Recurrent	  hypoxia	  secondary	  to	  obstructive	  events	  in	  OSA	  
will	  lead	  to	  pulmonary	  vasoconstriction,	  thereby	  increasing	  the	  pulmonary	  arterial	  pressure	  
and	  pulmonary	  hypertension.	  Prolonged	  hypertension	  will	  result	  in	  cor	  pulmonale.	  
Reversible	  cor	  pulmonale	  has	  been	  reported	  in	  severely	  affected	  OSA	  children	  (Luke,	  1965;	  
Sofer,	  1988).	  Marcus	  et	  al.	  (1998)	  suggested	  that	  children	  with	  OSA	  had	  higher	  diastolic	  
blood	  pressure	  during	  wakefulness	  and	  sleep	  compared	  with	  primary	  snorers.	  Kirk	  et	  al.	  
(1998)	  reported	  the	  presence	  of	  diurnal	  systemic	  hypertension	  in	  10%	  of	  50	  children	  with	  
OSA.	  Kohyama	  et	  al.	  (2003)	  showed	  that	  children	  with	  OSA	  had	  higher	  diastolic	  blood	  
pressure,	  which	  correlated	  with	  the	  AHI.	  However,	  Amin	  et	  al.	  (2004)	  found	  lower	  diastolic	  
pressure	  among	  children	  with	  OSA	  during	  wakefulness	  and	  Kaunzman	  et	  al.	  (1991)	  were	  
unable	  to	  show	  any	  abnormalities	  in	  diastolic	  or	  systolic	  arterial	  pressures	  in	  twenty-­‐two	  
children	  with	  OSA.	  These	  inconsistent	  findings	  of	  blood	  pressure	  in	  OSA	  children	  may	  be	  due	  
to	  small	  sample	  size	  and	  lack	  of	  healthy	  controls.	  
	  
Amin	  et	  al.	  (2004)	  investigated	  the	  heart	  size	  of	  twenty-­‐eight	  patients,	  nine	  of	  whom	  had	  
OSA	  and	  primary	  snoring,	  and	  found	  that	  the	  left	  ventricular	  mass	  index	  and	  wall	  thickness	  
were	  greater	  in	  children	  with	  OSA.	  Those	  with	  an	  AHI	  of	  10	  or	  more	  had	  a	  right	  and	  left	  
ventricular	  mass	  greater	  than	  the	  ninety-­‐fifth	  percentile.	  From	  the	  above	  studies,	  it	  is	  clear	  
that	  as	  a	  sequel	  of	  OSA,	  cardiopulmonary	  changes	  like	  pulmonary	  hypertension	  and	  cor	  
pulmonale	  also	  occur	  in	  children.	  However,	  because	  of	  limited	  sample	  size	  and	  lack	  of	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controls,	  further	  studies	  need	  to	  be	  done	  in	  children	  as	  well	  as	  in	  adults	  to	  evaluate	  the	  
cardiopulmonary	  changes	  and	  their	  effect	  on	  quality	  of	  life.	  
	  
Failure	  to	  thrive	  is	  one	  of	  the	  common	  features	  in	  OSA	  children.	  The	  pathogenesis	  
associated	  with	  failure	  to	  thrive	  in	  children	  with	  OSA	  is	  likely	  to	  be	  a	  combination	  of	  various	  
mechanisms	  that	  include	  increased	  resting	  energy	  expenditure	  due	  to	  increased	  effort	  of	  
breathing	  during	  resting	  period,	  difficulty	  in	  swallowing	  secondary	  to	  enlarged	  tonsils,	  and	  
abnormal	  release	  of	  growth-­‐related	  hormones	  (Li	  et	  al.,	  2003).	  Caloric	  intake	  and	  sleeping	  
energy	  expenditure,	  in	  addition	  to	  anthropomorphic	  measurements,	  were	  taken	  before	  and	  
after	  adenotonsillectomy	  in	  fourteen	  children	  confirmed	  to	  have	  OSA.	  Average	  sleeping	  
energy	  expenditure	  decreased	  and	  the	  mean	  weight	  z-­‐score	  increased	  after	  surgery	  without	  
any	  change	  in	  caloric	  intake	  (Li	  et	  al.,	  2003).	  Statistically	  significant	  increases	  in	  weight	  and	  
insulin-­‐like	  growth	  factor-­‐I	  levels	  were	  found	  in	  a	  group	  of	  children	  with	  OSA	  after	  
adenotonsillectomy	  (Bar	  et	  al.,	  1999).	  Fortunately,	  we	  are	  seeing	  less	  of	  this	  complication	  as	  
parents	  are	  becoming	  more	  aware	  of	  this	  condition	  and	  seeking	  medical	  intervention	  early.	  
	  
In	  1899,	  a	  reference	  was	  made	  by	  Hill	  (1899)	  in	  the	  British	  Medical	  Journal:	  “The	  stupid	  lazy	  
child	  who	  frequently	  suffers	  from	  headaches	  at	  school,	  breathes	  through	  his	  mouth	  instead	  
of	  his	  nose,	  snores	  and	  is	  restless	  at	  night,	  and	  wakes	  up	  with	  a	  dry	  mouth	  in	  the	  morning,	  is	  
well	  worthy	  of	  the	  solicitous	  attention	  of	  the	  school	  medical	  officer”.	  This	  describes	  the	  
unfortunate	  sequelae	  resulting	  from	  lack	  of	  recognition	  and	  treatment	  of	  OSA	  in	  children.	  
Since	  then,	  schooling	  problems	  have	  been	  repeatedly	  reported	  in	  children	  with	  SRBD	  (Ali	  et	  
al.,	  1993;	  Chervin	  et	  al.,	  1997)	  and	  may	  underlie	  more	  extensive	  behavioural	  disturbances,	  
such	  as	  restlessness,	  aggressive	  behaviour,	  hyperactivity	  and	  poor	  test	  performance.	  With	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the	  use	  of	  parental	  reports,	  a	  few	  studies	  have	  documented	  behavioural	  disturbance	  in	  
children	  with	  OSAS	  that	  resolve	  after	  adenotonsillectomy	  (Stradling	  et	  al.,	  1990;	  Ali	  et	  al.,	  
1996).	  Ali	  et	  al.	  (1996)	  found,	  in	  twelve	  children	  with	  OSAS,	  that	  there	  was	  a	  significant	  
reduction	  in	  inattention,	  aggression	  and	  hyperactivity	  after	  treatment	  with	  
adenotonsillectomy,	  as	  assessed	  using	  a	  parent	  rating	  scale.	  Owens	  et	  al.	  (2000)	  found	  
behavioural	  problems	  and	  mild	  deficits	  in	  executive	  functioning,	  attention	  and	  motor	  skills	  
in	  a	  small	  group	  of	  children	  with	  mild	  to	  moderate	  OSAS	  that	  improved	  after	  
adenotonsillectomy.	  O’Brien	  et	  al.	  (2004)	  evaluated	  a	  large	  cohort	  of	  1st	  graders	  in	  the	  
lowest	  10th	  percentile	  of	  their	  class	  and	  found	  that	  there	  was	  increased	  incidence	  of	  snoring	  
and	  nocturnal	  gas	  exchange	  abnormalities	  in	  297	  children,	  and	  there	  was	  a	  significant	  
improvement	  in	  school	  grade	  following	  adenotonsillectomy.	  The	  findings	  from	  the	  above	  
study	  suggest	  that	  there	  is	  a	  relationship	  between	  SRBD	  and	  neurocognitive	  deficit,	  but	  
further	  research	  is	  needed	  to	  establish	  whether	  this	  is	  a	  causal	  relationship.	  
	  
There	  is	  strong	  evidence	  to	  suggest	  an	  association	  between	  SRBD	  and	  attention	  deficit	  
hyperactivity	  disorder	  (ADHD)	  in	  children.	  It	  is	  estimated	  that	  up	  to	  30%	  of	  children	  with	  
SRBD	  have	  inattention	  and	  hyperactivity	  (Chervin	  et	  al.,	  2003).	  Up	  to	  one	  third	  of	  children	  
with	  frequent,	  loud	  snoring	  will	  display	  significant	  hyperactivity	  and	  inattention	  (Ali	  et	  al.,	  
1996),	  while	  the	  reciprocal	  also	  appears	  to	  be	  true	  that	  the	  ADHD	  children	  exhibit	  more	  
sleep	  disturbance	  when	  compared	  to	  normal	  children	  (Ball	  et	  al.,	  1997).	  The	  ADHD	  
symptoms	  that	  these	  children	  exhibit	  may	  not	  be	  true	  ADHD,	  but	  rather	  a	  lack	  of	  
behavioural	  inhibition	  secondary	  to	  repeated	  sleep	  arousals	  and	  intermittent	  hypoxic	  
episodes	  that	  affect	  working	  memory,	  motor	  control	  and	  self-­‐regulation	  of	  motivation	  
(Chervin	  et	  al.,	  2003).	  Most	  of	  the	  studies	  on	  ADHD	  children	  have	  relied	  on	  parental	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reporting	  rather	  than	  objective	  assessment	  like	  behaviour,	  depression	  or	  impaired	  school	  
performance.	  To	  summarize,	  studies	  suggest	  that	  SRBD	  does	  have	  a	  role	  to	  play	  in	  
neurocognitive	  deficit,	  and	  there	  is	  a	  relationship	  between	  ADHD	  and	  SRBD,	  but	  more	  
studies	  involving	  objective	  assessment	  tools	  rather	  than	  parental	  questionnaires,	  as	  used	  in	  
these	  studies,	  need	  to	  be	  done	  to	  further	  prove	  the	  relationship.	  	  
	  
1.4:	  Diagnosis	  
Polysonmography	  (PSG)	  is	  the	  gold	  standard	  investigation	  to	  diagnose	  and	  quantify	  SRBD	  
(Rembold	  et	  al.,	  2004;	  Schechter	  et	  al.,	  2002).	  Though	  PSG	  provides	  objective	  information	  
about	  sleep	  architecture,	  cardiac,	  respiratory	  and	  gas	  exchange,	  it	  is	  inconvenient	  for	  both	  
parent	  and	  child,	  as	  they	  have	  to	  spend	  a	  night	  in	  a	  sleep	  laboratory.	  Furthermore,	  PSG	  is	  a	  
labour-­‐intensive	  and	  onerous	  method	  for	  diagnosing	  SRBD,	  and	  limited	  availability	  of	  sleep	  
laboratories	  and	  expertise,	  forced	  clinicians	  to	  limit	  the	  use	  of	  PSG	  in	  diagnosing	  SRBD.	  Thus	  
the	  diagnosis	  is	  still	  made	  on	  a	  clinical	  basis	  without	  any	  objective	  evidence.	  The	  different	  
methods	  used	  in	  diagnosing	  SRBD	  are	  discussed	  below.	  
	  
1.4.1	  Parent	  reported	  symptoms:	  
Clinicians	  depend	  on	  parental	  reported	  symptoms	  that	  are	  indicative	  of	  OSA	  (snoring,	  
witnessed	  apnoea,	  laboured	  breathing	  and	  restless	  sleep).	  Certal	  et	  al.	  (2012)	  performed	  a	  
systematic	  review	  to	  assess	  the	  evidence	  for	  diagnostic	  accuracy	  of	  individual	  or	  combined	  
clinical	  symptoms	  and	  signs	  in	  predicting	  paediatric	  OSA	  and	  concluded	  that	  neither	  single	  
nor	  combined	  symptoms	  and	  signs	  have	  satisfactory	  performance	  in	  predicting	  paediatric	  
OSA.	  A	  review	  of	  the	  literature	  on	  parental	  reported	  symptom	  and	  their	  accuracy	  in	  
detecting	  the	  OSA	  is	  detailed	  in	  the	  tables	  below.	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Symptom:	  Snoring	  	  
Study	   N	   TP	   TN	   FP	   FN	   Sensitivity	   Specificity	  
Carroll	  et	  
al.	  (1995)	  
83	   30	   19	   29	   5	   0.86	   0.40	  
Chau	  et	  al.	  
(2003)	  
62	   20	   30	   10	   2	   0.91	   0.75	  
Xu	  et	  al.	  
(2006)	  
50	   30	   5	   14	   1	   0.97	   0.26	  
Leach	  et	  al.	  	  
(1992)	  
93	   32	   12	   32	   8	   0.76	   0.27	  
	  
Symptom:	  Excessive	  daytime	  sleepiness	  (EDS)	  
Study	   N	   TP	   TN	   FP	   FN	   Sensitivity	   Specificity	  
Carroll	  et	  
al.	  (1995)	  
83	   3	   40	   8	   32	   0.09	   0.83	  
Xu	  et	  al.	  
(2006)	  
50	   14	   11	   8	   17	   0.45	   0.58	  
Leach	  et	  al.	  	  
1992)	  
93	   6	   38	   6	   28	   0.18	   0.86	  
	  
	  
Symptom:	  Difficulty	  in	  breathing	  
Study	   N	   TP	   TN	   FP	   FN	   Sensitivity	   Specificity	  
Carroll	  et	  
al.	  (1995)	  
83	   31	   20	   28	   4	   0.89	   0.42	  
Chau	  et	  al.	  
(.2003)	  
62	   15	   31	   8	   7	   0.68	   0.79	  
Xu	  et	  al.	  
(2006)	  
50	   7	   18	   1	   24	   0.23	   0.95	  
Leach	  et	  al.	  
(1992)	  
93	   4	   39	   5	   30	   0.12	   0.89	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Symptom:	  Observed	  apnoea	  
Study	   N	  	   TP	   TN	   FP	   FN	   Sensitivity	   Specificity	  
Carroll	  et	  
al.	  (1995)	  
83	   26	   26	   22	   9	   0.74	   0.54	  
Chau	  et	  al.	  
(2003)	  
62	   12	   36	   4	   10	   0.55	   0.90	  
Xu	  et	  al.	  
(2006)	  
50	   11	   18	   1	   18	   0.35	   0.95	  
Leach	  et	  al.	  
(1992)	  
93	   16	   21	   23	   18	   0.47	   0.48	  
	  
Table	  5:	  Diagnostic	  accuracy	  of	  clinical	  symptoms	  and	  signs	  of	  each	  study	  adapted	  from	  
(Cetral	  et	  al.,	  2012)	  with	  slight	  modification.	  N=total	  number;	  TP=true	  positive;	  TN=true	  
negative;	  FP=false	  positive;	  FN=false	  negative.	  
	  
In	  the	  above	  studies,	  common	  parental	  reported	  symptoms	  were	  compared	  with	  the	  PSG	  
findings	  for	  OSA.	  In	  line	  with	  the	  recommendations	  of	  the	  American	  Association	  of	  Sleep	  
Medicine	  (AASM),	  AHI	  >1	  on	  PSG	  was	  considered	  as	  criteria	  for	  the	  diagnosis	  of	  OSA	  in	  these	  
studies.	  Snoring	  reported	  by	  parents	  had	  high	  sensitivity	  in	  these	  studies.	  In	  contrast,	  EDS,	  
difficulty	  in	  breathing	  and	  observed	  apnoea	  had	  relatively	  high	  specificity.	  For	  a	  disease	  
entity,	  if	  the	  sensitivity	  of	  a	  test	  is	  high,	  then	  a	  negative	  result	  can	  be	  used	  to	  rule	  out	  the	  
disease.	  Thus	  the	  absence	  of	  snoring	  may	  be	  useful	  to	  exclude	  the	  diagnosis	  of	  OSA.	  
However,	  the	  lower	  specificity	  for	  snoring	  may	  lead	  to	  a	  false	  diagnosis	  of	  OSA.	  Similarly,	  if	  
specificity	  is	  high,	  as	  in	  EDS,	  difficulty	  in	  breathing	  and	  observed	  apnoea	  for	  OSA,	  then	  a	  




In	  a	  systematic	  review	  of	  clinical	  assessment	  of	  paediatric	  obstructive	  sleep	  apnoea,	  Certal	  
et	  al.	  (2003)	  concluded	  that	  there	  is	  a	  need	  for	  a	  more	  reliable	  non-­‐invasive	  diagnostic	  tool	  
to	  diagnose	  this	  condition,	  as	  neither	  single	  nor	  combined	  symptoms	  and	  signs	  have	  
satisfactory	  performance	  in	  predicting	  paediatric	  OSA.	  
	  
1.4.2	  Questionnaires	  
Sleep	  questionnaires	  like	  the	  Epworth	  Sleepiness	  Scale	  (ESS)	  and	  the	  Snoring	  Symptoms	  
Inventory	  (SSI)	  are	  often	  used	  in	  screening	  the	  adult	  population	  for	  SRBD.	  These	  
questionnaires	  are	  relatively	  cost	  effective,	  easy	  to	  use	  and	  suitable	  for	  longitudinal	  
assessment	  of	  treatment	  effects.	  The	  optimal	  role	  of	  these	  questionnaire-­‐based	  sleepiness	  
assessments	  has	  been	  a	  subject	  of	  debate.	  For	  example,	  ESS>	  10	  demonstrated	  poor	  
sensitivity	  and	  specificity	  as	  a	  predictor	  of	  reduced	  mean	  sleep	  latency	  (Chervin,	  2000).	  	  
	  
Neither	  the	  ESS	  nor	  the	  SSI	  is	  well	  suited	  or	  validated	  for	  use	  in	  children	  to	  screen	  for	  OSA.	  A	  
review	  of	  the	  literature	  revealed	  many	  such	  questionnaires	  used	  to	  screen	  OSA	  in	  children.	  
One	  of	  the	  first	  sleep	  questionnaires	  used	  to	  screen	  children	  was	  proposed	  by	  Brouillette	  
and	  colleagues	  (Brouillette	  et	  al.,	  1984),	  who	  suggested	  that	  the	  OSA	  could	  be	  determined	  
by	  a	  questionnaire	  score	  and	  only	  children	  who	  received	  an	  intermediate	  score	  would	  need	  
further	  evaluation	  with	  overnight	  PSG.	  The	  sensitivity	  and	  specificity	  of	  these	  questionnaires	  
were	  35%	  and	  39%	  respectively.	  This	  questionnaire	  was	  used	  by	  other	  investigators	  who	  
found	  similar	  results,	  and	  hence	  is	  no	  longer	  being	  used.	  
	  
Owens	  and	  colleagues	  (Owens	  et	  al.,	  2000)	  developed	  the	  children’s	  sleep	  habit	  
questionnaire	  (CSHQ)	  for	  use	  in	  school-­‐aged	  children	  between	  four	  and	  ten	  years	  of	  age.	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This	  CSHQ	  is	  a	  retrospective,	  35-­‐item	  parent	  reported	  questionnaire	  designed	  to	  access	  
behaviour	  and	  a	  number	  of	  key	  scale	  domains.	  It	  includes	  the	  major	  presenting	  clinical	  sleep	  
complaints	  in	  this	  age	  group,	  like	  bedtime	  resistance,	  sleep	  onset	  delay,	  sleep	  duration,	  
anxiety	  around	  sleep,	  behaviour	  occurring	  during	  sleep,	  night	  walking,	  sleep	  disordered	  
breathing,	  parasomnia	  and	  daytime	  sleepiness.	  Parents	  are	  asked	  to	  recall	  sleep	  behaviour	  
occurring	  over	  a	  typical	  recent	  week.	  Item	  are	  rated	  on	  a	  three-­‐point	  scale	  as	  usually-­‐	  if	  the	  
sleep	  behaviour	  occurred	  five	  to	  seven	  times	  in	  a	  week,	  sometimes-­‐	  if	  the	  sleep	  behaviour	  
occurred	  two	  to	  four	  times	  in	  a	  week,	  and	  rarely-­‐	  for	  zero	  to	  one	  time	  in	  a	  week.	  Reliability	  
and	  validity	  data	  have	  been	  collected	  on	  a	  sample	  of	  495	  elementary	  school	  children	  and	  a	  
clinical	  sample	  from	  a	  paediatric	  sleep	  clinic.	  The	  CSHQ	  has	  a	  sensitivity	  of	  80%	  and	  
specificity	  of	  72%.	  
	  
A	  paediatric	  sleep	  questionnaire	  was	  developed	  by	  Chervin	  et	  al.	  (2000)	  to	  investigate	  the	  
presence	  of	  childhood	  SRBD	  with	  snoring,	  excessive	  daytime	  sleepiness	  and	  
inattentive/hyperactive	  behaviour	  in	  children	  aged	  two	  to	  eighteen	  years.	  Validity	  was	  
established	  by	  comparison	  to	  objective	  criteria	  -­‐	  PSG	  defined	  obstructive	  SRBD,	  and	  by	  
demonstrating	  that	  the	  questionnaire	  scale	  had	  substantial	  ability	  to	  predict	  diagnostic	  
classification.	  This	  is	  a	  parent-­‐filled	  questionnaire	  to	  assess	  SRBD	  among	  this	  age	  group;	  the	  
screening	  questions	  are	  focused	  on	  snoring,	  excessive	  daytime	  sleepiness	  and	  behaviour	  
changes.	  There	  are	  sixty-­‐nine	  items	  in	  total,	  with	  twenty-­‐two	  items	  for	  SRBD	  score.	  This	  
questionnaire	  showed	  that	  the	  snoring	  scores	  were	  associated	  with	  higher	  levels	  of	  
inattention	  and	  hyperactivity	  in	  children	  at	  a	  child	  psychiatry	  clinic,	  which	  suggests	  that	  
SRBD	  could	  be	  a	  cause	  of	  inattention	  and	  hyperactivity	  in	  some	  children.	  The	  sensitivity	  and	  




1.4.3	  Sleep	  Diaries	  
A	  sleep	  diary	  is	  a	  self-­‐report	  measure	  to	  quantify	  a	  child’s	  sleep	  pattern.	  It	  requires	  parents	  
or	  caregivers	  to	  document	  the	  time	  child	  went	  to	  sleep	  and	  woke	  up,	  any	  daytime	  naps	  
along	  with	  any	  interventions	  to	  help	  the	  child	  fall	  back	  to	  sleep.	  A	  typical	  sleep	  dairy	  involves	  
recording	  of	  the	  child’s	  sleep	  pattern	  for	  two	  weeks	  (Moriwaki	  et	  al.,	  2009).	  This	  diary	  will	  
provide	  important	  information	  about	  inadequate	  sleep	  hygiene,	  insomnia,	  frequent	  brief	  
awakening	  spells	  or	  information	  on	  EDS.	  Sleep	  diaries	  are	  often	  used	  in	  conjunction	  with	  
other	  techniques	  such	  as	  actigraphy.	  
	  
1.4.4	  Radiology	  
SRBD	  is	  a	  dynamic	  process	  occurring	  during	  sleep,	  so	  static	  films	  have	  a	  very	  limited	  role	  in	  
diagnosing	  SRBD.	  Lateral	  soft	  tissue	  radiography	  of	  the	  neck	  when	  the	  child	  is	  awake	  may	  
give	  an	  indication	  of	  the	  upper	  airway	  anatomy,	  but	  it	  may	  not	  predict	  the	  presence	  or	  
severity	  of	  obstruction	  contributing	  to	  symptoms	  of	  SRBD.	  Furthermore,	  it	  may	  not	  be	  
justified	  to	  expose	  the	  child	  to	  the	  effects	  of	  radiation	  in	  diagnosis	  or	  to	  use	  as	  a	  screening	  
tool	  for	  SRBD.	  
On	  the	  other	  hand,	  non-­‐ionizing	  radiation	  like	  MRI	  has	  been	  used	  extensively	  in	  adults.	  	  
Moriwakia	  et	  al.	  (2009)	  evaluated	  	  dynamic	  changes	  in	  the	  pharyngeal	  airway	  of	  thirty-­‐one	  
adult	  patients	  with	  OSAS	  by	  using	  ultrafast	  dynamic	  MRI	  scanning	  and	  concluded	  that	  
velopharynx	  is	  the	  commonest	  site	  for	  obstruction.	  Donnelly	  (2005)	  has	  reviewed	  the	  
indication	  of	  cine	  MR	  sleep	  studies	  in	  paediatric	  OSA	  and	  concluded	  that	  cine	  MRI	  is	  helpful	  
in	  depicting	  both	  anatomical	  causes	  of	  OSA	  and	  dynamic	  abnormalities	  that	  lead	  to	  
functional	  collapse	  in	  the	  airway.	  The	  only	  disadvantage	  of	  using	  a	  dynamic	  cine	  MRI	  is	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sedation	  of	  the	  child	  to	  induce	  sleep.	  Some	  argue	  that	  induced	  sleep	  using	  sedatives	  may	  
not	  be	  the	  same	  as	  natural	  sleep:	  although	  this	  is	  true,	  the	  muscle	  tone	  would	  be	  decreased	  
in	  both	  natural	  and	  induced	  sleep	  and	  the	  pathophysiology	  of	  OSA	  is	  a	  decrease	  in	  muscular	  
tone,	  which	  is	  being	  measured	  in	  the	  cine	  MRI.	  
	  
The	  process	  of	  cine	  MR	  imaging	  is	  similar	  to	  ordinary	  MR,	  but	  for	  the	  sedation	  of	  the	  child;	  
once	  asleep,	  the	  child	  is	  placed	  in	  an	  appropriate	  size	  head	  and	  neck	  vascular	  coil.	  With	  this	  
coil,	  the	  supraglottic	  airway	  from	  the	  nasopharynx	  can	  be	  imaged	  with	  the	  patient’s	  cervical	  
spine	  being	  in	  a	  neutral	  position.	  Cine	  MR	  sequences	  are	  performed	  in	  the	  midline	  sagittal,	  
as	  well	  as	  the	  transverse	  plane	  at	  the	  level	  of	  the	  middle	  portion	  of	  the	  tongue.	  These	  
images	  are	  then	  displayed	  in	  a	  cine	  format	  to	  create	  a	  real-­‐time	  movie	  of	  airway	  motion.	  
	  
1.4.5	  Audiotaping	  
	  Overnight	  audiotaping	  has	  been	  used	  to	  assess	  the	  presence	  of	  snoring	  or	  apnoea	  episodes	  
during	  sleep,	  but	  it	  has	  not	  been	  possible	  to	  reliably	  distinguish	  simple	  snoring	  from	  snoring	  
associated	  with	  sleep	  apnoea.	  Lamm	  et	  al.	  (1999)	  studied	  thirty-­‐six	  children	  with	  PSG	  
confirmed	  OSAS,	  by	  audiotaping	  their	  sleep,	  and	  found	  that	  audiotaping	  was	  71%	  sensitive	  
and	  80%	  specific	  in	  diagnosing	  OSAS.	  The	  authors	  concluded	  that	  if	  an	  abnormality	  in	  the	  
sleeping	  pattern	  is	  detected	  on	  audiotaping,	  it	  may	  need	  to	  be	  further	  evaluated	  to	  assess	  
the	  presence	  of	  sleep	  apnoea;	  however,	  if	  no	  abnormality	  is	  detected	  on	  audiotaping,	  then	  
the	  child	  may	  not	  have	  SRBD.	  
	  
1.4.6	  Overnight	  Oximetry	  
The	  diagnostic	  value	  of	  pulse	  oximetry	  in	  OSA	  is	  controversial.	  Pulse	  oximetry	  is	  a	  non-­‐
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invasive	  method	  to	  measure	  oxygen	  desaturation.	  It	  would	  have	  a	  greater	  role	  in	  the	  
diagnosis	  of	  OSA	  if	  all	  obstructive	  events	  were	  associated	  with	  oxygen	  desaturations.	  
Because	  an	  obstructed	  event	  may	  not	  necessarily	  be	  associated	  with	  oxygen	  desaturation,	  a	  
normal	  oximetry	  study	  may	  be	  mistaken	  for	  absence	  of	  OSA.	  The	  second	  controversy	  in	  the	  
use	  of	  pulse	  oximetry	  as	  a	  screening	  tool	  is	  the	  number	  of	  desaturation	  events	  and	  the	  level	  
of	  desaturation	  to	  diagnose	  OSA.	  	  
	  
Nixon	  et	  al.	  (2005),	  in	  their	  three-­‐phase	  study,	  developed	  and	  validated	  a	  severity	  scoring	  
system	  for	  overnight	  oximetry.	  In	  phase	  1,	  a	  severity	  score	  was	  developed	  by	  review	  of	  
preoperative	  overnight	  oximetry	  in	  children	  who	  had	  urgent	  adenotonsillectomy	  in	  1999–
2000.	  In	  phase	  2,	  the	  score	  was	  validated	  retrospectively	  in	  155	  children	  who	  had	  PSG	  
before	  adenotonsillectomy	  in	  1992–1998.	  In	  phase	  3,	  a	  twelve-­‐month	  prospective	  
evaluation	  of	  a	  protocol	  based	  on	  the	  score	  was	  conducted. In	  phase	  1,	  a	  4-­‐level	  severity	  
score	  was	  developed	  on	  the	  basis	  of	  number	  and	  depth	  of	  desaturation	  events	  (normal	  to	  
severely	  abnormal,	  categories	  1–4).	  In	  phase	  2,	  the	  McGill	  oximetry	  score	  correlated	  with	  
severity	  of	  OSA	  by	  PSG	  criteria.	  In	  phase	  3,	  a	  clinical	  management	  protocol	  was	  developed	  
based	  on	  the	  score.	  From	  this	  three-­‐phase	  study	  they	  devised	  the	  McGill	  Oximetry	  Scoring	  
System,	  as	  shown	  in	  the	  table	  below.	  
	  
	  

















































































































































































































































































































































































































In	  the	  above	  table,	  the	  authors	  validated	  a	  severity	  scoring	  system	  for	  overnight	  oximetry	  
from	  a	  three-­‐phase	  study.	  This	  score	  reflects	  the	  severity	  of	  OSA	  and	  prioritises	  treatment	  
on	  the	  basis	  of	  oximetry	  score.	  If	  the	  oximetry	  score	  is	  1	  then	  additional	  measures	  to	  rule	  
out	  sleep	  apnoea,	  like	  PSG,	  should	  be	  employed.	  If	  the	  score	  is	  2,	  then	  the	  patient	  needs	  to	  
be	  added	  to	  the	  waiting	  list	  for	  adenotonsillectomy.	  If	  the	  score	  is	  3,	  then	  surgery	  is	  
recommended	  within	  two	  weeks,	  and	  if	  the	  score	  is	  4,	  the	  surgery	  needs	  to	  be	  prioritized	  
and	  done	  within	  days.	  
	  
Brouillette	  et	  al.	  (2000)	  conducted	  a	  cross-­‐sectional	  study	  on	  349	  children	  referred	  to	  a	  
paediatric	  sleep	  lab	  for	  suspected	  OSA.	  Overnight	  pulse	  oximetry	  was	  compared	  with	  PSG	  
and	  the	  authors	  concluded	  that	  a	  positive	  pulse	  oximetry	  result	  increased	  the	  probability	  of	  
patients	  having	  OSA	  to	  97%.	  However,	  47%	  of	  children	  with	  negative	  or	  inconclusive	  
oximetry	  readings	  were	  positive	  for	  OSA	  on	  PSG.	  From	  this	  study,	  it	  is	  evident	  that	  negative	  
oximetry	  findings	  do	  not	  rule	  out	  OSA.	  Oeverland	  et	  al.	  (2002)	  conducted	  a	  prospective	  
study	  on	  one	  hundred	  consecutive	  patients	  referred	  for	  PSG	  to	  rule	  out	  SRBD	  in	  the	  adult	  
population	  and	  concluded	  that	  the	  sensitivity	  and	  specificity	  to	  diagnose	  moderate	  to	  
severe	  sleep	  apnoea	  (AHI>15)	  were	  0.86	  and	  0.88	  respectively.	  The	  corresponding	  figures	  
for	  milder	  sleep	  apnoea	  (AHI>5)	  were	  0.91	  and	  0.67.	  
	  
The	  Royal	  College	  of	  Paediatric	  and	  Child	  Health	  guidelines	  do	  suggest	  that	  there	  is	  a	  role	  for	  
overnight	  pulse	  oximetry	  (ONPO)	  in	  diagnosing	  SRBD,	  as	  a	  sequel	  of	  SRBD	  ventilation	  is	  
affected,	  and	  the	  simplest	  method	  of	  assessing	  ventilation	  is	  measurement	  of	  oxygenation	  
by	  ONPO.	  Abnormal	  desaturations	  in	  pulse	  oximetry	  recordings	  are	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1) >	  4	  dips	  per	  hour	  of	  >	  4%	  below	  baseline	  saturations	  
2) Abnormal	  clusters	  of	  4%	  desaturations(	  5	  or	  more	  such	  events	  in	  30	  min)	  
3) Prolonged	  desaturation	  below	  90%.	  
	  
Oximetry	  is	  affected	  by	  movement	  artefacts	  and	  by	  poor	  tissue	  perfusion.	  Visualisation	  of	  
the	  pulse	  waveform	  improves	  differentiation	  of	  genuine	  desaturations	  from	  artefacts	  
(Lafontaine	  et	  al.,	  1996).	  	  
	  
From	  the	  above	  studies	  and	  review	  of	  literature,	  it	  can	  be	  concluded	  that	  pulse	  oximetry	  has	  
a	  role	  in	  the	  diagnosis	  of	  OSA,	  but	  that	  negative	  oximetry	  results	  in	  the	  presence	  of	  
symptoms	  of	  OSA	  should	  be	  evaluated	  further	  using	  other	  methods.	  
	  
1.4.7	  Polysomnography	  
Polysomnography	  (PSG),	  the	  gold	  standard	  diagnostic	  tool	  for	  diagnosing	  paediatric	  SRBD,	  is	  
a	  recording	  of	  the	  physiological	  changes	  during	  sleep.	  These	  parameters	  are	  similar	  to	  the	  
adult	  ones,	  with	  a	  few	  exceptions.	  The	  characteristic	  montage	  as	  described	  in	  American	  
Academy	  of	  Sleep	  Medicine	  includes.	  
• Electroencephalogram	  (EEG)	  
• Electromyogram	  (EMG)	  
• Electrooculogram	  (EOG)	  
• ECG	  
• Nasal	  Pressure	  
• Oro	  nasal	  airflow	  
• End	  tidal	  PCO2	  
• Arterial	  oxygen	  saturation	  (spO2)	  with	  pulse	  waveform	  
• Chest	  and	  abdominal	  wall	  motion	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• Body	  position	  monitor	  
• Snoring	  microphone	  
• Video	  
Electroencephalogram	  (EEG)	  measures	  the	  brain	  neuronal	  activity.	  EEG	  measurement	  
involves	  placing	  two	  electrodes	  in	  the	  occipital	  region,	  three	  in	  the	  cranial	  region	  and	  three	  
in	  the	  frontal	  region	  to	  record	  the	  brain	  waves.	  Brain	  waves	  have	  a	  characteristic	  frequency,	  
amplitude	  and	  morphology	  and	  each	  stage	  of	  sleep	  has	  a	  characteristic	  brain	  wave	  
	  
	  	  




Alpha	  waves	  are	  the	  first	  brain	  waves:	  they	  are	  predominant	  in	  the	  relaxed	  wakefulness	  
state	  and	  have	  a	  frequency	  of	  8-­‐13	  Hz.	  Beta	  waves	  (spindle	  and	  	  K	  complexes)	  are	  
characteristic	  of	  stage	  2	  NREM	  sleep;	  they	  occur	  in	  the	  setting	  of	  variable	  low	  frequency	  
waves.	  Theta	  waves	  are	  predominant	  in	  stage	  1	  NREM	  and	  have	  a	  frequency	  of	  12-­‐14	  Hz.	  
Delta	  waves	  are	  predominant	  in	  stage	  3-­‐4	  NREM	  sleep	  and	  have	  a	  frequency	  between	  0.5	  
and	  2	  Hz.	  The	  EEG	  of	  REM	  sleep	  is	  very	  similar	  to	  the	  stage	  1	  NREM,	  but	  is	  characterized	  by	  
rapid	  oscillating	  eye	  movement	  and	  skeletal	  muscle	  atony.	  	  
Electromyogram	  (EMG)	  involves	  placing	  one	  electrode	  on	  the	  chin	  and	  one	  on	  each	  leg	  to	  
measure	  muscular	  activity	  during	  sleep.	  	  
	  
Electrooculogram	  (EOG)	  involves	  placing	  one	  electrode	  about	  half	  an	  inch	  on	  either	  side	  of	  
the	  lateral	  canthi	  to	  measure	  eye	  movements	  during	  sleep.	  Electrocardiogram	  (ECG)	  records	  
cardiac	  events	  during	  sleep.	  	  
	  
Nasal	  pressure	  and	  oro	  nasal	  airflow-­‐	  A	  thermistor	  is	  used	  to	  measure	  nasal	  pressure	  and	  
oro	  nasal	  airflow,	  particularly	  in	  children,	  as	  many	  of	  them	  have	  enlarged	  adenoids	  and	  
therefore	  breathe	  through	  their	  mouths.	  	  
	  
End	  tidal	  CO2-­‐	  End	  tidal	  CO2	  is	  a	  measure	  of	  hypoventilation,	  and	  is	  usually	  measured	  as	  a	  
side	  stream	  from	  a	  nasal	  cannula,	  or	  in	  an	  intubated	  patient,	  from	  the	  endotracheal	  tube.	  	  
	  
Pulse	  Oximetry	  with	  waveform	  is	  often	  useful	  to	  correlate	  desaturation	  events	  with	  the	  




Respiratory	  effort-­‐	  Sensors	  to	  measure	  the	  chest	  wall	  and	  abdominal	  wall	  movement	  are	  
used	  to	  monitor	  respiratory	  effort.	  Body	  positioning	  is	  frequently	  monitored,	  although	  this	  is	  
not	  as	  important	  as	  in	  adults.	  Snoring	  microphone	  and	  videotaping	  of	  the	  sleep	  pattern	  are	  
valuable	  adjuncts	  in	  polysomnography.	  
	  
Mitchell	  et	  al.	  (2007),	  in	  their	  prospective	  cohort	  study,	  assessed	  the	  persistence	  of	  OSA	  
symptoms	  before	  and	  after	  adenotonsillectomy	  on	  seventy-­‐nine	  children	  between	  three	  
and	  fourteen	  years	  using	  polysomnography.	  This	  study	  showed	  that	  mean	  preoperative	  AHI	  
for	  the	  study	  population	  was	  27.5%,	  which	  was	  statistically	  different	  from	  the	  mean	  post-­‐
operative	  AHI	  of	  3.5%.	  Similarly,	  many	  studies	  (Bixler et al., 2009; Goodwin et al., 2010)	  
have	  used	  PSG	  to	  diagnose	  SRBD.	  There	  is	  no	  doubt	  that	  PSG	  is	  a	  gold	  standard	  in	  diagnosing	  
SRBD,	  but	  the	  limitation	  of	  using	  PSG	  as	  a	  diagnostic	  tool	  is	  the	  non-­‐availability	  of	  sleep	  
centres	  equipped	  with	  PSG	  and	  the	  need	  for	  the	  child	  to	  spend	  the	  night	  in	  an	  unfamiliar	  
environment,	  apart	  from	  the	  cost	  factor.	  Moreover,	  the	  diagnostic	  tests	  described	  so	  far	  
assess	  the	  sequelae	  of	  upper	  airway	  obstruction,	  but	  not	  the	  severity	  of	  upper	  airway	  
obstruction,	  which	  would	  then	  lead	  onto	  SRBD.	  
	  
A	  proposal	  is	  put	  forward	  in	  this	  thesis	  is	  that	  as	  the	  crux	  for	  SRBD	  is	  upper	  airway	  
obstruction,	  management	  can	  be	  streamlined	  if	  a	  simple	  diagnostic	  test	  can	  measure	  
severity	  of	  upper	  airway	  obstruction.	  A	  review	  of	  the	  literature	  did	  not	  reveal	  any	  study	  to	  
measure	  the	  severity	  of	  upper	  airway	  obstruction,	  but	  there	  are	  a	  few	  studies	  that	  have	  
used	  spirometry	  to	  access	  the	  lower	  airway	  function	  (pulmonary	  function	  test)	  in	  children	  
with	  adenotonsillar	  hypertrophy.	  Yadav	  et	  al.	  (2003)	  used	  spirometry	  to	  measure	  pulmonary	  
function	  in	  forty	  children	  before	  and	  after	  adenotonsillectomy	  and	  found	  that	  there	  was	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statistically	  significant	  improvement	  in	  the	  pulmonary	  function,	  such	  as	  FIF50%,	  FEF50%,	  
FEV1/PEFR	  and	  FEV1/FEV0.5	  ratios	  after	  the	  surgery.	  Niedzielska	  et	  al.	  (2008)	  measured	  
pulmonary	  function	  and	  nasal	  flow	  in	  thirty	  children	  with	  adenoid	  hypertrophy	  by	  
spirometry	  and	  nasometric	  test	  and	  found	  a	  statistically	  significant	  improvement	  in	  the	  
nasometric	  flows	  and	  VC,	  FVC,	  PEF,	  FEV1/PEF	  and	  FEV1/FVC	  after	  adenoidectomy.	  In	  both	  
these	  studies,	  spirometry	  has	  been	  used	  to	  demonstrate	  improvement	  in	  pulmonary	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2.1	  Objective	  of	  the	  study	  
The	  objective	  of	  this	  pilot	  study	  was	  to	  assess	  the	  severity	  of	  airway	  obstruction	  in	  patients	  
undergoing	  tonsillectomy	  with	  or	  without	  adenoidectomy	  by	  measuring	  peak	  nasal	  and	  oral	  
inspiratory	  airflow.	  	  
	  
2.2	  Ethical	  Approval	  
The	  study	  was	  approved	  by	  the	  South	  East	  Wales	  Local	  Research	  Ethics	  Committee	  and	  
conducted	  in	  accordance	  with	  the	  International	  Conference	  of	  Harmonization’s	  Guidelines	  
for	  Good	  Clinical	  Practice	  and	  the	  World	  Medical	  Association’s	  Declaration	  of	  Helsinki.	  All	  
subjects	  had	  to	  sign	  a	  consent	  form	  before	  being	  enrolled	  onto	  the	  study	  and	  in	  the	  case	  of	  
the	  paediatric	  population,	  informed	  consent	  was	  obtained	  from	  the	  parent/guardian.	  
	  
2.3	  Assessment	  of	  safety	  and	  ethical	  issues	  
The	  measurement	  of	  peak	  nasal	  and	  oral	  inspiratory	  flow	  is	  a	  non-­‐invasive	  measurement	  
that	  is	  harmless,	  and	  no	  safety	  issues	  are	  expected.	  Any	  adverse	  events	  were	  documented	  
and	  any	  serious	  adverse	  events	  were	  aimed	  to	  be	  reported	  within	  48	  hours	  to	  the	  sponsor	  
and	  the	  ethics	  committee.	  Adverse	  events	  and	  serious	  adverse	  events	  related	  to	  the	  surgery	  
were	  not	  reported	  to	  the	  sponsor	  or	  the	  ethics	  committee,	  as	  they	  are	  not	  a	  consequence	  of	  
this	  study.	  
	  
One	  ethical	  issue	  considered	  by	  the	  investigators	  was	  that	  the	  patients	  and	  parents	  or	  
guardians	  should	  not	  feel	  in	  any	  way	  that	  they	  were	  obliged	  to	  participate	  in	  this	  study	  in	  
order	  to	  receive	  or	  accelerate	  their	  surgical	  treatment.	  In	  order	  to	  ensure	  that	  patients	  did	  
not	  feel	  under	  any	  pressure	  to	  join	  in	  the	  study,	  the	  first	  contact	  with	  the	  patients	  was	  by	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letter,	  explaining	  the	  study	  and	  asking	  them	  to	  respond	  if	  they	  wished	  to	  participate.	  Only	  
after	  patients	  had	  responded	  in	  the	  affirmative	  were	  they	  contacted	  by	  phone	  by	  the	  
investigator,	  to	  discuss	  the	  study	  and	  explain	  any	  aspects	  that	  were	  not	  clear	  to	  the	  patient.	  
Again,	  it	  was	  made	  clear	  at	  this	  stage	  that	  participation	  was	  entirely	  voluntary	  and	  would	  
not	  in	  any	  way	  affect	  their	  treatment.	  
	  
Another	  ethical	  issue	  was	  confidentiality	  of	  patient	  records	  and	  any	  information	  obtained	  
from	  the	  records.	  All	  information	  from	  records	  was	  maintained	  confidentially	  and	  the	  
records	  were	  only	  assessed	  by	  the	  clinical	  investigator.	  
	  
2.4	  Trial	  design	  and	  recruitment	  of	  patients	  
This	  was	  a	  prospective	  study	  carried	  out	  at	  University	  Hospital	  Wales	  and	  the	  Common	  Cold	  
Centre	  at	  Cardiff	  University.	  Recruitment	  was	  done	  from	  a	  cohort	  of	  patients	  on	  the	  waiting	  
list	  for	  tonsillectomy	  with	  or	  without	  adenoidectomy	  at	  University	  Hospital	  Wales,	  Cardiff.	  
These	  patients	  were	  sent	  a	  letter	  of	  invitation	  along	  with	  a	  patient	  information	  leaflet	  to	  
explain	  the	  research	  project	  and	  a	  response	  letter	  to	  convey	  their	  decision	  on	  participation.	  
Once	  patients	  had	  confirmed	  their	  willingness	  to	  take	  part,	  the	  investigator	  contacted	  them	  
over	  the	  telephone	  to	  discuss	  the	  project	  and	  answer	  any	  questions.	  	  
	  
On	  the	  day	  of	  surgery,	  the	  investigator	  obtained	  informed	  consent	  and	  a	  thorough	  
otorhinolaryngology	  examination	  was	  carried	  out	  and	  the	  tonsils	  were	  graded	  using	  the	  
Brodsky	  scale.	  The	  investigator	  measured	  peak	  oral	  and	  nasal	  inspiratory	  flow	  on	  the	  patient	  
using	  a	  portable	  inspiratory	  flow	  meter.	  An	  invitation	  was	  sent	  after	  surgery	  for	  a	  follow-­‐up	  
visit	  to	  the	  Common	  Cold	  Centre	  one	  month	  later,	  to	  repeat	  peak	  inspiratory	  oral	  and	  nasal	  
68 
 
flow	  measurements.	  The	  study	  recruited	  fifty	  patients	  who	  underwent	  pre-­‐operative	  
measurement	  of	  airflow	  and	  twenty-­‐five	  of	  these	  patients	  returned	  for	  the	  second	  visit	  at	  
the	  Common	  Cold	  Centre.	  
	  
2.5	  Selection	  and	  Withdrawal	  of	  Subjects	  
Recruitment	  was	  done	  from	  a	  cohort	  of	  patients	  on	  the	  waiting	  list	  for	  Tonsillectomy	  with	  or	  
without	  Adenoidectomy	  at	  the	  University	  Hospital	  Wales,	  Cardiff.	  
Inclusion	  criteria-­‐	  Patients	  referred	  for	  tonsillectomy	  with	  or	  without	  adenoidectomy	  	  
Exclusion	  Criteria-­‐	  Children	  less	  than	  five	  years	  of	  age	  and	  tonsillectomy	  done	  to	  rule	  out	  
malignancy.	  
	  
2.6	  Methods	  and	  Measurements	  
Peak	  Nasal	  Inspiratory	  Flow	  
The	  measurement	  of	  Peak	  Nasal	  Inspiratory	  Flow	  (PNIF)	  (litres/minute)	  was	  performed	  using	  







Figure	  5:	  In-­‐check	  Peak	  flow	  meter	  
	  
The	  measurement	  of	  PNIF	  has	  been	  previously	  used	  to	  measure	  nasal	  obstruction	  (Starling-­‐
Schwanz	  et	  al.,	  2005).	  	  The	  technique	  involves	  the	  subject	  placing	  a	  mask	  over	  the	  nose	  and	  
making	  a	  maximum	  effort	  to	  breathe	  in	  through	  the	  nose,	  as	  shown	  in	  the	  figure	  below.	  The	  












Figure	  6:	  Nasal	  mask	  attached	  to	  the	  in-­‐check	  portable	  inspiratory	  flow	  meter	  for	  
measurement	  of	  PNIF	  
	  
The	  following	  data	  were	  recorded	  at	  the	  pre-­‐operative	  visit	  1:	  -­‐	  
i. First	  PNIF	  value	  =	  PNIF	  (1)	  
ii. Second	  PNIF	  value	  =	  PNIF	  (2)	  
iii. Third	  PNIF	  value	  =	  PNIF	  (3)	  
	  
The	  following	  data	  was	  recorded	  at	  the	  post-­‐operative	  visit	  2:	  -­‐	  
i. 	  Fourth	  PNIF	  value	  =	  PNIF	  (4)	  
ii. Fifth	  PNIF	  value	  =	  PNIF	  (5)	  
iii. Sixth	  PNIF	  value	  =	  PNIF	  (6)	  
	  
Peak	  Oral	  Inspiratory	  Flow	  
The	  measurement	  of	  Peak	  Oral	  Inspiratory	  Flow	  (POIF)	  (litres/minute)	  was	  performed	  with	  
the	  In-­‐Check	  portable	  flow	  meter	  manufactured	  by	  Clement	  Clarke	  International	  Limited,	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England.	  The	  measurement	  of	  Peak	  oral	  expiratory	  flow	  is	  often	  used	  to	  measure	  lower	  
airway	  obstruction.	  	  However,	  measurement	  of	  POIF	  can	  be	  used	  as	  a	  measure	  of	  oral	  
obstruction,	  as	  the	  oral	  resistance	  due	  to	  anatomical	  narrowing	  secondary	  to	  enlarged	  
tonsillar	  tissue	  occurs	  during	  inspiration.	  The	  technique	  involves	  the	  subject	  placing	  the	  
peak	  inspiratory	  flow	  meter	  in	  the	  mouth	  and	  making	  a	  maximum	  effort	  to	  breathe	  in	  




Figure 7: Oral cannula attached to the peak inspiratory flow meter to measure the POIF. 
 
The	  following	  data	  were	  recorded	  at	  the	  pre-­‐operative	  visit	  1:	  -­‐	  
i. First	  POIF	  value	  =	  POIF	  (1)	  
ii. Second	  POIF	  value	  =	  POIF	  (2)	  
iii. Third	  POIF	  value	  =	  POIF	  (3)	  
	  
The	  following	  data	  were	  recorded	  at	  the	  post-­‐operative	  visit	  2:	  -­‐	  
i. 	  Fourth	  POIF	  value	  =	  POIF	  (4)	  
ii. Fifth	  POIF	  value	  =	  POIF	  (5)	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iii. Sixth	  POIF	  value	  =	  POIF	  (6)	  
	  
2.7	  Patient	  expenses	  
A	  single	  payment	  of	  £25	  pounds	  was	  made	  to	  the	  participants	  attending	  the	  second	  phase	  
of	  the	  study	  at	  the	  Common	  Cold	  Centre.	  
	  
2.8	  Statistical	  analysis	  
This	  was	  a	  pilot	  study	  to	  assess	  the	  upper	  airway	  obstruction	  in	  patients	  undergoing	  
tonsillectomy	  with	  or	  without	  adenoidectomy.	  The	  null	  hypothesis	  that	  there	  is	  no	  
difference	  between	  preoperative	  and	  postoperative	  peak	  inspiratory	  flow	  measurements	  
was	  tested.	  The	  Statistical	  Package	  for	  the	  Social	  Sciences	  version	  20	  for	  the	  Macintosh	  
platform	  was	  utilised	  for	  statistical	  analysis.	  Normal	  distributions	  were	  determined	  using	  the	  
quantile-­‐quantile	  (Q-­‐Q)	  plot	  and	  the	  Kolmogorov-­‐Smirnov	  test	  of	  normality.	  Pearson’s	  
correlation	  coefficient	  method	  was	  used	  to	  determine	  associations	  between	  normally	  
distributed	  data.	  Scatter	  diagrams	  were	  used	  to	  understand	  the	  association	  between	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3.1	  Pre-­‐operative	  data	  analysis	  
3.1	  (A)	  Demographics	  
The	  first	  fifty	  patients	  on	  the	  waiting	  list	  for	  tonsillectomy	  with	  or	  without	  adenoidectomy	  at	  
University	  Hospital	  of	  Wales	  who	  confirmed	  their	  acceptance	  to	  take	  part	  were	  recruited	  in	  
the	  first	  phase	  of	  the	  study.	  There	  were	  twenty-­‐eight	  females	  (56%)	  and	  twenty-­‐two	  males	  
(44%).	  The	  mean	  age	  was	  18.08	  years	  with	  a	  range	  from	  five	  to	  forty-­‐six	  years	  and	  a	  
standard	  deviation	  of	  10.92.	  The	  total	  numbers	  of	  patients	  in	  different	  age	  groups	  are	  listed	  
in	  the	  table	  below.	  
Age	  range	   No	  of	  subjects	   OSA	  
5-­‐10	   17	   12	  
11-­‐18	   10	   2	  
>19	   23	   3	  
	  
Table	  7:	  Demographic	  data	  
	  
All	  patients	  had	  suffered	  from	  attacks	  of	  recurrent	  tonsillitis	  at	  the	  time	  of	  surgery.	  Among	  
the	  fifty	  patients,	  thirty-­‐nine	  (78%)	  had	  a	  history	  of	  snoring,	  seventeen	  (34%)	  had	  symptoms	  
suggestive	  of	  Obstructive	  Sleep	  Apnoea	  (twelve	  of	  them	  in	  the	  age	  group	  5	  -­‐10,	  two	  in	  the	  
age	  group	  11-­‐18	  and	  three	  in	  the	  age	  group	  >19),	  of	  whom	  three	  had	  overnight	  pulse	  











The	  size	  of	  the	  tonsils	  was	  graded	  as	  per	  the	  Brodsky	  grade	  (Grade	  1-­‐Tonsil	  occupying	  less	  
than	  25%	  of	  oropharynx,	  Grade	  2-­‐	  Tonsil	  occupying	  between	  25-­‐50%	  of	  oropharynx,	  Grade	  
3-­‐	  Tonsil	  occupying	  between	  50-­‐	  75%	  of	  oropharynx	  and	  Grade	  4-­‐	  Tonsil	  occupying	  more	  
than	  75%	  of	  oropharynx).	  
	  
Brodsky	  Grade	   Frequency	   Percent	  (%)	  
	  
1	   2	   4.0	  
2	   12	   24.0	  
3	   33	   66.0	  
4	   3	   6.0	  
Total	   50	   100.0	  
	  
Table	  8:	  Frequency	  of	  tonsil	  size	  graded	  as	  per	  Brodsky’s	  grading	  in	  the	  study	  group.	  
	  
The	  past	  medical	  history	  of	  four	  patients	  included	  asthma,	  and	  they	  were	  on	  regular	  
inhalers.	  They	  had	  been	  stable	  on	  these	  medications	  for	  many	  years.	  None	  of	  the	  patients	  
were	  allergic	  to	  any	  medications.	  
	  












3.1(B)	  Pre-­‐operative	  data	  of	  the	  study	  group	  
N	   POIF	  1	   POIF	  2	   POIF	  3	   POIF-­‐M	   PNIF	  1	   PNIF	  2	   PNIF	  3	   PNIF	  -­‐M	  
1	   110	   150	   150	   150	   30	   30	   30	   30	  
2	   150	   140	   140	   150	   50	   40	   30	   50	  
3	   150	   160	   200	   200	   30	   30	   30	   30	  
4	   320	   320	   330	   330	   70	   50	   70	   70	  
5	   220	   270	   220	   270	   50	   70	   70	   70	  
6	   150	   200	   250	   250	   50	   70	   70	   70	  
7	   150	   160	   160	   160	   50	   50	   40	   50	  
8	   170	   210	   240	   240	   50	   70	   70	   70	  
9	   150	   170	   170	   170	   50	   40	   40	   50	  
10	   80	   100	   100	   100	   40	   50	   50	   50	  
11	   150	   160	   170	   170	   80	   60	   60	   80	  
12	   150	   160	   160	   160	   30	   40	   50	   50	  
13	   100	   140	   150	   150	   70	   70	   70	   70	  
14	   150	   170	   170	   170	   50	   70	   90	   90	  
15	   70	   120	   120	   120	   40	   40	   50	   50	  
16	   80	   70	   80	   80	   30	   40	   30	   40	  
17	   70	   80	   80	   80	   40	   40	   50	   50	  
18	   70	   80	   70	   80	   40	   40	   40	   40	  
19	   180	   170	   190	   190	   80	   70	   70	   80	  
20	   200	   250	   270	   270	   50	   50	   50	   50	  
21	   150	   150	   170	   170	   30	   40	   40	   40	  
22	   80	   90	   80	   90	   30	   30	   40	   40	  
23	   100	   120	   120	   120	   40	   50	   50	   50	  
24	   250	   270	   270	   270	   80	   120	   120	   120	  
25	   300	   350	   300	   350	   70	   60	   50	   70	  
	  	  	  	  	  	  	  	  	  26	   80	   70	   80	   80	   30	   30	   40	   40	  
27	   120	   150	   170	   170	   70	   70	   50	   70	  
28	   300	   350	   300	   350	   50	   80	   80	   80	  
29	   200	   300	   300	   300	   90	   100	   140	   140	  
30	   140	   150	   140	   150	   50	   60	   70	   70	  
31	   160	   200	   160	   200	   60	   60	   40	   60	  
32	   120	   140	   150	   150	   50	   50	   50	   50	  
33	   250	   300	   300	   300	   50	   40	   50	   50	  




























35	   100	   120	   120	   120	   50	   60	   50	   60	  
36	   80	   90	   90	   90	   30	   40	   50	   50	  
37	   70	   70	   50	   70	   30	   40	   40	   40	  
38	   50	   60	   70	   70	   40	   40	   40	   40	  
39	   200	   180	   180	   200	   100	   90	   70	   100	  
40	   150	   170	   180	   180	   50	   50	   50	   50	  
41	   200	   250	   250	   250	   50	   60	   60	   60	  
42	   50	   60	   70	   70	   40	   40	   40	   40	  
43	   100	   90	   80	   100	   40	   40	   50	   50	  
44	   100	   90	   90	   100	   50	   40	   40	   50	  
45	   90	   120	   130	   130	   50	   60	   50	   60	  
46	   120	   130	   100	   130	   50	   40	   40	   50	  
47	   200	   200	   240	   240	   50	   30	   50	   50	  
48	   200	   220	   230	   230	   70	   70	   80	   80	  
49	   70	   80	   60	   80	   30	   40	   40	   40	  
50	   150	   170	   170	   170	   50	   70	   70	   70	  
78 
 




	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF	  1	   50	   50	   320	   147.00	   69.142	  
	   	   	   	   	   	  
	  
Table	  10:	  Pre-­‐operative	  peak	  oral	  inspiratory	  flow	  1	  
	  
POIF-­‐1	  was	  the	  first	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  50	  l/min,	  the	  maximum	  measurement	  was	  320	  l/min,	  and	  the	  
mean	  was	  147	  l/min	  with	  a	  standard	  deviation	  of	  69.142.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF	  2	   50	   60	   350	   166.40	   78.552	  
	   	   	   	   	   	  
	  
Table	  11:	  Pre-­‐operative	  peak	  oral	  inspiratory	  flow	  2	  
	  
	  
POIF-­‐2	  was	  the	  second	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  60	  l/min,	  the	  maximum	  measurement	  was	  350	  l/min,	  and	  the	  






	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF	  3	   50	   50	   330	   167.40	   77.191	  
	   	   	   	   	   	  
	  
Table	  12:	  Pre-­‐operative	  peak	  oral	  inspiratory	  flow	  3	  
	  
	  
POIF-­‐3	  was	  the	  third	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  50	  l/min,	  the	  maximum	  measurement	  was	  330	  l/min,	  and	  the	  
mean	  was	  167.40	  l/min	  with	  a	  standard	  deviation	  of	  69.142.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF-­‐M	   50	   70	   350	   174.40	   79.595	  
	   	   	   	   	   	  
	  
Table	  13:	  Pre-­‐operative	  maximum	  peak	  oral	  inspiratory	  flow	  
	  
POIF-­‐M	  was	  the	  maximum	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  70	  l/min,	  the	  maximum	  measurement	  was	  350	  l/min,	  and	  the	  
mean	  was	  174.40	  l/min	  with	  a	  standard	  deviation	  of	  79.595.	  
	  
In	  order	  to	  normalize	  the	  measurements,	  so	  as	  to	  obtain	  a	  normal	  distribution,	  which	  will	  
also	  help	  to	  predict	  the	  repeatability	  of	  the	  measurements,	  the	  first	  measurement	  of	  peak	  
oral	  inspiratory	  flow	  (POIF-­‐1)	  was	  taken	  as	  1.	  The	  ratio	  of	  the	  second	  measurement	  of	  peak	  
oral	  inspiratory	  flow	  (POIF-­‐2)	  with	  that	  of	  POIF-­‐1	  was	  calculated	  to	  derive	  POIF	  2-­‐1.	  Similarly,	  
the	  ratio	  of	  the	  third	  measurement	  of	  peak	  oral	  inspiratory	  flow	  (POIF-­‐3)	  with	  that	  of	  POIF-­‐1	  




	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviati
on	  
POIF	  2-­‐1	   50	   0.8700	   1.7100	   1.137	   0.161	  
	   	   	   	   	   	  
	  
Table	  14:	  POIF	  2-­‐1	  
	  
POIF	  2-­‐1	  is	  the	  normalized	  value	  of	  the	  second	  measurement	  of	  POIF.	  POIF	  2-­‐1	  was	  
calculated	  for	  all	  fifty	  participants:	  the	  maximum	  POIF	  2-­‐1	  was	  1.71	  and	  the	  minimum	  was	  
0.87	  with	  a	  mean	  of	  1.137	  and	  standard	  deviation	  of	  0.161.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviati
on	  
POIF	  3-­‐1	   50	   0.7100	   1.7100	   1.149	   0.215	  
	   	   	   	   	   	  
	  
Table	  15:	  POIF	  3-­‐1	  
	  
POIF	  3-­‐1	  is	  the	  normalized	  value	  of	  the	  third	  measurement	  of	  POIF.	  The	  maximum	  POIF	  3-­‐1	  
was	  1.71	  and	  the	  minimum	  was	  0.71	  with	  a	  mean	  of	  1.149	  and	  standard	  deviation	  of	  0.215.	  
	  
	  
3.1(D)	  Relationship	  between	  POIF-­‐1,	  POIF	  2-­‐1,POIF	  3-­‐1	  
	  
A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  POIF	  1	  and	  POIF	  2-­‐1.	  The	  




A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  POIF	  1	  and	  POIF	  3-­‐1.	  The	  
mean	  difference	  in	  the	  ratio	  was	  0.150	  [0.088,	  0.210]	  and	  the	  t	  (49)	  =	  4.907,	  p	  <	  0.0001.	  	  
	  
	  
3.1	  (E)	  	  Effects	  of	  age	  on	  POIF-­‐M	  
	  
Using	  a	  linear	  regression	  model,	  with	  age	  as	  an	  independent	  factor	  and	  POIF-­‐M	  as	  a	  
dependent	  factor,	  there	  appears	  to	  be	  a	  linear	  relationship	  between	  age	  and	  POIF-­‐M.	  	  
	  
	  
Figure	  8:	  Relation	  between	  age	  on	  X	  axis	  and	  POIF-­‐M	  on	  Y	  axis.	  
	  
From	  the	  above	  scatter	  plot	  graph,	  age	  appears	  to	  have	  an	  influence	  on	  the	  POIF.	  The	  
correlation	  determined	  by	  Pearson’s	  product	  moment	  correlation	  coefficient	  (r)	  of	  0.603,	  
p<0.001.	  For	  every	  year’s	  increase	  in	  age,	  the	  POIF	  increases	  by	  4.394	  l/min.	  	  
82 
 
3.1	  (F)	  Descriptive	  analysis	  of	  PNIF	  (pre	  operative)	  
	  
Three	  measurement	  of	  PNIF,	  namely	  PNIF-­‐1,	  PNIF-­‐2	  and	  PNIF-­‐3,	  were	  obtained	  from	  all	  the	  
participants	  and	  the	  maximum	  PNIF	  (PNIF-­‐M)	  measurement	  was	  taken	  for	  final	  data	  
analysis.	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF	  1	   50	   30	   100	   51.00	   17.642	  
	   	   	   	   	   	  
	  
Table	  16:	  Pre-­‐operative	  peak	  nasal	  inspiratory	  flow	  1	  
	  
	  
PNIF-­‐1	  was	  the	  first	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  30	  l/min,	  the	  maximum	  measurement	  was	  100	  l/min,	  and	  the	  
mean	  was	  51	  l/min	  with	  a	  standard	  deviation	  of	  17.642.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF	  2	   50	   30	   120	   53.80	   18.940	  
	   	   	   	   	   	  
	  
Table	  17:	  Pre-­‐operative	  peak	  nasal	  inspiratory	  flow	  2	  
	  
PNIF-­‐2	  was	  the	  second	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  30	  l/min,	  the	  maximum	  measurement	  was	  120	  l/min,	  and	  the	  




	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF	  3	   50	   30	   140	   55.40	   21.209	  
	   	   	   	   	   	  
	  
Table	  18:	  Pre-­‐operative	  peak	  nasal	  inspiratory	  flow	  3	  
	  
PNIF-­‐3	  was	  the	  third	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  The	  
minimum	  measurement	  was	  30	  l/min,	  the	  maximum	  measurement	  was	  140	  l/min	  and	  the	  
mean	  was	  55.40	  l/min	  with	  a	  standard	  deviation	  of	  21.209.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF-­‐M	   50	   30	   140	   60.00	   21.665	  
	   	   	   	   	   	  
	  
Table	  19:	  Pre-­‐operative	  maximum	  peak	  nasal	  inspiratory	  flow	  	  
	  
	  
PNIF-­‐M	  was	  the	  maximum	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group.	  
The	  minimum	  measurement	  was	  30	  l/min,	  the	  maximum	  measurement	  was	  140	  l/min,	  and	  
the	  mean	  was	  60.00	  l/min	  with	  a	  standard	  deviation	  of	  21.665.	  
	  
In	  order	  to	  normalize	  the	  measurements,	  so	  as	  to	  obtain	  a	  normal	  distribution,	  which	  will	  
also	  help	  to	  predict	  the	  repeatability	  of	  the	  measurements,	  the	  first	  measurement	  of	  peak	  
nasal	  inspiratory	  flow	  (PNIF-­‐1)	  was	  taken	  as	  1.	  The	  ratio	  of	  the	  second	  measurement	  of	  peak	  
nasal	  inspiratory	  flow	  (PNIF-­‐2)	  with	  that	  of	  PNIF-­‐1	  was	  calculated	  to	  derive	  PNIF	  2-­‐1.	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Similarly,	  the	  ratio	  of	  the	  third	  measurement	  of	  peak	  nasal	  inspiratory	  flow	  (PNIF-­‐3)	  with	  
that	  of	  PNIF-­‐1	  was	  calculated	  to	  derive	  PNIF	  3-­‐1.	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF	  2-­‐1	   50	   1	   2	   1.04	   0.198	  
	   	   	   	   	   	  
	  
Table	  20:	  PNIF	  2-­‐1	  
	  
PNIF	  2-­‐1	  is	  the	  normalized	  value	  of	  the	  second	  measurement	  of	  PNIF.	  PNIF	  2-­‐1	  was	  
calculated	  for	  all	  fifty	  participants:	  the	  maximum	  PNIF	  2-­‐1	  was	  2	  and	  the	  minimum	  1,	  with	  a	  
mean	  of	  1.04	  and	  standard	  deviation	  of	  0.198.	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF	  3-­‐1	   50	   1	   2	   1.12	   0.328	  
	   	   	   	   	   	  
	  
Table	  21:	  PNIF	  3-­‐1	  
	  
PNIF	  3-­‐1	  is	  the	  normalized	  value	  of	  the	  third	  measurement	  of	  PNIF.	  PNIF	  3-­‐1	  was	  calculated	  
for	  all	  fifty	  participants:	  the	  maximum	  PNIF	  3-­‐1	  was	  2,	  and	  the	  minimum	  1,	  with	  a	  mean	  of	  








3.1	  (G)	  Relationship	  between	  PNIF	  1,	  PNIF	  2-­‐1,PNIF	  3-­‐1	  
	  
A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  PNIF	  1	  and	  PNIF	  2-­‐1.	  The	  
mean	  difference	  in	  the	  ratio	  was	  0.40	  [0.02,	  0.10]	  and	  t	  (49)	  =	  1.49,	  p	  <	  0.0001.	  
	  
A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  PNIF	  1	  and	  PNIF	  3-­‐1.	  The	  
mean	  difference	  in	  the	  ratio	  was	  0.120	  [0.03,	  0.21]	  and	  t	  (49)	  =	  2.585,	  p	  <	  0.0001.	  
	  
	  
3.1	  (H)	  Effects	  of	  age	  on	  PNIF-­‐M	  
Using	  a	  linear	  regression	  model,	  with	  age	  as	  an	  independent	  factor	  and	  PNIF-­‐M	  as	  a	  
dependent	  factor,	  there	  appears	  to	  be	  a	  linear	  relationship	  between	  age	  and	  PNIF-­‐M.	  	  
	  
	  




Form	  the	  above	  scatter	  plot	  graph,	  age	  appears	  to	  have	  an	  influence	  on	  the	  PNIF.	  The	  
correlation	  determined	  by	  Pearson’s	  product	  moment	  correlation	  coefficient	  (r)	  was	  0.381,	  
p<0.006.	  For	  every	  year’s	  increase	  in	  age,	  the	  PNIF	  increases	  by	  0.756	  l/min.	  	  
	  
	  
3.	  1(I)	  Relationship	  between	  pre-­‐operative	  POIF	  and	  PNIF	  
	  
The	  relationship	  between	  POIF	  and	  PNIF	  in	  each	  participant	  was	  tested	  using	  the	  Pearson	  
correlation.	  The	  correlation	  coefficient	  (r)	  was	  0.585,	  p<.0001.	  This	  shows	  that	  there	  is	  a	  
good	  correlation	  between	  POIF	  and	  PNIF,	  as	  demonstrated	  in	  the	  scatter	  plot	  below.	  
	  
	  




3.2	  	  Post-­‐operative	  data	  analysis	  
	  
3.2	  (A)	  Demographics	  
	  
Twenty-­‐five	  (50%)	  of	  the	  first	  phase	  participants	  agreed	  to	  take	  part	  in	  the	  second	  phase	  of	  
the	  study.	  There	  were	  thirteen	  females	  (52%)	  and	  twelve	  males	  (48%).	  The	  mean	  age	  was	  
20.76	  years	  with	  a	  range	  from	  five	  to	  forty-­‐six	  years	  and	  a	  standard	  deviation	  of	  11.68.	  All	  
patients	  had	  suffered	  from	  attacks	  of	  recurrent	  tonsillitis	  at	  the	  time	  of	  surgery.	  Among	  the	  
twenty-­‐five	  patients,	  nineteen	  (76%)	  had	  history	  of	  snoring	  and	  five	  (20%)	  had	  symptoms	  


















3.2(B)	  Post-­‐operative	  data	  	  
	  
	  




























N	   POIF	  4	   POIF	  5	   POIF	  6	   POIF-­‐M1	   PNIF	  4	   PNIF	  5	   PNIF	  6	   PNIF-­‐M1	  
1	   200	   250	   200	   250	   50	   50	   40	   50	  
2	   300	   320	   300	   320	   80	   90	   100	   100	  
3	   150	   170	   190	   190	   50	   70	   70	   70	  
4	   110	   120	   100	   120	   50	   60	   50	   60	  
5	   160	   170	   160	   170	   60	   60	   70	   70	  
6	   220	   230	   250	   250	   90	   90	   90	   90	  
7	   200	   260	   240	   260	   90	   90	   90	   90	  
8	   280	   300	   280	   300	   150	   130	   150	   150	  
9	   150	   150	   140	   150	   50	   50	   40	   50	  
10	   120	   100	   120	   120	   50	   60	   70	   70	  
11	   340	   350	   350	   350	   100	   120	   120	   120	  
12	   250	   270	   250	   270	   90	   90	   90	   90	  
13	   180	   240	   250	   250	   80	   80	   100	   100	  
14	   330	   320	   350	   350	   160	   160	   120	   160	  
15	   350	   350	   350	   350	   80	   80	   80	   80	  
16	   220	   200	   200	   220	   70	   70	   90	   90	  
17	   320	   350	   350	   350	   130	   150	   180	   180	  
18	   350	   350	   350	   350	   120	   140	   140	   140	  
19	   120	   140	   150	   150	   50	   50	   50	   50	  
20	   350	   350	   300	   350	   90	   70	   70	   90	  
21	   100	   100	   100	   100	   50	   50	   50	   50	  
22	   170	   180	   150	   180	   70	   70	   50	   70	  
23	   140	   160	   170	   170	   50	   70	   50	   70	  
24	   120	   150	   160	   160	   50	   70	   90	   90	  




3.2	  (C)	  	  Descriptive	  analysis	  of	  post-­‐operative	  POIF.	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF	  4	   25	   60	   350	   211.60	   92.000	  
	   	   	   	   	   	  
Table	  23:	  Post-­‐operative	  POIF-­‐4	  
	  
POIF-­‐4	  was	  the	  first	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  60	  l/min,	  the	  maximum	  measurement	  was	  350	  
l/min,	  and	  the	  mean	  was	  211.60	  l/min	  with	  a	  standard	  deviation	  of	  92.0.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF-­‐5	   25	   70	   350	   226.00	   92.105	  
	   	   	   	   	   	  
Table	  24:	  Post-­‐operative	  POIF-­‐5	  
	  
POIF-­‐5	  was	  the	  second	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  70	  l/min,	  the	  maximum	  measurement	  was	  350	  












	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF-­‐	  6	   25	   80	   350	   221.60	   88.961	  
	   	   	   	   	   	  
	  
Table	  25:	  Post-­‐operative	  POIF-­‐6	  
	  
	  
POIF-­‐6	  was	  the	  third	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  80	  l/min,	  the	  maximum	  measurement	  was	  350	  
l/min,	  and	  the	  mean	  was	  221.60	  l/min	  with	  a	  standard	  deviation	  of	  88.961.	  	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
POIF-­‐M1	   25	   80	   350	   232.40	   90.290	  
	   	   	   	   	   	  
	  
Table	  26:	  Post-­‐operative	  POIF-­‐M1	  
	  
POIF-­‐M1	  was	  the	  maximum	  peak	  oral	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  
after	  surgery.	  The	  minimum	  measurement	  was	  80	  l/min,	  the	  maximum	  measurement	  was	  









3.2	  (D)	  Descriptive	  analysis	  of	  post-­‐operative	  PNIF.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF-­‐4	   25	   40	   160	   78.00	   33.166	  
	   	   	   	   	   	  
	  
Table	  27:	  Post-­‐operative	  PNIF-­‐4	  
	  
PNIF-­‐4	  was	  the	  first	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  40	  l/min,	  the	  maximum	  measurement	  was	  160	  
l/min,	  and	  the	  mean	  was	  78	  l/min	  with	  a	  standard	  deviation	  of	  33.166.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF-­‐5	   25	   50	   160	   82.80	   32.599	  
	   	   	   	   	   	  
	  
Table	  28:	  Post-­‐operative	  PNIF-­‐5	  
	  
PNIF-­‐5	  was	  the	  second	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  50	  l/min,	  the	  maximum	  measurement	  was	  160	  






	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF-­‐6	   25	   40	   180	   83.60	   36.729	  
	   	   	   	   	   	  
	  
Table	  29:	  Post-­‐operative	  PNIF-­‐6	  
	  
PNIF-­‐6	  was	  the	  third	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  after	  
surgery.	  The	  minimum	  measurement	  was	  40	  l/min,	  the	  maximum	  measurement	  was	  180	  
l/min,	  and	  the	  mean	  was	  83.60	  l/min	  with	  a	  standard	  deviation	  of	  36.729.	  
	  
	  
	   N	   Minimum	   Maximum	   Mean	   Std.	  
Deviatio
n	  
PNIF-­‐M1	   25	   50	   180	   89.20	   36.046	  
	   	   	   	   	   	  
	  
Table	  30:	  Post-­‐operative	  PNIF-­‐MI	  
	  
PNIF-­‐M1	  was	  the	  maximum	  peak	  nasal	  inspiratory	  flow	  measured	  in	  the	  participant	  group	  
after	  surgery.	  The	  minimum	  measurement	  was	  50	  l/min,	  the	  maximum	  measurement	  was	  











3.3	  Relationship	  between	  POIF	  M	  (Pre-­‐operative	  maximum)	  and	  POIF	  M1	  (Post-­‐operative	  
maximum)	  
	  
The	  maximum	  pre-­‐operative	  peak	  oral	  inspiratory	  flow	  (POIF	  M)	  of	  the	  twenty-­‐five	  patients	  
attending	  the	  second	  phase	  of	  the	  study	  was	  compared	  with	  their	  maximum	  postoperative	  
peak	  oral	  inspiratory	  flow	  (POIF	  M1).	  	  	  
	  
1) POIF	  M1	  >	  POIF	  M	  	  -­‐	  17/25	  (68%)	  
	  
2) POIF	  M1=	  POIF	  M	  	  	  -­‐	  6/25	  (24%)	  
	  
3) POIF	  M1<	  POIF	  M	  	  	  -­‐	  2/25	  (8%)	  
	  
	  




The	  correlation	  of	  POIF	  M	  with	  POIF	  M1	  in	  each	  participant	  was	  tested	  using	  Pearson’s	  
correlation.	  The	  correlation	  coefficient	  (r)	  was	  0.850,	  p<0.0001.	  This	  shows	  that	  there	  is	  a	  
good	  correlation	  between	  POIF	  M1	  and	  POIF	  M,	  as	  demonstrated	  in	  the	  scatter	  plot	  above.	  
	  
A	  paired	  sample	  t-­‐test	  was	  used	  to	  find	  the	  relationship	  between	  POIF	  M1	  and	  POIF	  M.	  The	  
mean	  of	  POIF	  M	  in	  the	  second	  phase	  of	  the	  study	  was	  187.20	  and	  the	  mean	  of	  POIF	  M1	  was	  
232.40.	  The	  paired	  difference	  mean	  between	  POIF	  M1	  and	  POIF	  M	  was	  45.20	  [25.471,	  
























3.4	  Relationship	  between	  PNIF	  M	  (pre-­‐operative	  maximum)	  and	  PNIF	  M1	  (Post-­‐operative	  
maximum)	  
	  
The	  maximum	  pre-­‐operative	  peak	  nasal	  inspiratory	  flow	  (PNIF	  M)	  of	  the	  twenty-­‐five	  patients	  
attending	  the	  second	  phase	  of	  the	  study	  was	  compared	  with	  the	  maximum	  post-­‐operative	  
peak	  nasal	  inspiratory	  flow	  (PNIF	  M1).	  	  	  
	  
1) PNIF	  M1	  >	  PNIF	  M	  	  -­‐	  18/25	  (72%)	  
	  
2) PNIF	  M1=	  PNIF	  M	  	  	  -­‐	  4/25	  (16%)	  
	  























Figure	  12:	  Relationship	  between	  PNIF	  M1	  (Post-­‐operative)	  on	  the	  y-­‐axis	  and	  PNIF	  M	  (Pre-­‐
operative)	  on	  the	  x-­‐	  axis.	  
	  
Correlation	  of	  PNIF	  M	  with	  PNIF	  M1	  in	  each	  participant	  was	  tested	  using	  Pearson’s	  
correlation.	  The	  correlation	  coefficient	  (r)	  was	  0.663,	  p<0.0001.	  This	  shows	  that	  there	  is	  a	  
good	  correlation	  between	  PNIF	  M1	  and	  PNIF	  M,	  as	  demonstrated	  in	  the	  scatter	  plot	  above.	  
	  
A	  paired	  sample	  t	  test	  was	  used	  to	  find	  the	  relationship	  between	  PNIF	  M1	  and	  PNIF	  M.	  The	  
mean	  of	  PNIF	  M	  in	  the	  second	  phase	  of	  the	  study	  was	  67.20	  and	  the	  mean	  of	  PNIF	  M1	  was	  
89.20.	  The	  paired	  difference	  mean	  between	  PNIF	  M1	  and	  PNIF	  M	  was	  22.00	  [10.8222,	  














































The	  aim	  of	  this	  thesis	  was	  to	  assess	  the	  severity	  of	  airway	  obstruction	  in	  patients	  undergoing	  
tonsillectomy+/-­‐	  adenoidectomy.	  Clinicians	  often	  rely	  on	  patient	  reported	  symptoms	  of	  
SRBD	  and	  clinical	  examination	  to	  decide	  on	  the	  removal	  of	  the	  tonsils	  with	  or	  without	  
adenoids	  to	  relieve	  upper	  airway	  obstruction.	  	  	  The	  limitations	  and	  feasibility	  of	  obtaining	  
overnight	  polysomnography,	  which	  is	  the	  gold	  standard	  investigation	  for	  SRBD,	  is	  the	  main	  
reason	  to	  look	  for	  alternative	  means	  to	  assess	  upper	  airway	  obstruction.	  Evidence	  for	  a	  
simple	  non-­‐invasive,	  easily	  available	  and	  cost-­‐effective	  objective	  investigation	  method	  to	  
assess	  the	  severity	  of	  upper	  airway	  obstruction	  would	  guide	  clinicians	  in	  their	  decision-­‐
making	  process	  for	  surgical	  intervention.	  
	  
In	  the	  introduction	  part	  of	  this	  thesis,	  the	  aetiology,	  pathogenesis	  and	  various	  diagnostic	  
methods	  to	  diagnose	  SRBD	  were	  discussed.	  Although	  the	  emphasis	  was	  more	  on	  SRBD	  in	  
children,	  patients	  across	  different	  age	  groups	  undergoing	  tonsillectomy	  were	  included	  in	  
this	  study,	  so	  as	  to	  have	  a	  comparable	  group.	  But	  as	  this	  is	  a	  pilot	  study	  and	  the	  numbers	  in	  
the	  each	  group	  were	  very	  small,	  it	  was	  decided	  to	  analyse	  the	  results	  of	  whole	  study	  group	  
rather	  than	  according	  to	  different	  age	  groups.	  As	  discussed	  in	  the	  section	  on	  the	  
pathogenesis	  of	  SRBD,	  upper	  airway	  obstruction	  in	  these	  patients	  occurs	  during	  the	  
inspiratory	  phase	  of	  breathing.	  Measurement	  of	  the	  severity	  of	  upper	  airway	  obstruction	  
during	  inspiration	  could	  guide	  the	  decision-­‐making	  process	  with	  regard	  to	  relieving	  upper	  
airway	  obstruction	  by	  removing	  the	  tonsils	  with	  or	  without	  adenoids.	  In	  this	  study,	  peak	  oral	  
and	  nasal	  inspiratory	  flow	  meters	  have	  been	  used	  to	  measure	  obstruction	  caused	  in	  the	  
upper	  airway	  due	  to	  pathology	  of	  tonsil	  and	  adenoid	  tissue.	  The	  size	  of	  these	  lymphoid	  
tissues	  in	  the	  upper	  airway	  could	  be	  the	  main	  determinant	  factor	  in	  causing	  obstruction.	  The	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participant’s	  tonsil	  size,	  as	  discussed	  in	  the	  demographics	  section	  in	  Chapter	  3,	  were	  graded	  
using	  the	  Brodsky	  scale	  and	  it	  was	  found	  that	  66%	  had	  grade	  3	  enlarged	  tonsils	  and	  6%	  had	  
grade	  4	  enlarged	  tonsils.	  In	  total,	  72%	  of	  this	  group	  had	  their	  oropharyngeal	  space	  narrowed	  
by	  more	  than	  three	  quarters	  due	  to	  enlarged	  tonsils.	  This	  shows	  that	  there	  may	  be	  a	  
correlation	  between	  size	  of	  tonsils	  and	  tonsilar	  pathology	  (infection	  or	  obstruction).	  
	  
PNIF	  has	  previously	  been	  used	  to	  assess	  nasal	  patency	  in	  children	  aged	  from	  five	  to	  eighteen	  
years	  in	  the	  normal	  population	  (Papachristou	  et	  al.,	  2008;	  Van	  Spronsen	  et	  al.,	  2012)	  and	  in	  
patients	  with	  lower	  airway	  disease,	  but	  not	  with	  upper	  airway	  disease.	  POIF	  has	  not	  
previously	  been	  used	  to	  assess	  upper	  airway	  disease.	  The	  age	  group	  of	  our	  population	  
varied	  from	  five	  to	  forty-­‐six	  years.	  At	  the	  start	  of	  this	  study,	  there	  were	  concerns	  about	  
training	  a	  five	  year-­‐old	  child	  to	  perform	  PNIF	  and	  POIF.	  Papchristou	  et	  al.	  (2008)	  measured	  
PNIF	  in	  healthy	  children	  aged	  five	  to	  eighteen	  years,	  suggesting	  that	  it	  is	  possible	  to	  instruct	  
children	  as	  young	  as	  five	  years.	  In	  this	  study,	  there	  were	  five	  participants	  aged	  five	  years	  and	  
upon	  proper	  instruction	  and	  demonstration,	  they	  performed	  both	  the	  PNIF	  and	  POIF.	  
	  
Each	  participant	  was	  instructed	  to	  perform	  three	  attempts	  of	  both	  POIF	  and	  PNIF	  
measurements,	  and	  the	  maximum	  value	  of	  these	  three	  measurements	  was	  taken	  for	  
statistical	  assessments.	  As	  the	  age	  range	  in	  the	  study	  population	  varied	  from	  five	  to	  forty-­‐six	  
years,	  a	  big	  difference	  in	  these	  measurements	  was	  expected,	  as	  lung	  volume	  will	  obviously	  
increase	  with	  any	  increase	  in	  the	  body	  size	  due	  to	  normal	  growth	  towards	  puberty.	  
Someone	  as	  young	  as	  five	  years	  old	  would	  have	  a	  lower	  lung	  volume,	  as	  reflected	  by	  lower	  
POIF	  and	  PNIF	  measurements,	  when	  compared	  to	  an	  adult	  participant.	  The	  minimum	  pre-­‐
operative	  POIF	  was	  70	  l/min	  and	  the	  maximum	  POIF	  was	  350	  l/min	  with	  a	  mean	  of	  174.40	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l/min	  and	  standard	  deviation	  of	  79.59.	  The	  minimum	  pre-­‐operative	  PNIF	  was	  30	  l/min	  and	  
the	  maximum	  PNIF	  was	  140	  l/min	  with	  a	  mean	  of	  60	  l/min	  and	  standard	  deviation	  of	  21.66.	  
Linear	  regression	  models	  were	  used	  to	  show	  the	  relationship	  between	  age	  and	  both	  POIF	  
and	  PNIF.	  As	  demonstrated	  in	  Figure	  8	  (p.	  81),	  there	  appears	  to	  be	  a	  linear	  relationship	  
between	  age	  and	  pre-­‐operative	  maximum	  value	  of	  POIF,	  with	  r=0.603,	  p<0.0001.	  This	  study	  
also	  suggested	  that	  POIF	  increases	  by	  4.394	  l/min	  for	  every	  year	  increase	  in	  the	  age.	  
Similarly,	  the	  relationship	  between	  age	  and	  PNIF	  was	  demonstrated	  in	  Figure	  9	  (p.85),	  with	  
a	  correlation	  coefficient	  of	  r=0.	  381,	  p<0.0001.	  This	  study	  suggested	  that	  PNIF	  increases	  by	  
0.756	  l/min	  for	  every	  year	  increase	  in	  age.	  
	  
As	  discussed	  above,	  the	  age	  of	  the	  study	  population	  varied	  between	  five	  and	  forty-­‐six	  years.	  
In	  order	  to	  normalize	  the	  measurements,	  so	  as	  to	  obtain	  a	  normal	  distribution,	  which	  will	  
also	  help	  to	  predict	  the	  repeatability	  of	  the	  measurements,	  the	  first	  measurement	  of	  peak	  
oral	  inspiratory	  flow	  (POIF-­‐1)	  was	  taken	  as	  1.	  The	  ratio	  of	  the	  second	  measurement	  of	  peak	  
oral	  inspiratory	  flow	  (POIF-­‐2)	  with	  that	  of	  POIF-­‐1	  was	  calculated	  to	  derive	  POIF	  2-­‐1.	  Similarly,	  
the	  ratio	  of	  the	  third	  measurement	  of	  peak	  oral	  inspiratory	  flow	  (POIF-­‐3)	  with	  that	  of	  POIF-­‐1	  
was	  calculated	  to	  derive	  POIF	  3-­‐1.	  Similarly,	  the	  first	  measurement	  of	  peak	  nasal	  inspiratory	  
flow	  (PNIF-­‐1)	  was	  taken	  as	  1.	  The	  ratio	  of	  the	  second	  measurement	  of	  peak	  nasal	  inspiratory	  
flow	  (PNIF-­‐2)	  with	  that	  of	  PNIF-­‐1	  was	  calculated	  to	  derive	  PNIF	  2-­‐1.	  Similarly,	  the	  ratio	  of	  the	  
third	  measurement	  of	  peak	  nasal	  inspiratory	  flow	  (PNIF-­‐3)	  with	  that	  of	  PNIF-­‐1	  was	  
calculated	  to	  derive	  PNIF	  3-­‐1.	  
	  
A	  null	  hypothesis	  of	  no	  relationship	  between	  repeated	  measurements	  of	  both	  POIF	  and	  PNIF	  




A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  the	  first	  measurement	  of	  
POIF,	  which	  was	  presumed	  to	  be	  1	  and	  POIF	  2-­‐1.	  The	  mean	  difference	  in	  the	  ratio	  was	  0.137	  
[0.091,	  0.183]	  and	  t	  (49)	  =	  6.07,	  p	  <	  0.0001.	  Similarly	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  
relationship	  between	  the	  first	  measurement	  of	  POIF,	  which	  was	  presumed	  to	  be	  1	  and	  POIF	  
3-­‐1.The	  mean	  difference	  in	  the	  ratio	  was	  0.150	  [0.088,	  0.210],	  t	  (49)	  =	  4.907,	  p	  <	  0.0001.	  
This	  test	  shows	  that	  if	  POIF	  is	  repeated	  in	  100	  participants,	  95	  percent	  of	  the	  participants	  
will	  show	  a	  mean	  difference	  in	  the	  ratio	  of	  0.137	  between	  the	  first	  and	  the	  second	  
measurement	  and	  0.150	  between	  the	  first	  and	  the	  third	  measurement.	  
	  
A	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  relationship	  between	  the	  first	  measurement	  of	  
PNIF,	  which	  was	  presumed	  to	  be	  1	  and	  PNIF	  2-­‐1.	  The	  mean	  difference	  in	  the	  ratio	  was	  0.40	  
[0.02,	  0.10]	  and	  t	  (49)	  =	  1.49,	  p	  <	  0.0001.	  Similarly	  one-­‐sample	  t-­‐test	  was	  used	  to	  test	  the	  
relation	  between	  the	  first	  measurement	  of	  PNIF,	  which	  was	  presumed	  to	  be	  1	  and	  PNIF	  3-­‐1.	  
The	  mean	  difference	  in	  the	  ratio	  was	  0.120	  [0.03,	  0.21]	  and	  the	  t	  (49)	  =	  2.585,	  p	  <	  0.0001.	  
This	  test	  shows	  that	  if	  PNIF	  is	  repeated	  in	  100	  participants,	  95	  percent	  will	  show	  a	  mean	  
difference	  in	  the	  ratio	  of	  0.40	  between	  the	  first	  and	  the	  second	  measurement	  and	  0.120	  
between	  the	  first	  and	  the	  third	  measurement.	  	  
	  
The	  null	  hypothesis	  was	  rejected	  and	  the	  alternative	  hypothesis	  of	  a	  relationship	  between	  
repeated	  measurements	  of	  both	  PNIF	  and	  POIF	  was	  accepted.	  The	  test	  shows	  that	  repeated	  
practice	  will	  increase	  the	  measurements	  of	  both	  PNIF	  and	  POIF.	  	  Wihl	  et	  al.	  (1988)	  
demonstrated	  a	  difference	  of	  5l/min	  between	  repeated	  PNIF	  measurements,	  but	  contrary	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to	  that,	  this	  study	  population	  did	  not	  show	  any	  such	  fixed	  increment	  on	  repeated	  
measurements	  in	  each	  individual	  participant.	  	  
	  
Figure	  10	  (p.86)	  demonstrates	  the	  relationship	  between	  pre-­‐operative	  maximum	  values	  of	  
POIF	  and	  PNIF.	  In	  this	  study,	  there	  appears	  to	  be	  a	  correlation	  between	  POIF	  and	  PNIF	  pre-­‐
operatively	  as	  demonstrated	  with	  a	  Pearson	  correlation	  coefficient	  (r)	  of	  0.585,	  which	  is	  
statistically	  significant	  at	  p<0.0001.	  The	  values	  of	  POIF	  and	  PNIF	  are	  related	  as	  they	  are	  both	  
determined	  by	  the	  size	  of	  the	  lungs.	  
	  
During	  the	  inspiratory	  phase	  of	  breathing,	  the	  obstruction	  caused	  by	  the	  enlarged	  lymphoid	  
tissue	  in	  the	  nasopharynx	  and	  oropharynx	  will	  have	  an	  impact	  on	  the	  PNIF	  measurements,	  
while	  the	  enlarged	  lymphoid	  tissue	  in	  the	  oropharynx	  will	  impact	  the	  POIF	  measurements.	  
Post-­‐operative	  change	  in	  PNIF	  will	  be	  secondary	  to	  the	  removal	  of	  the	  adenoids	  and	  tonsils;	  
similarly,	  post-­‐	  operative	  change	  in	  POIF	  will	  be	  due	  to	  the	  removal	  of	  the	  tonsils.	  In	  this	  
study,	  all	  the	  participants	  underwent	  tonsillectomy	  and	  none	  of	  them	  had	  adenoidectomy;	  
despite	  this,	  post-­‐operative	  PNIF	  showed	  an	  increase	  compared	  to	  preoperative	  PNIF	  
measurements.	  The	  increase	  in	  the	  postoperative	  PNIF	  could	  be	  due	  to	  the	  increase	  in	  the	  
nasopharyngeal	  space	  dimension	  due	  to	  the	  removal	  of	  the	  tonsils.	  As	  76%	  of	  this	  study	  
population	  had	  tonsils	  that	  occupied	  more	  than	  three-­‐quarters	  of	  the	  oropharyngeal	  space	  
as	  per	  Bodsky’s	  scale,	  the	  reduction	  in	  the	  nasopharyngeal	  space	  could	  be	  due	  to	  the	  
impingement	  of	  the	  soft	  palate	  towards	  the	  nasopharynx.	  After	  tonsillectomy,	  this	  space	  




This	  study	  was	  designed	  to	  see	  if	  there	  was	  any	  difference	  between	  the	  maximum	  values	  of	  
pre-­‐operative	  and	  post-­‐operative	  POIF	  and	  PNIF.	  The	  scatter	  graph	  in	  Figure	  11	  (p.	  93)	  
demonstrates	  the	  relationship	  between	  the	  maximum	  values	  of	  pre-­‐operative	  and	  post-­‐
operative	  POIF	  measurements.	  Of	  the	  twenty-­‐five	  participants	  who	  completed	  the	  second	  
part	  of	  the	  study,	  seventeen	  participants	  (68%)	  demonstrated	  an	  increase	  in	  the	  
postoperative	  POIF,	  while	  in	  six	  participants	  (24%),	  postoperative	  POIF	  was	  similar	  to	  pre-­‐
operative	  POIF	  and	  in	  two	  participants	  (8%),	  postoperative	  POIF	  was	  less	  than	  the	  pre-­‐
operative	  POIF.	  The	  minimum	  pre-­‐operative	  maximum	  value	  of	  POIF	  in	  the	  second	  phase	  of	  
the	  study	  was	  80	  l/min	  and	  the	  maximum	  value	  was	  350	  l/min,	  with	  a	  mean	  of	  187.20	  l/min	  
and	  standard	  deviation	  of	  79.595.	  The	  minimum	  postoperative	  maximum	  value	  of	  POIF	  was	  
80	  l/min	  and	  the	  maximum	  value	  was	  350	  l/min,	  with	  a	  mean	  of	  232.40	  l/min	  and	  a	  
standard	  deviation	  of	  90.290.	  A	  paired	  sample	  t-­‐test	  was	  used	  to	  find	  the	  relationship	  
between	  maximum	  values	  of	  preoperative	  and	  postoperative	  POIF.	  The	  paired	  difference	  
mean	  between	  these	  both	  maximum	  value	  was	  45.20	  [25.471,	  64.929],	  t	  (24)	  =	  4.729,	  
p<0.0001.	  This	  test	  suggests	  that	  if	  100	  patients	  were	  to	  have	  tonsillectomy,	  the	  post-­‐
operative	  POIF	  would	  increase	  in	  95%	  of	  the	  patients	  by	  45	  l/min.	  	  
	  
The	  scatter	  graph	  in	  Figure	  12	  (P.96)	  demonstrates	  the	  relationship	  between	  the	  maximum	  
values	  of	  pre-­‐operative	  and	  post-­‐operative	  PNIF.	  Of	  the	  twenty-­‐five	  participants	  who	  
completed	  the	  second	  part	  of	  the	  study,	  eighteen	  participants	  (72%)	  demonstrated	  an	  
increase	  in	  the	  post-­‐operative	  PNIF,	  while	  in	  four	  participants	  (16%),	  post-­‐operative	  PNIF	  
was	  similar	  to	  pre-­‐operative	  PNIF	  and	  in	  three	  participants	  (12%)	  post-­‐operative	  PNIF	  was	  
less	  than	  pre-­‐operative	  PNIF.	  The	  minimum	  pre-­‐operative	  maximum	  value	  of	  PNIF	  was	  30	  
l/min	  and	  the	  maximum	  value	  was	  140	  l/min,	  with	  a	  mean	  of	  67.20	  l/min	  and	  a	  standard	  
104 
 
deviation	  of	  21.665.	  The	  minimum	  postoperative	  maximum	  value	  of	  PNIF	  was	  50	  l/min	  and	  
the	  maximum	  value	  was	  180	  l/min,	  with	  a	  mean	  of	  89.20	  l/min	  and	  standard	  deviation	  of	  
36.046.	  A	  paired	  sample	  t-­‐test	  was	  used	  to	  find	  the	  relationship	  between	  maximum	  values	  
of	  preoperative	  and	  postoperative	  PNIF.	  The	  paired	  difference	  mean	  between	  these	  both	  
maximum	  value	  was	  22.00	  [10.8222,	  33.178]:	  	  t	  (24)	  =	  4.062,	  p<0.0001.	  This	  test	  suggests	  
that	  if	  100	  patients	  having	  tonsillectomy,	  the	  postoperative	  PNIF	  would	  increase	  in	  95%	  of	  
the	  patients	  by	  22	  l/min.	  	  
	  
A	  paired	  sample	  t-­‐test	  was	  used	  in	  this	  study	  to	  investigate	  the	  relationship	  of	  POIF	  and	  PNIF	  
before	  and	  after	  surgical	  treatment.	  The	  null	  hypothesis	  was	  rejected	  and	  alternative	  
hypothesis	  of	  a	  statistically	  significant	  difference	  in	  both	  POIF	  and	  PNIF	  following	  
tonsillectomy	  was	  accepted.	  The	  change	  in	  measurements	  of	  both	  POIF	  and	  PNIF	  could	  also	  
be	  due	  to	  the	  learning	  effect	  of	  repeated	  measurements,	  as	  demonstrated	  earlier.	  However,	  
a	  review	  of	  the	  literature	  (Groth	  et	  al.,	  1986)	  on	  the	  effect	  of	  learning	  on	  repeated	  
measurements	  of	  lung	  function	  revealed	  that	  lung	  function	  is	  influenced	  by	  a	  variety	  of	  
confounding	  factors	  such	  as	  age	  sex,	  height,	  weight	  and	  other	  physical	  parameters,	  but	  not	  




































This	  study	  has	  demonstrated	  that	  a	  simple	  non-­‐invasive	  inspiratory	  flow	  meter	  could	  be	  
used	  to	  measure	  both	  POIF	  and	  PNIF.	  Both	  these	  measurements	  can	  be	  performed	  by	  
children	  as	  young	  as	  five	  years.	  Post-­‐operative	  POIF	  and	  PNIF	  demonstrated	  a	  statistically	  
significant	  increase	  compared	  to	  pre-­‐operative	  POIF	  and	  PNIF.	  
	  
This	  pilot	  study	  was	  designed	  to	  assess	  the	  severity	  of	  airway	  obstruction	  in	  patients	  
undergoing	  tonsillectomy	  with	  or	  without	  adenoidectomy	  by	  measuring	  peak	  nasal	  and	  oral	  
inspiratory	  airflow.	  The	  primary	  objective	  of	  the	  study	  was	  to	  obtain	  new	  knowledge	  about	  
the	  severity	  of	  airway	  obstruction	  in	  patients	  undergoing	  tonsillectomy	  with	  or	  without	  
adenoidectomy.	  
	  
The	  results	  of	  this	  study	  show	  that	  the	  three	  measurements	  of	  POIF	  and	  PNIF	  are	  
reproducible.	  There	  appears	  to	  be	  correlation	  between	  pre-­‐operative	  POIF	  and	  PNIF,	  and	  
both	  these	  measurements	  have	  a	  linear	  relationship	  with	  age.	  This	  study	  also	  demonstrated	  
that	  there	  is	  a	  good	  correlation	  between	  the	  maximum	  value	  of	  pre-­‐operative	  POIF	  and	  the	  
maximum	  value	  of	  post-­‐operative	  POIF,	  and	  POIF	  increased	  on	  an	  average	  by	  45	  l/min	  after	  
surgery.	  	  A	  similar	  correlation	  has	  been	  demonstrated	  between	  maximum	  values	  of	  pre-­‐
operative	  PNIF	  and	  maximum	  values	  of	  post-­‐operative	  POIF,	  and	  postoperative	  PNIF	  
increased	  on	  average	  by	  22	  l/min	  after	  surgery.	  
	  
The	  findings	  of	  this	  study	  suggest	  that	  peak	  flow	  measurements	  can	  be	  used	  as	  an	  objective	  
method	  to	  assess	  the	  severity	  of	  upper	  airway	  obstruction	  and	  aid	  clinicians	  in	  the	  decision-­‐
making	  process	  for	  surgical	  intervention	  to	  relieve	  upper	  airway	  obstruction.	  Both	  nasal	  and	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oral	  peak	  flow	  measurements	  are	  non-­‐invasive,	  cost	  effective	  and	  time	  effective	  methods	  of	  
assessing	  upper	  airway	  obstructive	  when	  compared	  with	  other	  objective	  upper	  airway	  
obstructive	  assessment	  methods.	  
	  
Although	  the	  current	  study	  is	  based	  on	  a	  small	  sample	  of	  participants,	  the	  findings	  suggest	  
that	  peak	  flow	  methods	  can	  be	  used	  as	  measures	  to	  assess	  upper	  airway	  obstruction,	  and	  
that	  surgery	  of	  the	  upper	  airway	  does	  increase	  peak	  inspiratory	  flow	  rates.	  
	  
Several	  limitations	  of	  this	  pilot	  study	  need	  to	  be	  acknowledged.	  The	  sample	  size	  is	  small,	  
with	  fifty	  participants	  in	  the	  first	  phase	  and	  an	  attrition	  rate	  of	  fifty	  percent	  in	  the	  second	  
phase	  to	  twenty-­‐five	  participants.	  The	  attrition	  rate	  was	  greater	  in	  children	  compared	  to	  
adults,	  as	  it	  was	  difficult	  to	  convince	  parents	  to	  take	  time	  off	  work	  to	  accompany	  their	  
children	  to	  the	  second	  phase	  of	  this	  study	  in	  a	  non-­‐hospital	  environment.	  This	  attrition	  rate	  
could	  have	  been	  decreased	  by	  conducting	  the	  second	  phase	  of	  this	  study	  in	  a	  hospital	  
environment.	  	  
	  
The	  second	  limitation	  of	  this	  study	  is	  that	  the	  increase	  in	  the	  postoperative	  peak	  inspiratory	  
flow	  could	  be	  due	  to	  other	  confounding	  factors,	  such	  as	  the	  variability	  of	  lung	  volumes,	  pre-­‐
operatively	  starved	  participants,	  anxiety	  before	  the	  surgery	  and	  body	  mass	  index.	  
	  
The	  third	  limitation	  of	  this	  study	  is	  clinical	  assessment	  of	  adenoid	  hypertrophy.	  None	  of	  the	  
participants	  had	  a	  direct	  visualization	  of	  the	  adenoid	  tissue	  prior	  to	  surgery.	  It	  is	  challenging	  
to	  assess	  the	  adenoid	  tissue,	  particularly	  in	  children,	  by	  flexible	  nasendoscopic	  examination,	  




The	  other	  significant	  limitation	  to	  this	  study	  is	  that	  participants	  were	  listed	  for	  tonsillectomy	  
for	  recurrent	  tonsillitis,	  although	  thirty-­‐four	  percent	  of	  the	  participants	  clearly	  
demonstrated	  symptoms	  of	  sleep-­‐related	  breathing	  disorders.	  This	  could	  potentially	  be	  
overcome	  by	  using	  objective	  assessment	  methods	  rather	  than	  just	  clinical	  judgement.	  
	  
Larger	  multi-­‐centred	  randomized	  control	  trails	  using	  the	  same	  methodology	  could	  provide	  
more	  definitive	  evidence	  regarding	  the	  use	  of	  peak	  inspiratory	  flow	  measures	  in	  assessing	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Adenotonsillectomy	  is	  currently	  indicated	  as	  a	  treatment	  for	  sleep-­‐related	  breathing	  
disorders	  in	  children	  because	  removal	  of	  the	  tonsils	  opens	  up	  the	  airway	  and	  lowers	  airway	  
resistance	  to	  breathing.	  Overnight	  pulse	  oximetry	  and	  polysomnography	  are	  the	  two	  
common	  investigations	  for	  the	  diagnosis	  of	  sleep-­‐related	  breathing	  disorders,	  but	  these	  are	  
overnight	  and	  time-­‐consuming	  procedures.	  We	  propose	  that	  simple	  non-­‐invasive	  
measurements	  of	  peak	  inspiratory	  flow	  rates	  may	  help	  in	  decision-­‐making	  for	  patient	  
selection	  for	  surgical	  treatment	  of	  sleep-­‐related	  breathing	  disorders.	  Since	  the	  upper	  airway	  
cause	  of	  any	  sleep-­‐related	  breathing	  disorder	  is	  believed	  to	  be	  obstruction	  of	  the	  oral	  and	  
nasal	  airways	  due	  to	  enlarged	  tonsils	  or	  adenoids,	  it	  seems	  reasonable	  that	  patient	  selection	  
for	  surgery	  could	  be	  better	  managed	  using	  simple	  measurements	  of	  the	  severity	  of	  airway	  




A	  recent	  well-­‐designed	  cross	  sectional	  study	  of	  about	  seven	  hundred	  children	  in	  the	  USA	  
found	  that	  the	  prevalence	  of	  primary	  snoring	  was	  15.5%	  and	  sleep	  apnoea	  1.2%	  (Bixler	  et	  
al.,	  2009).	  The	  increasing	  interest	  in	  sleep-­‐related	  breathing	  disorders	  has	  led	  to	  more	  
diagnoses,	  and	  a	  position	  paper	  published	  by	  ENT-­‐UK	  (the	  British	  Association	  of	  
Otorhinolaryngology—Head	  and	  Neck	  Surgery)	  has	  estimated	  that	  about	  a	  quarter	  of	  the	  
27,400	  paediatric	  tonsillectomies	  in	  2008-­‐9	  in	  the	  UK	  were	  carried	  out	  for	  obstructive	  
conditions	  (Nixon	  et	  al.,	  2005).	  Overnight	  pulse	  oximetry	  and	  polysomnography	  are	  the	  two	  
common	  investigations	  for	  sleep	  related	  breathing	  disorders.	  Polysomnography	  (sleep	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study)	  and	  pulse	  oximetry	  are	  overnight	  and	  time-­‐consuming	  (Goldstein	  et	  al.,	  2011;	  Kohler	  
et	  al.,	  2008).	  A	  proposal	  put	  forward	  in	  thesis	  that	  a	  simple	  non-­‐invasive	  measurements	  of	  
peak	  inspiratory	  flow	  rates	  could	  help	  in	  decision-­‐making	  for	  adeno/tonsillectomy	  for	  the	  
treatment	  of	  sleep-­‐related	  breathing	  disorders.	  Peak	  inspiratory	  flow	  is	  a	  simple	  non-­‐
invasive	  measure	  of	  lower	  airway	  obstruction	  that	  may	  also	  be	  used	  to	  measure	  obstruction	  
of	  the	  upper	  airway	  due	  to	  tonsil	  enlargement.	  Peak	  oral	  inspiratory	  flow	  would	  give	  a	  
measure	  of	  oral	  obstruction	  due	  to	  enlarged	  tonsils	  and	  peak	  nasal	  inspiratory	  flow	  would	  
give	  a	  measure	  of	  nasal	  obstruction	  due	  to	  enlarged	  adenoids.	  Peak	  nasal	  inspiratory	  flow	  
has	  previously	  been	  used	  to	  measure	  nasal	  airway	  resistance	  in	  children	  (Goodwin,	  et	  al.,	  
2010;	  Hultcrantz	  et	  al.,	  1995),	  but	  peak	  oral	  inspiratory	  flow	  has	  not	  been	  previously	  
measured	  in	  children,	  although	  it	  has	  been	  used	  to	  measure	  upper	  airway	  obstruction	  in	  
adults	  (Anuntaseree	  et	  al.,	  2001).	  
	  
2.0	  Objective	  and	  purpose:	  
This	  pilot	  study	  will	  assess	  the	  severity	  of	  airway	  obstruction	  in	  patients	  undergoing	  
tonsillectomy	  +/-­‐	  adenoidectomy	  by	  measuring	  peak	  nasal	  and	  oral	  inspiratory	  airflow.	  The	  
primary	  objective	  of	  the	  study	  is	  to	  obtain	  new	  knowledge	  about	  the	  severity	  of	  airway	  
obstruction	  in	  those	  patients	  selected	  for	  surgery	  for	  the	  treatment	  of	  sleep-­‐related	  
breathing	  disorders.	  
	  
3.0	  Trial	  design	  and	  recruitment	  of	  patients	  
Prospective	  study	  at	  University	  Hospital	  Wales	  and	  the	  Common	  Cold	  Centre,	  Cardiff	  
University.	  Recruitment	  will	  be	  done	  from	  the	  cohort	  of	  patients	  on	  the	  waiting	  list	  for	  
tonsillectomy	  +/-­‐	  adenoidectomy	  at	  University	  Hospital	  Wales,	  Cardiff.	  These	  patients	  will	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be	  sent	  a	  letter	  of	  invitation	  along	  with	  a	  patient	  information	  leaflet	  to	  explain	  the	  research	  
project	  and	  a	  response	  letter	  to	  convey	  their	  decision	  on	  participation.	  If	  the	  patients	  are	  
willing	  to	  take	  part	  in	  the	  study,	  then	  the	  investigator	  will	  contact	  them	  by	  telephone	  to	  
discuss	  the	  project	  and	  answer	  any	  questions	  they	  have	  regarding	  the	  project.	  On	  the	  day	  of	  
surgery,	  the	  investigator	  will	  obtain	  informed	  consent	  and	  a	  thorough	  otorhinolaryngology	  
examination	  will	  be	  carried	  out	  and	  the	  tonsils	  will	  be	  graded	  using	  the	  Brodsky	  scale.	  The	  
investigator	  will	  measure	  peak	  oral	  and	  nasal	  inspiratory	  flow	  on	  the	  patient	  using	  a	  
portable	  inspiratory	  flow	  meter.	  An	  invitation	  will	  be	  sent	  after	  surgery	  to	  attend	  a	  Follow-­‐
up	  visit	  to	  the	  Common	  Cold	  Centre	  one	  month	  later	  to	  repeat	  the	  peak	  inspiratory	  oral	  and	  
nasal	  flow	  measurements.	  The	  study	  aims	  to	  recruit	  fifty	  patients	  to	  undergo	  the	  pre-­‐
operative	  measurement	  of	  airflow	  and	  it	  is	  anticipated	  that	  around	  thirty	  patients	  will	  
return	  for	  the	  second	  visit	  at	  the	  Common	  Cold	  Centre.	  
	  
4.0	  Selection	  and	  Withdrawal	  of	  Subjects:	  
Recruitment	  will	  be	  done	  from	  the	  Cohort	  of	  patients	  on	  the	  waiting	  list	  for	  Tonsillectomy	  
+/-­‐	  Adenoidectomy	  at	  the	  University	  Hospital	  Wales,	  Cardiff.	  
	  
4.1	  Inclusion	  criteria-­‐	  Patients	  referred	  for	  tonsillectomy	  +/-­‐	  adenoidectomy	  	  
	  
4.2	  Exclusion	  Criteria-­‐	  Children	  less	  than	  five	  years	  of	  age	  and	  tonsillectomy	  done	  to	  rule	  out	  
malignancy.	  
	  
5.0	  Treatment	  of	  Subjects	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This	  study	  will	  not	  affect	  the	  surgical	  treatment	  of	  the	  patients	  in	  any	  way.	  There	  are	  no	  
interventions	  apart	  from	  the	  examination	  of	  the	  patient	  to	  assess	  tonsil	  size	  and	  the	  
measurements	  of	  peak	  nasal	  and	  oral	  inspiratory	  flow.	  
	  
6.0	  Methods	  and	  Measurements	  
Peak	  Nasal	  Inspiratory	  Flow	  
The	  measurement	  of	  Peak	  Nasal	  Inspiratory	  Flow	  (PNIF)	  (litres/minute)	  will	  be	  performed	  
using	  the	  In-­‐Check	  portable	  nasal	  flow	  meter	  manufactured	  by	  Clement	  Clarke	  International	  
Limited,	  England,	  according	  to	  the	  study	  site	  documented	  procedure	  for	  Measurement	  of	  
Peak	  Nasal	  Inspiratory	  Flow.	  
The	  measurement	  of	  PNIF	  has	  been	  previously	  used	  to	  measure	  nasal	  obstruction.	  	  The	  
technique	  involves	  the	  subject	  placing	  a	  mask	  over	  the	  nose	  and	  making	  a	  maximum	  effort	  
to	  breathe	  in	  through	  the	  nose.	  	  The	  subject	  will	  be	  asked	  if	  they	  wish	  to	  gently	  blow	  their	  
nose	  prior	  to	  any	  measurement.	  
The	  following	  data	  will	  be	  recorded	  at	  the	  pre-­‐operative	  visit	  1:	  -­‐	  
iv. First	  PNIF	  value	  =	  PNIF	  (1)	  
v. Second	  PNIF	  value	  =	  PNIF	  (2)	  




Peak	  Oral	  Inspiratory	  Flow	  
The	  measurement	  of	  Peak	  Oral	  Inspiratory	  Flow	  (POIF)	  (litres/minute)	  will	  be	  performed	  
using	  the	  In-­‐Check	  portable	  nasal	  flow	  meter	  manufactured	  by	  Clement	  Clarke	  International	  
Limited,	  England.	  The	  measurement	  of	  POIF	  is	  often	  used	  to	  measure	  lower	  airway	  
obstruction	  but	  can	  also	  be	  used	  as	  a	  measure	  of	  oral	  obstruction	  if	  the	  oral	  resistance	  is	  
high,	  as	  in	  cases	  of	  tonsillar	  obstruction	  of	  the	  oral	  airway.	  	  
The	  following	  data	  will	  be	  recorded	  at	  the	  pre-­‐operative	  visit	  1:	  -­‐	  
iv. First	  POIF	  value	  =	  PNIF	  (1)	  
v. Second	  POIF	  value	  =	  PNIF	  (2)	  
vi. Third	  POIF	  value	  =	  PNIF	  (3)	  
7.0	  Assessment	  of	  safety	  and	  ethical	  issues	  
The	  measurement	  of	  peak	  nasal	  and	  oral	  inspiratory	  flow	  is	  a	  non-­‐invasive	  measurement	  
that	  is	  harmless	  and	  no	  safety	  issues	  are	  expected.	  Any	  adverse	  events	  will	  be	  documented	  
and	  any	  serious	  adverse	  events	  will	  be	  reported	  within	  48	  hours	  to	  the	  sponsor	  and	  the	  
ethics	  committee.	  Adverse	  events	  and	  serious	  adverse	  events	  related	  to	  the	  surgery	  will	  not	  
be	  reported	  to	  the	  sponsor	  or	  the	  ethics	  committee,	  as	  they	  are	  not	  a	  consequence	  of	  this	  
study.	  
	  
One	  ethical	  issue	  considered	  by	  the	  investigators	  is	  that	  the	  patients	  and	  their	  parents	  or	  
guardians	  should	  not	  feel	  in	  any	  way	  that	  they	  are	  obliged	  to	  participate	  in	  this	  study	  in	  
order	  to	  receive	  or	  accelerate	  their	  surgical	  treatment.	  In	  order	  to	  ensure	  that	  the	  patients	  
do	  not	  feel	  under	  any	  pressure	  to	  join	  in	  the	  study,	  the	  first	  contact	  with	  the	  patients	  will	  be	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by	  letter	  explaining	  the	  study	  and	  asking	  them	  to	  respond	  if	  they	  wish	  to	  participate.	  Only	  
after	  the	  patients	  have	  responded	  in	  a	  positive	  way	  will	  they	  be	  contacted	  by	  phone	  by	  the	  
investigator,	  to	  discuss	  the	  study	  and	  explain	  any	  aspects	  that	  may	  not	  be	  clear	  to	  the	  
patient.	  Again,	  it	  will	  be	  made	  clear	  at	  this	  stage	  that	  participation	  is	  entirely	  voluntary	  and	  
will	  not	  in	  any	  way	  affect	  their	  treatment.	  
	  
Another	  ethical	  issue	  is	  confidentiality	  of	  patient	  records	  and	  any	  information	  obtained	  from	  
these	  records.	  All	  information	  from	  records	  will	  be	  kept	  confidential	  and	  the	  records	  will	  
only	  be	  accessed	  by	  the	  clinical	  investigator.	  
	  
8.0	  Statistics	  
This	  is	  a	  pilot	  study	  to	  obtain	  new	  knowledge	  and	  no	  formal	  statistical	  plan	  is	  proposed	  
apart	  from	  exploration	  of	  the	  data	  in	  tables	  and	  graphs.	  The	  data	  obtained	  from	  the	  study	  
may	  be	  used	  for	  a	  power	  calculation	  for	  a	  larger	  study	  at	  a	  later	  stage.	  Examples	  of	  the	  type	  
of	  exploratory	  analysis	  that	  will	  be	  performed	  are:	  
1.	  Scatter	  graphs	  of	  the	  data	  to	  look	  for	  outliers,	  and	  to	  examine	  distribution	  of	  data	  to	  
determine	  if	  there	  is	  a	  normal	  distribution	  or	  other.	  
2.	  Comparisons	  of	  pre-­‐operative	  and	  post-­‐operative	  peak	  flow	  measurements	  with	  normal	  
population	  data	  in	  the	  published	  literature.	  
3.	  Assessments	  of	  changes	  in	  peak	  flow	  due	  to	  surgery.	  
	  
9.0	  Funding	  and	  use	  of	  University	  and	  Hospital	  facilities	  and	  resources	  
The	  study	  will	  be	  funded	  from	  the	  research	  funds	  of	  the	  Common	  Cold	  Centre,	  Cardiff	  
University.	  The	  study	  will	  form	  part	  of	  the	  research	  undertaken	  by	  the	  Clinical	  Investigator,	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who	  is	  a	  qualified	  ENT	  surgeon,	  during	  his	  appointment	  as	  an	  ENT	  Research	  Fellow	  at	  the	  
Common	  Cold	  Centre,	  Cardiff	  University.	  The	  study	  will	  not	  involve	  the	  use	  of	  any	  extra	  
resources	  in	  terms	  of	  staff	  or	  space	  at	  the	  University	  Hospital,	  as	  participating	  patients	  will	  
be	  seen	  by	  the	  Clinical	  Investigator	  during	  their	  normal	  pre-­‐operative	  assessment.	  The	  
Clinical	  Investigator	  will	  also	  see	  the	  patients	  at	  the	  Common	  Cold	  Centre	  as	  part	  of	  his	  
normal	  research	  work.	  
	  
10.0	  Regulatory	  and	  Governance	  Approval	  and	  Indemnity	  
The	  study	  is	  not	  a	  clinical	  trial	  and	  does	  not	  need	  regulatory	  approval.	  The	  study	  will	  be	  
submitted	  for	  approval	  to	  Cardiff	  University	  Research	  and	  Commercial	  Division,	  Cardiff	  and	  
Vale	  Research	  and	  Development	  Office	  and	  the	  South	  East	  Wales	  Ethics	  Committee.	  
	  
The	  study	  will	  be	  indemnified	  by	  the	  sponsor,	  Cardiff	  University,	  for	  any	  harm	  patients	  may	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  Information	  &	  Informed	  Consent	  
Study	  title	  	  	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep	  related	  breathing	  disorders.	  
Part	  1	  tells	  you	  the	  purpose	  of	  the	  study	  and	  what	  will	  happen	  to	  you	  if	  you	  take	  part.	  
Part	  2	  gives	  you	  more	  detailed	  information	  about	  the	  conduct	  of	  the	  study.	  
The	  study	  will	  investigate	  the	  effect	  of	  tonsillectomy	  and	  adenoidectomy	  on	  obstruction	  of	  
the	  nose	  and	  throat.	  
This	  research	  is	  sponsored	  by:	  
Cardiff	  University,	  Cardiff.	  
PART	  1	  of	  the	  Information	  Sheet	  
What	  is	  the	  purpose	  of	  this	  study?	  
Obstruction	  of	  the	  nose	  and	  throat	  by	  enlarged	  tonsils	  may	  disturb	  breathing	  during	  sleep.	  
The	  aim	  of	  this	  study	  is	  to	  investigate	  if	  surgery	  to	  remove	  tonsils	  and	  adenoids	  will	  relieve	  
obstruction	  of	  the	  nose	  and	  throat.	  
Why	  have	  I	  been	  chosen?	  
You	  have	  been	  invited	  to	  participate	  because	  you	  are	  on	  the	  waiting	  list	  to	  have	  surgery	  to	  
remove	  Adenoids+/-­‐	  Tonsils.	  
Do	  I	  have	  to	  take	  part?	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No,	  taking	  part	  is	  your	  decision.	  If	  you	  decide	  you	  don’t	  want	  to	  take	  part,	  your	  care	  will	  not	  
change	  in	  any	  way.	  But	  if	  you	  decide	  to	  take	  part	  then	  we	  will	  ask	  you	  to	  sign	  a	  consent	  form	  
to	  show	  you	  have	  agreed	  to	  participate.	  You	  are	  free	  to	  withdraw	  at	  any	  time,	  without	  
giving	  a	  reason.	  	  
What	  will	  happen	  if	  I	  decide	  to	  take	  part	  and	  how	  long	  will	  it	  take?	  
You	  will	  be	  contacted	  by	  one	  of	  the	  research	  team,	  who	  will	  discuss	  the	  project	  with	  you	  
over	  the	  telephone	  and	  answer	  any	  queries.	  On	  the	  day	  of	  surgery	  at	  University	  Hospital,	  
the	  researcher	  will	  examine	  you,	  and	  after	  obtaining	  written	  consent,	  will	  take	  
measurements	  of	  obstruction	  of	  the	  nose	  and	  throat	  by	  asking	  you	  to	  breathe	  in	  rapidly	  
through	  a	  Peak	  Flow	  meter.	  This	  will	  usually	  take	  about	  3	  -­‐5	  minutes	  in	  total.	  If	  you	  get	  
upset	  at	  any	  time	  during	  the	  study,	  we	  will	  stop.	  An	  invitation	  will	  be	  sent	  after	  the	  surgery	  
for	  a	  follow-­‐up	  visit	  to	  the	  Common	  Cold	  Centre	  one	  month	  later,	  to	  repeat	  the	  same	  peak	  
flow	  measurement.	  
What	  is	  a	  peak	  flow	  meter?	  
It	  is	  a	  small,	  hand-­‐held	  device	  used	  to	  measure	  a	  person's	  ability	  to	  breathe	  air	  in	  or	  out	  
through	  the	  nose	  or	  mouth.	  This	  type	  of	  meter	  is	  commonly	  used	  to	  measure	  breathing	  
difficulty	  in	  persons	  suffering	  from	  asthma	  and	  the	  measurement	  is	  harmless.	  
What	  will	  I	  have	  to	  do	  during	  this	  peak	  flow	  measurement?	  
In	  order	  to	  measure	  nasal	  obstruction,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  possible	  
through	  the	  nose	  whilst	  using	  a	  facemask	  connected	  to	  the	  meter.	  In	  order	  to	  measure	  
throat	  obstruction,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  possible	  through	  the	  mouth	  
via	  a	  plastic	  tube	  connected	  to	  the	  meter.	  Each	  measurement	  will	  be	  repeated	  three	  times,	  




What	  are	  the	  possible	  side	  effects	  of	  the	  test?	  
The	  measurement	  of	  nasal	  and	  throat	  airflow	  is	  harmless	  and	  this	  type	  of	  measurement	  is	  
commonly	  made	  on	  patients	  with	  asthma,	  so	  no	  side	  effects	  are	  expected.	  
What	  are	  the	  possible	  disadvantages/	  inconvenience	  of	  taking	  part	  in	  the	  study?	  
On	  the	  day	  of	  surgery,	  the	  researcher	  will	  examine	  you,	  and	  after	  obtaining	  written	  consent,	  
will	  take	  measurements	  using	  the	  Peak	  flow	  meter.	  An	  invitation	  will	  be	  sent	  after	  the	  
surgery	  for	  a	  follow-­‐up	  visit	  to	  the	  Common	  Cold	  Centre	  one	  month	  later,	  to	  repeat	  the	  
same	  peak	  flow	  measurement.	  You	  will	  be	  paid	  £25	  travel	  expenses	  for	  the	  visit	  to	  the	  
Common	  Cold	  Centre.	  The	  Centre	  is	  situated	  on	  Museum	  Avenue	  in	  Cardiff	  City	  Centre.	  
What	  are	  the	  probable	  benefits	  of	  taking	  part	  in	  the	  study?	  
Your	  treatment	  will	  not	  be	  affected	  in	  any	  way	  but	  we	  may	  find	  out	  more	  information	  about	  
how	  your	  tonsils	  and	  adenoids	  may	  be	  obstructing	  your	  nose	  and	  throat	  and	  affecting	  your	  
breathing.	  The	  study	  will	  help	  us	  to	  identify	  whether	  doing	  surgery	  on	  Adenoids	  and	  Tonsils	  
will	  improve	  breathing	  through	  the	  nose	  and	  throat.	  This	  research	  may	  help	  the	  selection	  of	  
patients	  for	  the	  treatment	  of	  sleep-­‐related	  breathing	  disorders.	  
	  
During	  the	  course	  of	  the	  study	  you	  can	  contact	  the	  Principal	  Investigator.	  
Mr	  Srinivasalu	  Bathala	  
Research	  Fellow,	  








PART 2 of the Information Sheet 
What if new relevant information becomes available? 
Sometimes	  during	  the	  course	  of	  a	  research	  project,	  new	  information	  becomes	  available	  
about	  the	  study.	  If	  this	  happens,	  your	  research	  doctor	  will	  tell	  you	  in	  a	  timely	  manner	  about	  
it	  and	  discuss	  with	  you	  whether	  you	  want	  to	  continue	  in	  the	  study.	  If	  you	  decide	  to	  
withdraw,	  your	  research	  doctor	  will	  make	  arrangements	  for	  your	  care	  to	  continue.	  If	  you	  
decide	  to	  continue	  in	  the	  study,	  you	  will	  be	  asked	  to	  sign	  an	  updated	  consent	  form.	  Also,	  on	  
receiving	  new	  information,	  your	  research	  doctor	  might	  consider	  it	  to	  be	  in	  your	  best	  
interests	  to	  withdraw	  you	  from	  the	  study.	  He	  will	  explain	  the	  reasons	  and	  arrange	  for	  your	  
care	  to	  continue.	  
What	  will	  happen	  if	  I	  don't	  want	  to	  carry	  on	  with	  the	  study?	  
If	   you	   decide	   to	   withdraw	   from	   the	   study,	   this	   will	   not	   affect	   your	   treatment.	   All	   data	  
provided	  by	  you	  before	  withdrawal	  will	  still	  be	  recorded	  for	  use	  in	  the	  study	  	  
What	  happens	  if	  there	  is	  a	  problem?	  
Complaints:	   If	   you	  have	  concerns	  about	  any	  aspect	  of	   the	   study,	   you	   should	   speak	   to	   the	  
researcher,	   who	  will	   do	   his	   best	   to	   answer	   any	   questions.	   Any	   complaints	   that	   you	   have	  
about	  the	  study	  or	  the	  way	  it	  is	  conducted	  should	  be	  sent	  to:	  Professor	  Ron	  Eccles,	  Director,	  
Common	  Cold	  Centre	  and	  Healthcare	  Clinical	  Trials,	  Cardiff	  University,	  Cardiff	  CF10	  3AX,	  Tel:	  
02920	   874102,	   email:	   eccles@cardiff.ac.uk.	   OR	   to	   Corporate	   Compliance	   Unit	   (COCOM),	  
Cardiff	  University,	  email:	  cocom@cardiff.ac.uk,	  Tel:	  02920	  879639.	  




Will	  my	  taking	  part	  in	  this	  study	  be	  kept	  confidential? 
Yes,	   all	   the	   information	  will	   be	   anonymous.	   All	   those	   persons	   involved	   in	   looking	   at	   data	  
from	  the	  study	  will	  have	  a	  duty	  of	  confidentiality	  to	  you	  as	  a	  research	  participant	  and	  we	  will	  
do	  our	  best	  to	  meet	  this	  duty.	  
Involvement	  of	  the	  General	  Practitioner/Family	  doctor	  (GP)	  
Your	  GP	  will	  not	  be	  contacted.	  However,	  we	  may	  ask	  you	  to	  contact	  your	  GP	  if	  there	  are	  any	  
findings	  from	  the	  tests	  that	  require	  further	  medical	  investigation.	  
What	  will	  happen	  to	  the	  results	  of	  the	  research	  study?	  
We	  may	  publish	  the	  results	  in	  scientific	  journals,	  but	  you	  will	  not	  be	  identified	  in	  any	  report	  
or	   publication.	   However,	   no	   personal	   data	   will	   be	   sent	   outside	   the	   Centre.	   The	   protocol	  
summary	  may	   be	   posted	   on	   a	   publicly	   available	   protocol	   register	   and	   a	   summary	   of	   the	  
study	  results	  may	  be	  posted	  on	  a	  publicly	  available	  results	  register.	  
Who	  is	  organising	  and	  funding	  the	  research?	  
Cardiff	  University.	  
Who	  has	  reviewed	  the	  study?	  
This	  research	  has	  been	  reviewed	  and	  approved	  by:	  
South	  East	  Wales	  Local	  Research	  Ethics	  Committees	  
Business	  Services	  Centre,	  
Churchill	  House	  	  







During	  the	  course	  of	  the	  study	  you	  can	  contact	  the	  Principal	  Investigator. 
Mr	  Srinivasalu	  Bathala	  
Research	  Fellow	  






Mobile	  no-­‐	  07912503865.	  
	  
Patient	  Reply	  Slip.	  
I	  am	  willing	  /not	  willing	  to	  take	  part	  in	  the	  above	  mentioned	  study.	  
I	  can/	  cannot	  be	  contacted	  over	  the	  telephone.	  
My	  telephone	  number	  is………………………………	  
Signature……………………………………	  









Study	  Number:	   	  
Screening	  Number:	   	   	   	   	   	   	  
Patient	  Initials:	   	   	   	  
	  
Informed	  Consent	  Form	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep-­‐related	  breathing	  disorder	  
Name	  of	  Researcher:	  	  Mr	  Srinivasalu	  Bathala	  
Information	   Please	  Initial	  box	  
1. I	  confirm	  that	  I	  have	  read	  and	  understood	  the	  patient	  
information	  leaflet	  for	  the	  above	  study.	  I	  have	  had	  the	  
opportunity	  to	  consider	  the	  information,	  ask	  questions	  
and	  have	  these	  answered	  satisfactorily.	  
	  
2. I	  understand	  that	  my	  participation	  is	  voluntary	  and	  that	  
I	  am	  free	  to	  withdraw	  at	  any	  time	  without	  giving	  any	  
reason,	  without	  medical	  care	  or	  legal	  rights	  being	  
affected.	  
	  
3. I	  understand	  that	  the	  relevant	  section	  of	  my	  medical	  
notes	  and	  data	  collected	  during	  the	  study	  may	  be	  




where	  it	  is	  relevant	  to	  my	  taking	  part	  in	  this	  research.	  I	  
give	  permission	  for	  these	  individuals	  to	  have	  access	  to	  
my	  records	  and	  understand	  that	  such	  information	  will	  
be	  treated	  as	  confidential.	  
4. I	  have	  the	  right	  to	  ask	  to	  see	  the	  data	  about	  me	  that	  has	  
been	  collected	  and	  if	  anything	  is	  incorrect	  I	  can	  ask	  to	  
have	  it	  corrected	  
	  
5. I	  agree	  to	  the	  information	  being	  processed	  and	  stored	  
in	  coded	  form,	  so	  that	  my	  identity	  is	  kept	  confidential.	  
	  
6. I	  agree	  to	  take	  part	  in	  the	  above	  study	   	  
	  	  
Investigator	  delegate	  (Person	  taking	  Consent)	  I	  have	  explained	  and	  discussed	  with	  the	  
patient	  the	  nature	  and	  purpose	  and	  requirements	  of	  the	  study.	  I	  will	  ensure	  a	  copy	  of	  
this	  patient	  information	  leaflet	  is	  provided	  to	  the	  patient.	  
	  
PARTICIPANT	  (PARENT	  OR	  GUARDIAN	  IF	  UNDER	  18	  YEAYEARS	  OF	  AGE)	  
	  	  	  	  	  	  	  	  	  Signed…………………………………………………………………………………….	  







	  	  	  	  Signed…………………………………………………………………………………….	  
	  	  	  	  Name	  (BLOCK	  LETTERS)	  …………………………………………………………	  
	  	  	  	  Date	  (dd/mmm/yy)……………………………………………………………………..	  
	  	  	  	  	  I	  have	  explained	  the	  study	  to	  the	  above	  participant	  and	  he/she	  has	  indicated	  his/her	  	  	  	  	  














Information	  sheet	  for	  Children	  aged	  5-­‐	  10	  years	  	  	  	  	  	  
This	  information	  is	  to	  be	  shown/	  read	  by	  their	  parent	  or	  guardian	  
What	  is	  happening	  to	  me?	  
	  
You	  are	  in	  the	  hospital	  to	  have	  your	  tonsils	  removed.	  While	  you	  are	  here,	  we	  are	  asking	  if	  
you	  would	  take	  part	  in	  a	  test	  called	  a	  study.	  
We	  would	  like	  to	  tell	  you	  about	  this.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  
Your	  mom	  and	  dad	  talked	  to	  the	  doctors	  and	  said	  it	  was	  ok	  for	  you	  to	  take	  part	  in	  the	  study.	  	  
What	  will	  the	  doctor	  do?	  	  







In	  order	  to	  measure	  how	  blocked	  your	  nose	  is,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  
possible	  through	  the	  nose	  via	  a	  plastic	  tube	  connected	  to	  the	  meter	  as	  shown	  in	  the	  diagram	  
below.	  Each	  measurement	  will	  be	  repeated	  three	  times	  and	  it	  takes	  about	  three	  minutes	  for	  
this	  measurement	  to	  be	  taken.	  
	  
	  
In	  order	  to	  measure	  how	  blocked	  your	  throat	  is,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  
possible	  through	  the	  mouth	  via	  a	  plastic	  tube	  connected	  to	  the	  meter	  as	  shown	  in	  the	  
diagram	  below.	  Each	  measurement	  will	  be	  repeated	  three	  times	  and	  it	  takes	  about	  three	  





Do	  I	  have	  to	  do	  the	  study?	  
No,	  not	  at	  all.	  
	  
It	  is	  up	  to	  you.	  Just	  say	  if	  you	  don’t	  want	  to	  carry	  on.	  Nobody	  will	  mind	  and	  you	  will	  still	  be	  
looked	  after.	  If	  you	  do,	  you	  will	  need	  to	  write	  your	  name	  (if	  you	  can)	  on	  the	  form.	  
Will	  I	  have	  to	  come	  back	  to	  the	  hospital	  again?	  
No,	  although	  you	  will	  come	  to	  see	  the	  same	  doctor	  in	  one	  month’s	  time	  at	  Cardiff	  University	  






Assent	  form	  for	  Children	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep-­‐related	  breathing	  disorders.	  
(To	  be	  completed	  by	  the	  child	  and	  their	  parent/guardian)	  
Child	  (or	  if	  unable,	  parent	  on	  their	  behalf)/young	  person	  to	  circle	  all	  they	  agree	  with:	  
Has	  somebody	  explained	  this	  project	  to	  you?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Do	  you	  understand	  what	  this	  project	  is	  about?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Have	  you	  asked	  all	  the	  questions	  you	  want?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/	  No	  
Have	  you	  had	  your	  questions	  answered	  	  
in	  a	  way	  you	  want?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/	  No	  
Do	  you	  understand	  it’s	  OK	  to	  stop	  taking	  
part	  at	  any	  time?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Are	  you	  happy	  to	  take	  part?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
If	  any	  answers	  are	  No	  or	  you	  don’t	  want	  to	  take	  part,	  don’t	  sign	  your	  name.	  
If	  you	  do	  want	  to	  take	  part,	  you	  can	  write	  your	  name	  below.	  
Your	  name	  
Date	  
The	  doctor	  who	  explained	  this	  procedure	  to	  you	  needs	  to	  sign	  too:	  
Print	  Name	  










Consent	  for	  participation	  in	  study	  by	  parent/guardian.	  
	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep-­‐related	  breathing	  disorders.	  
	  
I	  have	  read	  and	  understood	  the	  nature	  of	  the	  above	  study	  as	  explained	  in	  the	  information	  
sent	  to	  me	  by	  Mr	  Bathala.	  I	  confirm	  that	  I	  have	  had	  the	  opportunity	  to	  ask	  questions.	  
I	  understand	  that	  as	  part	  of	  the	  study:	  (Please	  put	  your	  initials	  in	  the	  boxes	  if	  you	  agree	  to	  
sign	  at	  the	  bottom	  of	  the	  letter	  where	  indicated)	  
	  
Information	   Please	  Initial	  	  
Box	  
1. I	  confirm	  that	  I	  have	  read	  and	  understood	  the	  patient	  
information	  leaflet	  for	  the	  above	  study.	  I	  have	  had	  the	  
opportunity	  to	  consider	  the	  information,	  ask	  questions	  
and	  have	  these	  answered	  satisfactorily.	  
	  
2. I	  understand	  that	  my	  child’s	  participation	  is	  voluntary	  and	  
that	  we	  are	  free	  to	  withdraw	  at	  any	  time	  without	  giving	  
any	  reason,	  without	  medical	  care	  or	  legal	  rights	  being	  
affected.	  
	  
3. I	  understand	  that	  the	  relevant	  section	  of	  my	  child’s	  




looked	  at	  by	  individuals	  from	  this	  NHS	  Health	  Board,	  
where	  it	  is	  relevant	  to	  my	  child’s	  taking	  part	  in	  this	  
research.	  I	  give	  permission	  for	  these	  individuals	  to	  have	  
access	  to	  my	  child’s	  records	  and	  understand	  that	  such	  
information	  will	  be	  treated	  as	  confidential.	  
4. I	  have	  the	  right	  to	  ask	  to	  see	  the	  data	  about	  my	  child	  that	  
has	  been	  collected	  and	  if	  anything	  is	  incorrect	  I	  can	  ask	  to	  
have	  it	  corrected	  
	  
5. I	  agree	  to	  the	  information	  being	  processed	  and	  stored	  in	  
coded	  form,	  so	  that	  my	  child’s	  identity	  is	  kept	  
confidential.	  
	  
6. I	  agree	  for	  my	  child	  to	  take	  part	  in	  the	  above	  study	   	  
	  
Investigator	  delegate	  (Person	  taking	  consent)	  I	  have	  explained	  and	  discussed	  with	  the	  
patient	  the	  nature	  and	  purpose	  and	  requirements	  of	  the	  study.	  I	  will	  ensure	  that	  a	  copy	  of	  
this	  patient	  information	  leaflet	  is	  provided	  to	  the	  patient.	  
	  	  	  	  	  	  	  	  	  	  	  (PARENT	  OR	  GUARDIAN)	  
Signed…………………………………………………………………………………….	  
Name	  (BLOCK	  LETTERS)	  …………………………………………………………	  






Name	  (BLOCK	  LETTERS)	  …………………………………………………………	  
Date	  (dd/mmm/yy)……………………………………………………………………..	  
I	  have	  explained	  the	  study	  to	  the	  above	  parent	  and	  he/she	  has	  indicated	  their	  child’s	  






















Information	  sheet	  for	  children	  (11-­‐16	  years)	  
This	  information	  is	  to	  be	  shown/	  read	  by	  their	  parent	  or	  guardian	  
Aim:	  To	  assess	  your	  breathing	  after	  surgery	  on	  Tonsils	  +/-­‐	  Adenoids.	  
	  
Why	  have	  I	  been	  chosen?	  
With	  your	  help,	  we	  can	  find	  out	  whether	  removing	  the	  tonsils	  and	  adenoids	  has	  any	  effect	  
on	  obstruction	  in	  the	  nose	  and	  throat.	  This	  will	  help	  doctors	  to	  select	  patients.	  
	  
What	  will	  happen	  next?	  
On	  the	  day	  of	  surgery,	  the	  doctor	  will	  examine	  you	  and	  ask	  you	  to	  breathe	  in	  through	  a	  
Peak	  Flow	  meter.	  The	  pictures	  on	  the	  next	  page	  show	  how	  this	  might	  be	  done.	  
	  
Will	  I	  have	  to	  come	  back	  again	  to	  the	  hospital?	  
No,	  although	  you	  will	  have	  to	  come	  back	  one	  month	  later	  to	  Cardiff	  University	  to	  see	  the	  
same	  doctor,	  who	  will	  ask	  you	  to	  again	  breathe	  in	  through	  a	  Peak	  Flow	  meter.	  
	  	  
In	  order	  to	  measure	  how	  blocked	  your	  nose	  is,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  
possible	  through	  the	  nose	  via	  a	  plastic	  tube	  connected	  to	  the	  meter	  as	  shown	  in	  the	  diagram	  
below.	  Each	  measurement	  will	  be	  repeated	  three	  times	  and	  it	  takes	  about	  3	  minutes	  for	  this	  








In	  order	  to	  measure	  how	  blocked	  your	  throat	  is,	  you	  will	  be	  asked	  to	  breathe	  in	  as	  rapidly	  as	  
possible	  through	  the	  mouth	  via	  a	  plastic	  tube	  connected	  to	  the	  meter	  as	  shown	  in	  the	  
diagram	  above.	  Each	  measurement	  will	  be	  repeated	  three	  times	  and	  it	  takes	  about	  3	  










Assent	  form	  for	  Children	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep-­‐related	  breathing	  disorders.	  
(To	  be	  completed	  by	  the	  child	  and	  their	  parent/guardian)	  
Child	  (or	  if	  unable,	  parent	  on	  their	  behalf)/young	  person	  to	  circle	  all	  they	  agree	  with:	  
Has	  somebody	  explained	  this	  project	  to	  you?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Do	  you	  understand	  what	  this	  project	  is	  about?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Have	  you	  asked	  all	  the	  questions	  you	  want?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/	  No	  
Have	  you	  had	  your	  questions	  answered	  	  
in	  a	  way	  you	  want?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/	  No	  
Do	  you	  understand	  it’s	  OK	  to	  stop	  taking	  
part	  at	  any	  time?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
Are	  you	  happy	  to	  take	  part?	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Yes/No	  
If	  any	  answers	  are	  No	  or	  you	  don’t	  want	  to	  take	  part,	  don’t	  sign	  your	  name.	  
If	  you	  do	  want	  to	  take	  part,	  you	  can	  write	  your	  name	  below.	  
Your	  name	  
Date	  
The	  doctor	  who	  explained	  this	  procedure	  to	  you	  needs	  to	  sign	  too:	  
Print	  Name	  










Consent	  for	  participation	  in	  study	  by	  parent/guardian.	  
	  
Study	  Title:	  A	  pilot	  study	  on	  the	  assessment	  of	  upper	  airway	  obstruction	  in	  patients	  
undergoing	  Tonsillectomy	  +/-­‐	  Adenoidectomy	  for	  sleep-­‐related	  breathing	  disorders.	  
	  
I	  have	  read	  and	  understood	  the	  nature	  of	  the	  above	  study	  as	  explained	  in	  the	  information	  
sent	  to	  me	  by	  Mr	  Bathala.	  I	  confirm	  that	  I	  have	  had	  the	  opportunity	  to	  ask	  questions.	  
I	  understand	  that	  as	  part	  of	  the	  study:	  (Please	  put	  your	  initials	  in	  the	  boxes	  if	  you	  agree	  to	  
sign	  at	  the	  bottom	  of	  the	  letter	  where	  indicated)	  
	  
Information	   Please	  Initial	  	  
Box	  
1. I	  confirm	  that	  I	  have	  read	  and	  understood	  the	  patient	  
information	  leaflet	  for	  the	  above	  study.	  I	  have	  had	  the	  
opportunity	  to	  consider	  the	  information,	  ask	  questions	  
and	  have	  these	  answered	  satisfactorily.	  
	  
2. I	  understand	  that	  my	  child’s	  participation	  is	  voluntary	  and	  
that	  we	  are	  free	  to	  withdraw	  at	  any	  time	  without	  giving	  
any	  reason,	  without	  medical	  care	  or	  legal	  rights	  being	  
affected.	  
	  
3. I	  understand	  that	  the	  relevant	  section	  of	  my	  child’s	  




looked	  at	  by	  individuals	  from	  this	  NHS	  Health	  Board,	  
where	  it	  is	  relevant	  to	  my	  child’s	  taking	  part	  in	  this	  
research.	  I	  give	  permission	  for	  these	  individuals	  to	  have	  
access	  to	  my	  child’s	  records	  and	  understand	  that	  such	  
information	  will	  be	  treated	  as	  confidential.	  
4. I	  have	  the	  right	  to	  ask	  to	  see	  the	  data	  about	  my	  child	  that	  
has	  been	  collected	  and	  if	  anything	  is	  incorrect	  I	  can	  ask	  to	  
have	  it	  corrected	  
	  
5. I	  agree	  to	  the	  information	  being	  processed	  and	  stored	  in	  
coded	  form,	  so	  that	  my	  child’s	  identity	  is	  kept	  
confidential.	  
	  
6. I	  agree	  for	  my	  child	  to	  take	  part	  in	  the	  above	  study	   	  
	  
Investigator	  delegate	  (Person	  taking	  consent)	  I	  have	  explained	  and	  discussed	  with	  the	  
patient	  the	  nature	  and	  purpose	  and	  requirements	  of	  the	  study.	  I	  will	  ensure	  that	  a	  copy	  of	  
this	  patient	  information	  leaflet	  is	  provided	  to	  the	  patient.	  
	  	  	  	  	  	  	  	  	  	  	  (PARENT	  OR	  GUARDIAN)	  
Signed…………………………………………………………………………………….	  
Name	  (BLOCK	  LETTERS)	  …………………………………………………………	  






Name	  (BLOCK	  LETTERS)	  …………………………………………………………	  
Date	  (dd/mmm/yy)……………………………………………………………………..	  
I	  have	  explained	  the	  study	  to	  the	  above	  parent	  and	  he/she	  has	  indicated	  their	  child’s	  






























	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Appendix	  5	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Demographics	  data	  
	  
	  














35	   F	   7	   YES	   NO	   NO	   NO	   NO	   NO	   3	  36	   F	   6	   YES	   NO	   NO	   NO	   NO	   NO	   3	  37	   F	   5	   YES	   YES	   YES	   YES	   NO	   ASTHMA	   3	  38	   M	   5	   YES	   YES	   YES	   YES	   NO	   NO	   3	  39	   F	   13	   YES	   YES	   YES	   NO	   NO	   NO	   2	  40	   F	   12	   YES	   YES	   YES	   NO	   NO	   NO	   2	  41	   F	   22	   YES	   YES	   NO	   NO	   NO	   NO	   3	  42	   F	   5	   YES	   YES	   YES	   YES	   NO	   NO	   3	  43	   M	   10	   YES	   YES	   NO	   NO	   NO	   NO	   3	  44	   M	   7	   YES	   YES	   YES	   YES	   NO	   NO	   3	  45	   M	   8	   YES	   YES	   YES	   YES	   NO	   NO	   3	  46	   F	   9	   YES	   YES	   YES	   YES	   NO	   NO	   3	  47	   F	   24	   YES	   YES	   NO	   NO	   NO	   NO	   2	  48	   F	   19	   YES	   NO	   NO	   NO	   NO	   NO	   3	  49	   F	   5	   YES	   YES	   NO	   NO	   NO	   NO	   3	  50	   M	   14	   YES	   YES	   YES	   YES	   NO	   NO	   3	  
	  
